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"We can't solve problems 
 by using the same kind of thinking we 
 used when we created them." 
Albert Einstein 
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Zusammenfassung 
 
Inorganische Phosphathomöostase und Regulierung ist prinzipiell ein Phänomen, 
das in der Niere kontrolliert wird. Der Natrium-Phosphatkotransporter NaPi-2a, in der 
apikalen Zellmembran des proximalen Tubulus, wirkt dabei entscheidend mit. 
Phosphatdefizite stimulieren die Expression des Na/Pi-Kotransporters in der Niere 
hauptsächlich auf Ebene des Proteins. Dies ist notwendig um normale 
Phosphatwerte im Plasma wiederherzustellen.  
Mit Hilfe von RNA Genexpressionsstudien (Mikroarray Analyse) wurden neue 
Einblicke in das die Expressionsverhalten von Genen in der Niere untersucht. Hierzu 
wurden die Effekte einer fünftägigen und später vierzehnstündigen Spezialdiät mit 
reduziertem Phosphatgehalt (LPD, 0.1%) relativ zu einer Phosphatüberdosis (HPD, 
1.2%) an Wildtypmäusen (C57BL/6) untersucht. Dazu wurden die Nieren entfernt, 
RNA isoliert und auf Genchips hybridisiert. Anschliessend wurden die Daten 
ausgewertet und die Genveränderungen zusätzlich mit quantitativer Real Time PCR 
(RT-qPCR) untersucht. Bisherige Analysen ergaben, dass die Expression vieler 
Gene, die im Bereich des Energiehaushaltes, wie z. B. Glukosehaushalt und der 
oxydativen Phosphorylierung, eine Rolle spielen, nach fünf Tagen jedoch nicht nach 
vierzehn Stunden stark gehemmt wurden.  
In der Niere wird die Expression der 1α,25-(OH)2-Vitamin D3 Hydroxylase (1α-
Hydroxylase) durch den Phosphathaushalt im Organismus reguliert. Schon nach 
wenigen Tagen ist ein Unterschied in 1α-hydroxylase mRNA Mengen zwischen LPD 
und HPD Mäusen nachweisbar. In dieser Studie war die Menge der 1α-Hydroxylase 
mRNA nach fünf Tagen LPD im Vergleich zu HPD zehn Mal höher. 
Des weiteren wurde in dieser Studie ein neuer SLC Transporter, SLC16A14/MCT14, 
entdeckt, der durch LPD nach fünf Tagen reguliert wurde. Diese Beobachtung war 
bis zu diesem Zeitpunkt mit Phosphat nicht in Verbindung gebracht worden.  
Da die Wahrscheinlichkeit grösser ist auf Gene zu stossen, die direkt durch frühe 
Phosphatdefizite beeinflusst werden, wurden verschiedene Zeitpunkte nach einer 
Phosphatdiät gewählt (4, 8, und 14 Stunden) und Mäusenieren auf RNA-Ebene 
untersucht. Die mRNA der 1α-Hydroxylase und SLC16A14/MCT14 wurde mit Hilfe 
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von RT-qPCR quantifiziert. Die Resultate ergaben, dass sich die 1α-Hydroxylase 
mRNA nach keinem der drei Zeitpunkte signifikant änderte. Für SLC16A14/MCT14 
hingegen, wurde nach vierzehn Stunden eine vierfache Hemmung gemessen. Aus 
diesem Grund wurde eine neue Mikroarrayanalyse nach vierzehn Stunden 
Phosphatdefizit durchgeführt. Diesmal konnten keine Gene gefunden werden, die 
Teil der Atmungskette sind, auch solche nicht, die starken Einfluss auf den 
Energiehaushalt haben. Jedoch wurden drei Gene (PEPCK, SNAT3, Glud1) der 
Gluconeogenese/Ammoniakgenese identifiziert, die in der Regulierung des Säure-
Basen Metabolismus eine wichtige Rolle spielen. Zudem hatte eine vierzehnstündige 
Phosphatreduzierung eine hemmende Wirkung auf die Gene HMGCS, HMGCR, und 
Cyp51, die mit der Synthese des Cholesterins in Verbindung gebracht werden. Es ist 
bekannt, dass der Anteil von Cholesterin in der Zellmembran die Fluidität dieser 
beeinflusst. Auch gibt es Untersuchungen die beweisen, dass die Funktion von NaPi-
2a sowohl direkt als auch indirekt durch Cholesterin beeinflusst wird. Des weiteren 
wurden Gene gefunden, die beim Zelltod und der Zellalterung (z.B. p53bp2, p21) 
eine wichtige Rolle spielen, wie auch Gene (z.B. EEA1) die für den frühen 
endosomalen Τransport verantwortlich sind. Auch wurden Gene reguliert, die 
allerdings schon in anderen Organen identifiziert wurden, aber noch weitgehend 
unerforscht sind im Zusammenhang mit Phosphathomöostase oder des NaPi-
Kotransporters. Einige dieser Gene sind: Cholecystokinin A Rezeptor (CCKAR), 
Osteomodulin, FK506 binding protein (FK506BP), and Acyl-CoA thioesterase 1 
(Acot1).  
 
Der zweite Teil dieser Dissertation befasst sich mit der Charakterisierung des 
Monocarboxylattransporters SLC16A14/MCT14, der im Gefolge beider 
Mikroarrayanalysen auffällig war. Dieser Transporter wurde bei Wildtypmäusen 
mehrmals auf der Ebene des Proteins und der mRNA untersucht. Erste Resultate 
ergaben dass durch Phosphatentzug die relative Menge des SLC16A14/MCT14 
Proteins und der mRNA in der Niere verändert werden kann. Erste Bestimmungen 
ergaben, dass SLC16A14/MCT14 im Tubulus rectus distalis des Nephrons lokalisiert 
ist und durch Phosphatdiäten nach vierzehn Stunden und fünf Tagen im proximalen 
Tubulus reguliert wird. SLC16A14/MCT14 wurde durch eine cRNA Injektion in 
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Froscheier (Xenopus laevis Oozyten) exprimiert um anschliessend erste 
Transportstudien durchzuführen. Bisherige Resultate deuten darauf hin, dass 
SLC16A14/MCT14 Aminosäuren wie L-Alanin, L-Methionin und L-Glutamat 
transportiert. Weitere Transportstudien wären sinnvoll um die Kinetik des 
SLC16A14/MCT14 zu entschlüsseln, um dadurch auch den Zusammenhang mit der 
Phosphathomöostase zu verstehen. 
Phosphatdiäten verursachen, wie in dieser Studie untersucht wurde, verschiedene 
Anpassungsmechanismen in der Niere. Mehrere metabolische Bahnen (Pathways) 
wurden dabei genauer untersucht, in denen Gene vorkamen, die für die 
Phosphathomöostase bisher noch keine bekannte Rolle spielten, und womöglich 
durch diese Studie neues Interesse geweckt haben. Da nach fünf Tagen 
Phosphatmangels eine grosse Anzahl 
 von Genen in der Atmungskette ein möglicher Hinweis auf Störungen des 
Energiehaushaltes hinweist, ist es auch weiter wahrscheinlich Gene vorzufinden die 
nicht von Phosphat direkt beeinflusst wurden.  Die meisten Gene die nach einer 
fünftägigen Phosphatmangelphase beeinflusst wurden, nicht aber nach 14 Stunden, 
deuten auf eine kurzzeitige Regulierung einiger metabolischer Bahnen (z. B. 
Cholesterinsynthese, Säure/Basenhausalt). Allerdings wurden einige Gene, die nach 
beiden Zeitperioden bestimmt wurden, in der vorliegenden Untersuchung auch in 
gemeinsame metabolische Bahnen eingeteilt werden können. Ob diese Bahnen 
einen Zusammenhang mit NaPi-2a haben ist noch ausstehend.  
Die Konsequenzen einer Phosphatmangelernährung im Organismus wirken sich auf 
die Expression von bestimmten Genen der Niere aus und sind offenbar zeitbedingt. 
Die Anzahl und Spezifität der Gene während einer akuten Phophatmangelphase 
unterscheidet sich dabei wesentlich von einer chronischen Phase. Einen Hinweis für 
eine Veränderung auf Genexpressionsebene durch Phosphat könnte SLC16a14 
sein, da schon frühzeitig und über länger Zeit, eine reduzierte mRNA nachgewiesen 
wurde die zusätzlich auf Ebene des Proteins bestimmt werden konnte.     
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Summary 
 
Phosphate (Pi) homeostasis and regulation is mainly realized in the kidney by the 
proximal tubules. The abundance of sodium Pi cotransporters, in particular NaPi-2a, 
determines the reabsorption rate of Pi. Therefore, low Pi-diet intake can directly affect 
the NaPi-2a abundance in the apical membrane of the renal proximal tubule by 
increasing the presence of the Na/Pi-cotransporter in order to restore normal Pi 
serum values. 
In this study, a change in renal gene expression was investigated upon administering 
low (LPD) and high Pi-diets (HPD) to mice (C57BL/6). After 5 days (“chronic”) Pi-
diets, isolated renal RNA was hybridized to mouse whole genome chips, and data 
was evaluated and analyzed. Results showed, as expected, an increase in 1α,25-
(OH)2-Vitamin D3 hydroxylase (1α-hydroxylase) mRNA levels (10-fold). This 
compensation is well known to occur after a long term Pi deprivation. Also, an 
unknown SLC transporter (SLC16A14/MCT14) was found to be down-regulated 4-
fold. However, a large number of regulated genes were found to be part of the 
energy metabolism (respiratory chain, glycolysis) indicating a possible impact on fuel 
mechanisms that are inhibited by LPD. Eventually, this effect may not be caused 
directly by LPD but rather by epiphenomenons that influence the energy state of the 
organism and therefore might lead to false interpretations related to 
hypophosphatemia. In order to investigate genes that directly act upon dietary Pi 
restriction, it was suggested to repeat microarray analysis at an earlier time point. 
Thus, different time points were initially investigated by RT-qPCR for 1α-hydroxylase 
and SLC16A14/MCT14. Interestingly, no change in RNA levels was detected after 4 
and 8 hours for either gene. Also, no change of 1α-hydroxylase was observed 14 
hours after administering the LPD, but SLC16A14/MCT14 was down-regulated 
strongly (4 fold) as observed previously after a “chronic” LPD. Therefore an “acute” 
time point for the administration of a LPD (in relation to HPD) was set to 14 hours 
based on SLC16A14/MCT14 regulation and independent of the Vitamin D response. 
Results obtained by microarray analysis revealed a number of genes grouped in 
cholesterol biosynthesis and lipid metabolism. Since cholesterol content in the cell 
10 Summary 
 
Effects of changes in dietary phosphate on renal gene expression  
 
membrane regulates the fluidity of the membrane and is known to directly and 
indirectly affect the activity of NaPi-2a, it was not further surprising to find various 
genes involved in this pathway. Other genes were coding for Heat Shock Proteins 
(HSP), known as intracellular stress responders. These were further found to be 
involved in regulating p53bp2 and p21 activity that are known to act during apoptosis 
and senescence. Moreover, a few genes (e.g. EEA1) were grouped in early 
endosomal trafficking. When microarray data was compared, a number of genes 
were also found to be significantly regulated during both periods (14 hours and 5 
days). However, these genes had not been previously related to dietary Pi changes, 
nor had they been linked to the regulation of NaPi-2a abundance at the renal brush 
border membrane (BBM). Among these genes are Cholecystokinin A Receptor 
(CCKAR), Osteomodulin, FK506 binding protein (FKBP51), and Acyl-CoA 
thioesterase 1 (Acot1). Unfortunately many of these have not been characterized 
thoroughly (e.g. Osteomodulin) nor have they been related previously to renal Pi 
reabsorption or Pi homeostasis. Many genes regulated after a long term (5 days) Pi 
deprivation were not found to be regulated after 14 hours of LPD intake, indicating 
two different mechanisms involved during LPD adaptation. 
 
The second half of this thesis focuses on the characterization of the 
SLC16A14/MCT14 transporter, a member of the monocarboxylate family. It was 
shown to be a stable dietary Pi responder after a LPD, relative to HPD, 
administration. A time period of 14 hours and 5 days of LPD, caused a decrease in 
abundance of the SLC16A14/MCT14 transporter in the kidney on RNA and protein 
level. A first approach using in-situ hybridization studies were not concluding. 
However, having raised and purified an antibody for SLC16A14/MCT14, and using 
immunohistochemical approaches on wild type mice (C57BL/6), SLC16A14/MCT14 
protein was localized apically in the thick ascending limb (TAL) and the area close to 
the macula densa. Interestingly, wild type mice that were submitted to a LPD 
presented, as shortly as 14 hours and thereafter, almost no transporter in the kidney. 
In contrast, those mice that received a HPD presented the transporter in the proximal 
tubule and some in the TAL. This was consistent in mice that received a chronic LPD 
and HPD for 5 days.  
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A myc-tagged SLC16a14 transporter was expressed in Xenopus laevis oocytes and 
successfully localized at the plasma membrane. Preliminary transport studies using 
radioactively labeled substrates indicate that SLC16A14/MCT14 carries amino acids 
(L-Alanine, L-Methionine and L-Glutamate).  
Regulatory mechanisms that act in response to dietary Pi are distinct after 14 hours 
and 5 days. New pathways were studied that included many genes which had not 
been previously involved in the regulation of renal Pi. Pi homeostasis may harvest 
more regulatory mechanisms than known to date. This study provides insights into 
these mechanisms and implicates genes that may play a more important role in the 
near future than previously assumed. Eventually, this may be important to 
understand physiological responses in the context of the Na/Pi-cotransport 
mechanism. It would also be of interest to understand the role of SLC16A14/MCT14 
during “acute” and “chronic” adaptation to changes in dietary Pi. Therefore, it would 
be necessary to understand SLC16A14/MCT14 kinetics. More studies are required to 
elucidate the mechanisms of adaptation in response to dietary Pi.   
The effects of Pi deficiency on renal gene expression differ between an “acute” and a 
“chronic” phase. This may indicate a change in renal behavior according to time 
dependent Pi deficiency in the organism. SLC16a14 was shown in this study to 
respond after a short- and a long-term Pi deficiency and may therefore be considered 
as a robust indicator of Pi homeostasis.  
 
 
 
 
 
 
12 Introduction 
 
Effects of changes in dietary phosphate on renal gene expression  
 
Introduction 
 
For all organisms, ranging from uni- to pluricellular, phosphorus is a requisite for life.  
It plays a major role in plasma membrane formation, cell energy metabolism, 
enzymatic reactions and cell signaling [1]. When the evolutionary step was made 
towards multicellular complex organisms, phosphorus took over additional functions, 
such as maintaining acid-base homeostasis and the formation of bone tissue. In 
mammals, the kidney is a key regulatory organ to maintain constant levels of 
phosphate in the blood serum.  
 
 
The Kidney 
 
The kidney, a paired, bean-shaped organ serves three major functions in the living 
organism: First, it clears the body from toxic metabolic waste products. Second, it 
plays a central role in regulating fluid status, electrolyte balance and acid-base 
homeostasis in the blood. Third, it is an endocrine system, involved in releasing 
hormones to control calcium metabolism (Vitamin D3), blood flow, blood pressure 
(renin) and erythropoiesis (erythropoyetin).  
Human kidneys, localized behind the peritoneum on each side of the vertebral 
column, have a weight of approximately 150 g each (Figure 1). A thin, fibrous, non-
distensible capsule of connective tissue covers the kidney. In the middle of its 
concave shape is an opening called hilus. At this point, the renal artery enters and 
the renal vein and ureter exit. This opening is also shared by the lymphatic vessels 
and nerves that also pass through. A cross section of the organ reveals a cortex with 
a granular aspect due to the presence of glomeruli and highly convoluted epithelial 
structures called tubules. More central, the medulla presents no glomeruli, but rather 
parallel tubular structures and small blood vessels. 
The Renal Blood Flow (RPF) is the amount of blood delivered to the kidney per unit 
time (in a 70 kg human 1 L/min or 20% of the cardiac output). A high blood flow is 
necessary for kidney function in order to receive a good supply of oxygen and 
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nutrients, but especially to form the ultra-filtrate by the glomeruli. Each substance 
cleared in the kidney has a certain filtration characteristic. Clearance provides 
information on how well a solute is cleared from the plasma, but this alone cannot 
provide information on precise sites and mechanisms of the handling of a given 
solute. Thus, the integration of glomerular filtration, tubular reabsorption, and tubular 
secretion determines the clearance of a solute. Finally, nutrients and other 
compounds are reabsorbed into blood. Fine tuning of secretion and reabsorption 
determines how much of a given metabolite is finally excreted.  
 
                    
Figure 1. The kidney is localized in the retro-peritoneum. It is subdivided into a cortex and medullary region. 
These sections have specific functions such as filtration and reabsorption, respectively. The medulla uses an 
interstitial hyperosmotic condition to form concentrated urine by reabsorbing water. Image taken from 
www.mdconsult.com. 
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The Nephron is the functional unit of the kidney 
 
In each human kidney an epithelial unit structure, the nephron, is present about 1 
million times. Each nephron is independent until the point where it merges into the 
collecting tubule (Figure 2). 
From a morphological point of view the nephron serves certain functions, depending 
whether the urinary filtrate passes through juxtamedullary nephrons, situated in the 
cortex close to the outer medulla, or in cortical nephrons, located in the outer cortex. 
Juxtamedullary nephrons possess relatively long loops that extend far into the 
medulla, whereas cortical nephrons have rather short loops. The nephron can be 
subdivided into various sections (Figure 2); the glomerulus (Glo), the proximal tubule 
(PT), the loop of Henle (LoH), the thick ascending limb (TAL), the distal tubule and 
finally the collecting duct (CD), where connecting tubules of various nephrons merge 
together. It is the integration of all subunits of the nephron that finally determines how 
a solute is excreted in the urine. The epithelial cells of the tubules are held together 
by tight junctions, creating a limited trans-epithelial passage. This epithelia becomes 
tighter the further the tubule extends towards the end of the nephron. 
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Figure 2. The functional unit of the kidney is the nephron. There are two types of nephrons both localized in the 
cortex: juxtamedullary nephrons, situated in the cortex at the border of the outer medulla, and superficial 
nephrons in the cortex, presenting the majority of the nephrons in the kidney. Superficial nephrons can also be 
identified by their relative short thin loop of Henle and their pronounced length of thick ascending limb when 
compared to the juxtamedullary nephrons.  
 
 
The Glomerulus and the juxtaglomerular apparatus 
 
The nephron contains two important functional sites, the glomerulus (Figure 3 A), 
where blood plasma is filtered, and the tubule, which is lined by epithelia that 
reabsorb and secrete solutes. As mentioned before, a high renal blood flow allows 
the nephron to create an ultra-filtrate at the level of the glomerulus. At this point, the 
capillary tufts that originate from the renal artery, pass into Bowman‟s capsule. Here, 
a filtration barrier consisting of capillary endothelium, glomerular basement 
membrane, and podocyte foot processes allow the blood plasma to pass from the 
vascular into the tubular system. This barrier is covered with negatively charged 
proteoglycans and glycoproteins that help to restrict filtration of negatively charged 
ions and proteins. As blood plasma undergoes the process of ultra-filtration, the 
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concentration of the primary filtrate of solutes (e.g. amino acids, sugars, and 
electrolytes) reflects the concentration in the plasma.  
Two parameters can affect the process of ultra-filtration, the blood pressure and the 
filtration barrier. When the blood pressure drops, the process of filtration will reduce 
itself, unless compensatory mechanisms (e.g. vasoconstriction) occur via the 
baroreceptors located in the afferent arteriole.  The filtration barrier, when damaged, 
can affect renal handling of metabolites (Figure 3 B). 
The juxtaglomerular apparatus (JGA) attaches close to the glomerulus at the height 
of the TAL. The JGA is formed by the macula densa and the granular cells. The 
macula densa is a region of specialized epithelial cells of the thick ascending limb 
(Figure 3 A). Here, the afferent arterioles have specialized smooth muscle cells 
called granular cells or juxtaglomerular cells. By storing and releasing renin, they 
control, via a complex feedback mechanism, not only the renal blood flow and 
filtration rate, but also indirectly sodium balance and systemic blood pressure.  
 
                              
Figure 3. (A) Detailed scheme of the glomerulus. It filters the plasma from the afferent arteriole and releases its 
primary filtrate into Bowman‟s space. A tight regulation of water balance and blood flow is controlled at the level of 
the macula densa. Here, renin is released by the granular cells of the smooth muscle. (B) The filtration barrier is a 
structure, where vascular and epithelial components combine to form the site of ultra-filtration provided by a high 
blood flow. It is a tight filtration membrane composed of capillary endothelium, glomerular basement membrane, 
and podocyte foot processes. 
 
 
The Proximal Tubule  
 
The proximal tubule (PT) can be subdivided into two segments, the proximal 
convoluted tubule (PCT) and the proximal straight tubule (PST) (Figure 4 A & B). 
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These can also be classified in S1, S2, and S3 segments. The PCT is the S1 
segment together with the first half of the S2 section. The PST contains the second 
half of the S2 section ending in the S3 segment. The PT is the first epithelial structure 
of the nephron that participates in processing of primary urine. Apart from water, 
large amounts of solutes (e.g. glucose, Pi, amino acids, and bicarbonate) are 
reabsorbed along the PT. The apical site of the proximal tubular cell is characterized 
by numerous microvilli endowed with various transporters. This enlargement of the 
apical surface correlates with the main function of the nephron segment, namely to 
reabsorb the bulk of filtered fluid and solutes. At this stage, two thirds of the entire 
filtered fluid is reabsorbed. Cell complexity progressively declines from S1 to S3 
segments, correlating with a gradual decrease of reabsorptive rates along the tubule. 
On the basolateral side, there are numerous interdigitations that come in close 
contact with the blood vessels. Various mitochondria are in close contact with the 
basolateral membrane.  The number of mitochondria decreases as cell complexity 
diminishes from S1 to S3 segment. The lateral membranes of the PT are 
characterized by various interdigitations.  
 
 
The Loop of Henle 
 
This structure continues from the last part of the PT further into the medulla of the 
kidney (Figure 4 C, D & E). The thin descending- and ascending-limbs have a less 
complex cellular structure than the PT. They contain fewer mitochondria and little cell 
membrane amplification. They are poorly developed in the superficial nephrons, but 
they play a more important role in the long loops of juxtamedullary nephrons. The 
epithelial cells, extending into the thick ascending limb (TAL) up to the macula densa, 
are characterized by various invaginations containing a large number of mitochondria 
at their basolateral cell membrane. These physiological adapted cells are responsible 
for creating a hyperosmotic environment in the renal medullary interstitium. 
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The Distal Tubule and the Collecting Duct 
 
Based on ultra-structural studies, the “classical distal tubule“, starting at the macula 
densa, can be distinguished in a distal convoluted tubule (DCT), the connecting 
tubule (CNT) and the initial collecting tubule (ICT) (Figure 4 F, G, & H). 
The DCT has very similar cell structure as the TAL and ends at the transition point to 
the CNT. The CNT consists of two types of cells which exert specific functions; the 
connecting tubule cells and the intercalated cells. The two segments that follow are 
the initial collecting tubule (ICT) and the cortical collecting tubule (CCT) (Figure 4 I), 
before and after the confluence of two nephrons, respectively. They contain two cell 
populations; the intercalated and the principal cells. The intercalated cells contribute 
to acid-base transport (H+/HCO3
-) and potassium (K+) reabsorption. The principal 
cells, making up two thirds of the cell population in the cortical collecting tubule, 
secrete K+, and reabsorb Na+ and water. 
Towards the end of the collecting duct, cells become progressively taller and the 
number of intercalated cells diminishes. In this segment, the cells continue the 
transport of electrolytes and the hormonally regulated mechanism of water and urea 
transport. Towards the end of the duct, by the inner medullary collecting duct, the 
cells join the papillary ducts and become extremely tall (Figure 4 J & K). 
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Figure 4. The nephron is a combined structure of different functional cells. The proximal tubule (PT) has a 
complex brush border membrane (BBM) that starts at the (A) proximal convoluted tubule (PCT) and merges into 
(B) the proximal straight tubule (PST). (C) The thin descending loop starts at the end of the PST and reaches into 
the medulla, turning back to the cortex as part of (D) the thin ascending loop. The cells of (E) the thick ascending 
limb (TAL) are complex again and specialized at a region called the macula densa, responsible for a negative 
feedback to control water and salt metabolism. The distal nephron is differentiated into (F) the distal convoluted 
tubule (DCT) and (G) the connecting tubule (CNT). The CNT is composed of two types of cells; the principal and 
the intercalated cells that can also be found in the (H) initial collecting tubule (ICT) and the (I) cortical collecting 
tubule (CCT). (J) The outer medullary collecting duct (OMCD) and (K) the inner medullary collecting duct (IMCD) 
form the final structures of the nephron, with less complex and more rudimentary cells compared to previous 
nephron segments. 
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Phosphate Homeostasis 
 
Many important biological functions are dependent on phosphate (Pi) (H2PO4
-, 
HPO4
2-). Pi has been shown to play important roles in energy metabolism [2-3], 
nucleic acid synthesis [4], cellular signaling [5], muscle function [6-7], cellular 
membrane integrity [8], enzyme functions [9], bone mineralization [10] and lipid 
metabolism [11]. 
Pi can be measured virtually in every body fluid. In human serum, phosphorus is 
present as inorganic phosphorus or phosphate, lipid phosphorus, or phosphoric 
ester. Free Pi only represents approximately 50% of the total serum phosphorus and 
ranges, depending on age (in humans), from 0.83-1.34 mM [1]. The bone is a major 
reservoir of phosphorus that complexes with calcium as hydroxyapatite mineral, with 
10 g of phosphorus per 100 g of dry fat-free bone tissue, whereas in comparison, 
muscle contains 0.2 g/100 g of fat-free and brain 0.3 g/100 g of fresh tissue [12]. 
Given such a wide distribution and tight regulation of Pi, it is evident that deviations 
from normal values can cause clinical diseases (i.e. rhabdomyolysis, muscle 
weakness, impaired leukocyte function, and altered bone mineralization leading to 
rickets or osteomalacia [13-15]). 
The small intestine and the kidneys both have the ability to regulate Pi availability in 
the body. The small intestine absorbs Pi from the diet, and the kidneys control the 
excretion by reabsorption, depending on the needs of the organism [16]. In normal 
healthy individuals, urinary excretion of Pi reflects intestinal absorption (Figure 5). 
There are numerous factors that control Pi absorption in the intestine or its 
reabsorption in the kidney. The most important factor controlling intestinal absorption 
of Pi is 1α,25-(OH)2-Vitamin D3 (Vitamin D). Nevertheless, increase of Pi absorption 
has been observed in various studies lacking the specific vitamin D receptor (VDR) or 
active Vitamin D3 [17-22].  
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Figure 5. Pi distribution in the body. A constant level of Pi is held in the blood plasma, whereas changes can 
indicate pathological disturbances due to kidney dysfunction, intestinal malabsorption or bone disease. In healthy 
individuals, a net excretion in the kidney parallels the net absorption in the gut. The kidneys play a major role in 
regulating Pi homeostasis by controlling its reabsorption in the proximal tubule. Image taken from [1]. 
 
 
Phosphate reabsorption in proximal tubules 
 
Pi is freely filtered in the glomerulus. The PCT and PST are the major sites for Pi 
reabsorption; approximately 80% of the filtered Pi is reabsorbed along these nephron 
segments. Other segments may reabsorb traces of remaining Pi (Figure 6 A), but 
detailed mechanisms are not known. Under balanced condition, approximately 10% 
of filtered Pi is excreted in the urine. In the PT, reabsorption of Pi is a transcellular 
process initiated by Na+-coupled transporters (Na/Pi-cotransporters) located at the 
brush border membrane (BBM) [23-25]. Three Na/Pi-cotransporters have been 
described to be involved in Pi-reabsorption: two members of the SLC34 family (NaPi-
2a and NaPi-2c) [26] and one member of the SLC20 family (Pit-2) [27]. Radioactive 
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phosphorus (32P) studies have revealed sodium dependence for NaPi-2a, NaPi-2c 
and Pit-2. These transporters have been studied extensively using tracer fluxes in OK 
cells, oocytes, insect Sf-9 cells, as well as LLC-PK1 [28-35]. In oocytes, the transport 
mechanism has also been investigated using electrophysiological techniques (e.g. 
electrovoltage clamping) [36-41]. 
There are different transport properties for these three renal Pi carriers. Pit-2 and 
NaPi-2a mediate electrogenic transport across the plasma membrane [27]. NaPi-2a 
carries preferentially divalent inorganic Pi with a net positive charge (3 Na+ with 1 
HPO4
2-) [26], whereas Pit-2 carries also a net positive charge (2 Na+ with 1 H2PO4
-) 
using monovalent inorganic Pi. For NaPi-2c, transport is electroneutral (2 Na+ and 1 
HPO4
-2), with a preference for divalent inorganic Pi (Figure 6 B). 
Pi reabsorption in the PT depends on NaPi-2a cotransporter abundance in the BBM. 
NaPi-2c has also been shown to participate, but to a lesser degree than NaPi-2a. 
However, in mice loss of function mutation in the SLC34a3 gene encoding NaPi-2c 
presented hypophosphatemic rickets with hypercalciuria [42]. NaPi-2c has also been 
shown to play a more important role in weaning animals [43]. Based on NaPi-2a 
knock out studies, the transporter was shown to be responsible for 70-80% of apical 
flux of Pi [44], where the remaining 20-30% is probably reabsorbed by NaPi-2c. 
Latter was also shown to increase up to three times on protein levels in NaPi-2a 
knock out mice without significant changes in NaPi-2c mRNA [43, 45]. 
In-situ hybridization and RT-qPCR studies have shown the presence of NaPi-2a and 
NaPi-2c mRNA in the renal PT. Protein localization was determined through 
immunohystochemistry in the PT [46-47]. For NaPi-2a, an inter-nephronal 
heterogeneity was determined between superficial and juxtamedullary nephrons [46]. 
Regarding NaPi-2a protein distribution, S3 segments of the juxtamedullary nephrons 
presented more NaPi-2a at the BBM than the superficial nephrons [46]. 
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A         B 
 
Figure 6. (A) Pi reabsorption along the nephron. The proximal tubule is responsible for up to 80% of Pi 
reabsorption depending on dietary changes or hormonal regulation. This process is mainly achieved via the 
transcellular pathway using an active, sodium driven Pi transporter (NaPi-2a). (B) The three Na/Pi cotransporters 
NaPi-2a, NaPi-2c, and Pit-2 are located at the apical membrane of the epithelial cells in the nephron, mainly in the 
proximal tubule. Image taken from [48]. 
 
 
Using RT-qPCR, heterogeneity for NaPi-2a mRNA was proven to exist between S1 
and S3 segments along the juxtamedullary nephrons, but found to be absent in the 
superficial nephrons [49].  
The importance of NaPi-2a is reflected by the effects of minor changes in its 
expression, causing clinical significant alterations in Pi homeostasis. Homozygous 
knock-out mice for NaPi-2a presented increased urinary excretion of Pi, 
hyposphosphatemia, elevated serum concentration of Vitamin D, hypercalcemia, 
hypercalciuria, and reduced amount of circulating PTH [44]. Even though NaPi-2c is 
responsible for only 20% of total Pi reabsorption, a mutation of NaPi-2c can lead to Pi 
wasting, demonstrating its critical involvement in Pi homeostasis [50-51]. In humans, 
a homozygous in-frame duplication of 21 base pairs of NaPi-2a gene, with a 
consequent loss of membrane localization and activity, is associated with Fanconi‟s 
syndrome. Despite the similarities between mice and humans after a loss of function 
in NaPi-2a, the dysfunction of other transporters observed in humans as a result of 
Fanconi‟s syndrome has not been observed in mice. One possible explanation for 
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this difference could be that NaPi-2a knock-out models present no mutated NaPi-2a 
protein, which may have a potential effect on other proximal tubular transport 
functions [52]. This however still needs to be confirmed.  
 
 
Physiological regulation of phosphate 
 
In order to fulfill an overall Pi homeostasis, it is necessary to control renal excretion of 
Pi.  The main regulatory site is the PT. Regulated reabsorption is achieved by 
controlling the amount of Na/Pi-cotransporters at the BBM. Pi reabsorption in the 
kidney is related to a change in maximum velocity (Vmax) of the Na/Pi-cotransport.  
A series of factors (see Table 1) are responsible for the regulation of Pi reabsorption 
and the abundance of Na/Pi-cotransporters at the proximal tubular BBM. In the 
following paragraphs, single factors that regulate Pi-reabsorption will be discussed 
briefly. Two regulators, dietary Pi and parathyroid hormone will be discussed 
separately in more detail later.  
Vitamin D (1α,25-(OH)2-vitamin D3) has been demonstrated to stimulate proximal 
tubular Pi reabsorption [53-54]. However, due to interfering factors, it is difficult to 
discriminate between direct and indirect effects of Vitamin D action, since in-vivo it is 
closely related to changes in PTH and calcium concentrations [55-56]. This will be 
further discussed later in context of dietary Pi.  
Insulin has been shown to stimulate the Na/Pi-cotransport in the BBM, in addition to 
inhibiting the phosphaturic effect of PTH [57-58]. Some specific binding sites have 
been discovered for insulin at the basolateral membrane of proximal tubular epithelial 
cells [59-60].  
Growth hormone and insulin like growth factor one (IGF-1), which is locally 
produced by the kidney, stimulate proximal tubular Pi transport [61-62]. When IGF-1 
receptors are stimulated at the basolateral membranes of the PT, the intracellular 
phospholipase C pathway is triggered [63]. Epidermal growth factor (EGF) has been 
demonstrated to stimulate Pi reabsorption in perfused PTs, and inhibit Pi transport in 
OK and LLC-PK1 cells [64-66].  
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Glucocorticoids decrease Pi reabsorption [67-68]. These effects have been shown 
to occur in-vitro as well as in-vivo and can be observed independently of PTH 
concentrations [69]. It is possible, that during “chronic” metabolic acidosis, high 
plasma glucocorticoid levels cause a phosphaturic response [67, 70].  
Thyroid hormone increases the abundance of NaPi-2a cotransporters in the BBM 
and thus renal Pi reabsorption [71-72]. In cultured OK cells, thyroid hormone caused 
de-novo protein synthesis [73]. Another lipophilic hormone is β-estradiol, which has 
been reported to decrease renal tubular Pi transport [74]. 
Atrial natriuretic peptide (ANP) inhibits Pi transport. It is still uncertain whether ANP 
acts directly or not, since ANP receptors were not found in proximal tubular cells [75-
76]. 
Calcitonin can mediate a decrease in Na/Pi-cotransport, independently from PTH 
and cAMP [77-78]. A possible rise in intracellular calcium could mediate this effect.  
Glucagon has the opposite effect on Na/Pi-cotransport than insulin. Administration of 
this hormone increases phosphaturia. It was suggested that it is an indirect effect of 
cAMP release from the liver when pharmacological doses of glucagon were given 
[79].  
Phosphatonins have been recently described in tumour induced osteomalacia (TIO) 
and other diseases associated with bone resorption and phosphaturia [16, 40, 80]. 
Renal Pi wasting had been directly linked to serum factors affecting Na/Pi-cotransport 
in the kidney, while also inhibiting the Vitamin D responsive pathway [40]. The most 
studied phosphatonins are: Fibroblast growth factor 23 (FGF-23), frizzled related 
protein-4 (sFRP-4), fibroblast growth factor 7 (FGF-7) and matrix extracellular 
phosphoglycoprotein (MEPE). The latter two were shown to inhibit Pi transport in-
vitro (renal epithelial cells) and in-vivo (rat), without blocking compensational increase 
in serum Vitamin D levels, or direct inhibition of 1α-hydroxylase activity seen in other 
hypophosphatemic cases [16, 81-87].  
Prostaglandins (e.g. PGE2) are produced in the kidney and PGE2 has been shown 
to antagonize the effect of PTH under physiological conditions [88]. Whether the 
cAMP signaling cascade is involved, is not known.  
Dopamine acts during “acute” renal denervation by increasing renal Pi excretion 
independently of the action of PTH levels in plasma. Both, the precursor L-dopa and 
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dopamine reduce the expression of NaPi-2a and thus Pi transport, as has been 
demonstrated in isolated rabbit proximal tubules and OK cells [89-93]. 
Fasting has been correlated with phosphaturia. Why Pi is excreted in fasting rats is 
not known. It may be a hormonal interaction (e.g. glucagon) that is involved during 
fasting [94-95].   
Plasma calcium changes can lead to direct changes in PTH levels that can act on Pi 
reabsorption in the kidney [96-97]. In-vitro however, extracellular calcium was shown 
to affect NaPi-2a in the proximal tubular BBM [98]. Perfused proximal tubules have 
demonstrated an increase in Na/Pi-cotransport in response to high Ca2+ 
concentrations [99]. In contrast, OK cells in-vitro increased Na/Pi-cotransport when 
exposed to low calcium concentrations [100]. It is suggested that the calcium 
receptor is involved in mediating this effect. 
Acid-Base disturbances can affect Pi reabsorption in the PT. An alkaline intratubular 
pH leads to stimulation of the NaPi-cotransporter while acidic conditions inhibit the 
cotransporter [101-102]. This may be due to protons competing with sodium ions for 
the binding site of the cotransporter. “Chronic” metabolic acidosis decreases Pi 
reabsorption while “acute” metabolic acidosis does not. Some data suggests that the 
elevation of glucocorticoids during “chronic” metabolic acidosis may be responsible 
for phosphaturia. Respiratory alkalosis stimulates Pi reabsorption and respiratory 
acidosis causes Pi excretion [67-68, 70, 103]. 
Volume expansion causes Pi excretion in the urine and reduction of NaPi-2a 
abundance in the BBM. It has been questioned whether the effect of volume 
expansion on NaPi-2a is either directly or indirectly related to the action of humoral 
factors (i.e. ANP, dopamine) [104]. 
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Decreased Pi transport Increased Pi transport 
High Pi-diet Low Pi-diet 
PTH and related peptide PTHrP Growth hormone 
Glucocorticoids Insuline 
Chronic metabolic acidosis Thyroid hormone 
Acute respiratory acidosis 1,25α(OH)2Vitamin D3 
Aging  Chronic metabolic alkalosis 
Phosphatonins High potassium diet 
ANP High calcium diet 
Fasting Stanniocalcin 
Hypokalemia  
Hypercalcemia  
Diuretics  
Calcitonin  
 
Table 1. Hormonal and non-hormonal factors play a role in proximal tubular Pi reabsorption. PTH, Vitamin D, and 
Pi-diets are included under the most studied factors modulating Na/Pi-cotransport at the BBM. Phosphatonins 
have recently been described to be involved in renal Pi wasting. 
 
 
Regulation of phosphate excretion by parathyroid hormone  
 
In humans, there are four parathyroid glands located on the posterior surface of the 
left lobe of the thyroid and additional two on the right. In total, the glands weigh 
approximately 500 mg and consist mainly of chief cells (parathyroid cells) which are 
specialized gland cells that secrete parathyroid hormone (PTH). The main regulator 
of PTH secretion is serum calcium concentration, acting via a negative feedback 
mechanism. This involves calcium-sensing receptors located in the chief cells that 
are activated by low calcium concentrations. Vitamin D and Pi have also been 
observed to act on PTH secretion [105]. 
Renal Pi cotransporter NaPi-2a is greatly decreased upon PTH stimulation with 
consequent phosphaturia. Rodents that had been injected with PTH presented within 
minutes later lower NaPi-2a abundance at their renal proximal tubular BBM 
compared to their controls [106]. During prolonged increase of PTH, a reduction in 
mRNA content of NaPi-2a was observed in the PT [106]. In addition, in-vitro studies 
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with OK cells showed a decrease of intrinsic and transfected rat NaPi-2a 
cotransporter [107-108]. A rapid recovery of NaPi-2a follows after PTH inhibition. In 
OK cells, this recovery has been shown to be dependent on protein synthesis [109-
110]. The effect of PTH on NaPi-2a is three times faster than on NaPi-2c which also 
appears to be modulated by dietary Pi, growth, and FGF-23 [19, 111-114]. For Pit-2, 
the only regulators that have been identified to date are dietary Pi and potassium 
depletion [115-116].  
 
 
Figure 7. PTH controls serum Pi and calcium levels in the organism. The PT is the main site of PTH action by 
regulating the abundance of Na/Pi-cotransporters in the apical membrane. PTH stimulates Pi excretion and 
calcium retention as well as Vitamin D synthesis.  
 
 
Parathyroidectomized (PTX) animals have shown up-regulation of NaPi-2a in 
absence of any changes in mRNA levels [106]. PTH receptors have been localized to 
the apical and basolateral membranes of the PT and OK cells [117-120]. 
Experiments realized with cultured cell lines and renal proximal tubular preparations 
indicated that PTH regulation of NaPi-2a occurs through receptor dependent 
increase of cAMP, diacylglycerol (DAG), and inositol triphosphate (IP3) [121-125]. 
These messengers, acting through several kinases including protein kinase A (PKA) 
and C (PKC), lead to the inhibition of apical brush border Na/Pi-cotransport. This is 
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due to lower abundance of NaPi-2a, and thus, a reduction in Vmax value [121, 126-
127].  
Recent studies have revealed that associated membrane proteins may be involved in 
trafficking of NaPi-2a [128]. PDZ containing proteins (Postsynaptic protein PSD95, 
Drosophila protein dlg (discs large)-A and tight junction protein ZO-1) such as PDZK1 
and Na+/H+ exchanger regulatory factor (NHERF1) interact and colocalize with NaPi-
2a and are assumed to play an important role in the apical distribution of NaPi-2a at 
the membrane [129-132]. When kinase cascades are activated in response to PTH, 
NaPi-2a is retrieved and internalized into subapical vesicles [133-135]. Interestingly, it 
is not NaPi-2a that is submitted to phosphorylation, but rather its binding protein 
NHERF-1 [136-137]. NHERF-1 was shown to bind via its first PDZ domain to specific 
sequences in C-terminal ends of target proteins [138-139]. NHERF-1 has also been 
demonstrated to bind through its C-terminal end to cytoskeletal interacting proteins 
MERM, (moesin, ezrin, radixin, and merlin) [140]. The first PDZ domain contains a 
Ser77 which is submitted to phosphorylation in response to PTH (and dopamine), 
leading to the dissociation of the NaPi-2a/NHERF-1 complex [135, 137]. The 
separation of NaPi-2a from NHERF-1 is important for correct removal of NaPi-2a 
from the apical BBM and for entering into the endocytic pathway [141]. It may be, that 
NHERF-1 functions as a NaPi-2a retention signal and when NHERF-1 is absent, it 
limits NaPi-2a abundance at the surface of the membrane [131-132]. Once NaPi-2a 
internalization is completed, the cotransporter is degraded in the lysosomes [110, 
120, 142].  
 
 
Regulation by dietary phosphate 
 
Dietary intake of Pi influences its reabsorption and excretion in the urine. When a 
high Pi-diet (HPD) is administered, Pi excretion increases while a low Pi-diet (LPD) 
decreases Pi excretion [143-144]. Abundances of NaPi-2a, NaPi-2c and Pit-2 are 
altered by changes of dietary Pi intake, independent of PTH and other factors [23, 
47, 119-120, 145-146]. Dietary Pi restriction (5 days, “chronic”) has been shown to 
increase the expression of NaPi-2a in S1-S3 segments without changes in the mRNA 
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distribution profile. This suggests that NaPi-2a adaptation to Pi imbalances is not due 
to changes in mRNA levels. Overall, an axial heterogeneity is more pronounced in 
HPD treated animals than in LPD animals [49]. During Pi deprivation, a resistance 
has been documented to the phosphaturic effect of PTH [147-149]. This may be due 
to the reduced dopamine synthesis in the nephron during Pi deficiency. 
Administration of PTH to LPD animals, followed by dopamine injection, were shown 
to overcome phosphaturia [150]. Moreover, micro puncture studies demonstrated in 
acutely thyro-parathyroidectomized (TPTX) rats, that the response to changes in Pi 
adaptation is mainly reflected by changes in Pi reabsorption by superficial nephrons 
[151], and to a lesser extent by the distal nephron. The response to Pi diets in the 
brush border membrane vesicles (BBMV) is specific for Pi. Other Na+-coupled 
transporters, such as Na+-dependent L-proline or D-glucose transport, are not affected 
by changes in dietary Pi. Kinetics for Pi transport, demonstrate an increase in Vmax in 
LPD animals without any changes in the apparent affinity (Km).  
Renal adaptation to dietary Pi deprivation can be classified in an early and a “chronic” 
phase. The early phase is imminent, and can be detected in the BBM within hours (2 
- 4 h) [152-154]. It is characterized by a fall in serum Pi concentration and is PTH 
independent. Some evidence suggests, that decreased synthesis of dopamine in the 
nephron may be involved in the response of the early renal adaptation to dietary Pi 
restriction [150]. A shuttle mechanism for the co-transporter has been proposed and 
confirmed for the rapid phase adaptation at the BBM. This would explain the post-
transcriptional regulation of NaPi-2a without any changes in its mRNA levels [145, 
154-156]. An opposite adaptation to Pi has been shown after phosphate infusion; 
where 40 thereafter a diminished sodium dependent uptake was detected [157]. 
When OK cells were incubated in the presence of a Pi transport inhibitor (PFA), 
followed by its removal, NaPi-2a abundance increased rapidly [155, 158]. Even in 
presence of RNA or protein synthesis inhibitors, increase in amount of NaPi-2a 
occurred. This suggests that the mechanism for Na/Pi-cotransport may be controlled 
by the availability of sub apical pools of NaPi-2a cotransporter proteins that are 
recruited to the membrane upon LPD stimulation. Adaptation to “chronic” dietary Pi 
restriction involves de-novo synthesis of Na/Pi-cotransporter protein that is completed 
after several days [159-161]. This process is fundamental for Pi homeostasis. 
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“Chronic” adaptation can be inhibited with the administration of actinomycin D to LPD 
animals [162]. 
Experiments with rats under fasting conditions have demonstrated that reabsorption 
of Pi is not as pronounced as after LPD [94, 163-165]. When compared to normal Pi-
diet (NPD) rats, fractional excretion of Pi (UPiV) was lower in animals deprived of 
food, but significantly higher than in LPD rats. Tracer studies with BBM preparations 
of these animals showed higher Pi uptake for LPD than for NPD rats. However, 
uptake of fasted rats was just below that of NPD rats [163]. The reason why total 
fasting does not correlate with the increased Pi uptake of animals on LPD is still 
unknown. An explanation would be that during starvation metabolic acidosis 
accounts for a higher phosphaturia. In addition, supply of metabolic energy is 
reduced, which is required for proximal tubular function and the expression of the 
NaPi-2a cotransporter in the BBM.  
 
 
The role of Vitamin D in response to dietary phosphate 
 
The Vitamin D axis is known to respond to dietary Pi changes in the organism. Thus, 
after a LPD ingestion, an increase in renal expression of 1α-hydroxylase (Cyp27B1) 
with consequent action of Vitamin D can be detected [1]. Renal expression of the 
Cyp27B1 gene generates the enzyme 1α-hydroxylase [166]. A specific mechanism 
involving the epithelial cell surface receptors megalin/cubulin is known for the 25-OH-
D3/DBP complex uptake at the apical BBM of the renal PT cell. Knock-out (KO) mice 
for megalin show a reduced Vitamin D metabolite level and a clear vitamin D 
deficiency. Hypophosphatemia is an important regulator for 1α-hydroxylase [167-
170]. The increase of Vitamin D levels in serum in response to LPD has been shown 
to be independent of PTH levels. However, after realizing hypophysectomy, the 
response of Vitamin D was completely abolished [167, 171]. Even though serum Pi 
levels have not been associated with changes in growth hormone (GH) secretion 
[171], it is suggested that the pituitary GH-IGF-I axis may be a mediator of 1α-
hydroxylase synthesis in response to hypophosphatemia [172-174]. 
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Hypophysectomized (HPX) rats set on LPD restored 1α-hydroxylase activity after the 
administration of GH [172-175]. 
A time course for isolated mitochondrial 1α-hydroxylase activity was determined in 
LPD and HPD animals, but no increase of activity was observed after the first day of 
LPD [176]. On the second day of LPD, a linear increase which became more 
pronounced until reaching the highest expression on the 8th day was attained. Similar 
data was collected using RT-qPCR methods with no increase in 1α-hydroxylase gene 
expression level until the second day [176]. Moreover, different LPDs were tested to 
investigate the degree of stimulation necessary to reach the highest activity of 1α-
hydroxylase. A significant increase was determined with 0.02% of Pi, reaching an 8 
fold increase with 0.2% and no change with 0.6% compared to control diet (1%). RT-
qPCR data confirmed this activity for gene expression level as well [176]. 
 
 
Phosphate sensors and an intestine-kidney axis responsible for Pi 
homeostasis 
 
Individual cells have the ability to sense Pi in their environment and to respond 
accordingly to maintain homeostasis. Unicellular organisms have developed 
“phosphate sensors” [177-179] that allow them to sense their external media by 
generally changing the phosphorylation state of intracellular proteins that in turn 
affect the transcription level of nuclear proteins. Mammals have biologically inherited 
this sensing mechanism by which Pi is held constant intracellularly. Several studies 
have revealed evidence for Pi signaling mechanisms residing in the gastrointestinal 
tract and in the parathyroid gland of rodents [180], but the exact mechanism of action 
still remains unknown to date. Rats, after a duodenal Pi infusion, had a change in 
fractional excretion of Pi within 10 min without any changes in serum Pi values [181]. 
This was also confirmed in TPTX rats, where Pi excretion was imminent upon 
duodenal Pi loading, indicating an independent mechanism of PTH action. Also, no 
significant changes in concentration of phosphaturic peptides (e.g. FGF-23, sFRP-4) 
in normal and in PTX rats were determined after duodenal Pi loading. Moreover, this 
data suggests a Pi sensor in the intestine, that controls renal excretion of Pi within a 
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short time period after sensing it in the intestinal mucosa [181]. The phosphaturic 
response of the kidney is not mediated by any of the known agents that have been 
classified to stimulate Pi excretion. Renal denervation excluded the nervous system 
to be involved in this mechanism. After intraduodenal infusion of Pi in rats, a 
homogenate was prepared from the intestinal mucosa of these rats, and after 
isolating the proteins they were infused into a new group of rats which caused 
consequent Pi excretion in the animal. This experiment indicated a factor present in 
the intestine responsible for the phosphaturic action in the kidney [181]. More studies 
need to be performed to confirm and elucidate the mechanisms behind these actions. 
 
 
Aims of the Study 
 
There are various indications that point to changes in expression of renal genes after 
administering different Pi diets.  
First, an alteration of NaPi-2a protein expression level is associated with a change in 
the content of dietary Pi ingestion [1]. However, this change is not observed on gene 
expression level. Interestingly, NaPi-2c was shown to increase its mRNA abundance 
upon administering a low Pi diet [49]. Second, 1α-hydroxylase, the enzyme 
responsible for activating Vitamin D, was demonstrated to increase gene expression 
levels upon ingesting a low Pi-diet [1, 176]. However, this change occurs after 1 day 
of LPD [176], even though a rapid adaptation due to increased abundance of NaPi-
2a at the BBMV is observed. These data not only indicate that NaPi-2a regulation is 
Vitamin D independent, but also implies that there may be other factors involved 
during short term adaptation to LPD.  
This thesis focuses on data obtained by investigating changes in renal genes through 
microarray analysis after administering a low Pi diet when compared to mice that 
received a high Pi diet. This will be investigated after different periods, after a chronic 
(5 days) and an acute (14 hours) period. It will be of special interest to analyze genes 
and pathways shared after both periods since these will have higher possibilities to 
be directly affected by changes in dietary Pi. Therefore new genes found in this study 
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could lead to the understanding of Pi homeostasis and renal handling of Pi during low 
Pi diet administration.   
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Materials and Methods 
 
Animals and collection of organs and blood 
 
For all animal studies performed in this work, male C57BL/6 mice of age between 10 
and 13 weeks were used (purchased either from the Institute für Labortierkunde 
(University of Zürich) or from Harlan (Animal research laboratory). All animal 
handlings were carried out in accordance with the Swiss Animal Welfare Laws and 
approval of the local veterinary authority (Kantonales Veterinäramt). Mice were kept 
in a temperature and humidity controlled atmosphere, with a 12 hour light and dark 
cycle. 
At the end of each experimental period, animals were anesthetized intraperitoneally 
using ketamine (4 mg/mouse) in combination with xylazine (0.8 mg/mouse). Venous 
blood was collected from each mouse and centrifuged in the presence of heparin 
(8000 r.p.m. for 3 min) to separate blood cells from plasma. Plasma was snap frozen 
in liquid nitrogen and stored at -80°C. After extraction of the kidneys, capsules were 
removed and kidneys were snap frozen in liquid nitrogen and stored at -80°C.  
 
 
Experimental Setups 
 
Phosphate diets 
 
Diets, containing different amounts of phosphorus, were purchased from Provimi 
Kliba AG (CH-4303 Kaiseraugst). The phosphorus content of the diets used was 
either 1.2% (high Pi-diet; HPD) or 0.1 % (low Pi-diet; LPD). Both diets contained the 
same amount of calcium. 
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“Chronic” (5 days) adaptation to different Pi-diets: 
 
After arrival, animals were adapted to facility conditions for a few days, and 
afterwards separated in two groups (routinely 6 animals per group). One group 
received a HPD while the other group received a LPD for 5 days. Water and food 
were supplied ad-libitum.  
 
 
“Acute” adaptation to different Pi-diets: 
 
In order to investigate short term effects of different Pi-diets, mice were trained to eat 
the HPD for 5 days during a 3 hour period (6 pm-9 pm), and on the 6th day they were 
separated into two groups. HPD and LPD, respectively, were given at 6 pm and 
removed at 9 pm. Mice were sacrificed after different time points (4, 8 and 14 h), 
followed by the collection of blood and kidneys.  
In a second set of experiments, mice were trained to eat the HPD for 3 hours (6 to 9 
pm) in normal cages for 3 days. On the 4th day they were placed in metabolic cages 
(Tecniplast 3600M021, Buguggiate, Italy). Urine was collected in 24 h intervals and 
water consumption was measured every 24 h. They continued to receive HPD for the 
following 2 days during the 3 h evening period. On the 3rd day in metabolic cages, the 
experimental group (6 mice) was changed to LPD while the control group continued 
to eat the HPD. The following morning (8 am), 14h after receiving LPD and HPD, 
animals were sacrificed after collecting blood and kidneys.  
 
 
RNA related methods 
 
Total RNA isolation and quality control 
 
Total RNA was extracted from whole kidney tissue (RNeasy Mini extraction kit, 
Qiagen, Cat. No. 74104). 20 to 30 mg of renal tissue was homogenized on ice with 
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the help of a glas-teflon potter (B.Braun, Melsungen AG) in 600 μl RLT buffer™ 
(Qiagen, Germany) supplemented with 1% β-mercaptoethanol (Sigma, USA). The 
resulting homogenate was further processed according to the protocol of the 
manufacturer, and final total RNA was eluted with RNAse free water. 
The concentration of total RNA was determined spectrophotometrically (NanoDrop 
ND-1000 Spectrophotometer, Deleware, USA). Quality of total RNA was analyzed by 
the RNA 6000 Nano LabChip (Agilent technology, Cat. No. 5065-4476) and the 2100 
Bioanalyzer (Agilent technology, Waldbronn, Germany). Quality was based on the 
260 nm/280 nm ratio and the RIN (RNA Integration) number. 
 
 
Hybridization of total renal RNA to whole mouse genome 
microrarray chips 
 
All hybridization experiments were done in and by the Functional Genomics Center 
Zürich (FGCZ). Only samples of total RNA with a 260 nm/280 nm ratio between 1.8 
and 2.1, a 28S/18S ratio between 1.5 and 2, and a RIN greater than 8 were used for 
hybridization to microarray chips. Total RNA samples (2 μg) were reverse-transcribed 
into double-stranded cDNA and then in-vitro transcribed in the presence of biotin-
labeled nucleotides using an IVT Labeling Kit (Affymetrix Inc., P/N 900449, Santa 
Clara, CA). Following purification and quantification using BioRobot Gene Exp – 
cRNA Target Prep (Qiagen AG, Switzerland), the quality of labeled cRNA was 
determined using Bioanalyzer 2100. Before hybridization to GeneChip® Mouse 
Genome 430 2.0 arrays (Affymetrix) (16 h at 45°C), biotin-labeled cRNA samples (15 
μg) were fragmented randomly into 35–200 bp at 94°C using fragmentation buffer 
(Affymetrix Inc., P/N 900371, Santa Clara, CA). This was finally mixed in 300 μl of 
hybridization mix (Affymetrix Inc., P/N 900720, Santa Clara, CA) containing 
hybridization controls and control oligonucleotide B2 (Affymetrix Inc., P/N 900454, 
Santa Clara, CA). After GeneChip® hybridization, arrays were washed using an 
Affymetrix Fluidics Station 450 FS450_0001 protocol. In order to determine the 
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fluorescent intensities emitted by the labeled targets, an Affymetrix GeneChip 
Scanner 3000 (Affymetrix Inc., Santa Clara, CA) was used. 
Obtained data were processed using the software GCOS 1.4 (Affymetrix Inc., Santa 
Clara, CA). By means of the MAS5 algorithm [182], probe cell intensities were 
calculated and summarized for the respective probe sets. Global scaling was 
performed to compare the expression values of the genes from chip to chip, which 
resulted in the normalization of the trimmed mean of each chip to target intensity 
(TGT value) of 500, as detailed in the statistical algorithms description document of 
Affymetrix (2002). Before performing the statistical analysis, quality control measures 
were considered. These included adequate scaling factors (between 1 and 3 for all 
samples) and appropriate numbers of present calls calculated by application of a 
signedrank call algorithm [183]. Using the following parameters the efficiency of the 
labeling reaction and the hybridization performance was controlled: Present calls and 
optimal 3'/5' hybridization ratios (around 1) for the housekeeping genes (GAPDH and 
ACO7), for the poly A spike in controls and the prokaryotic control (BIOB, BIOC, 
CREX, BIODN). A simplified schematic presentation of a microarray chip can be 
seen in Figure 8. 
 
Figure 8. Scheme of a microarray analysis experimental process. Image taken from [184]. 
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Analysis of Microarray data and Pathway toolkits 
 
Microarray gene lists obtained were analyzed using Rosetta Resolver® 
(CeibaSolutions, MA, USA) provided by the FGCZ of the University of Zürich. 
Unpaired student t-test (p < 0.05, n = 4) was applied for statistical analysis for each 
experimental group (HPD and LPD). Gene expression profiles were compared 
intrinsically within each group before evaluating gene expression sets between 
groups. 
 Web based gene set analysis toolkit (WEBGESTALT) is one of many 
programs that is freely accessible on the internet and that is currently used for 
gene data obtained from humans and mice. By incorporating different public 
resources it enables scientists to integrate large data sets to obtain pathways 
and gene patterns that would not be detected otherwise. The program was 
originally designed for functional genomics and large scale genetic studies, 
from which high amount of data are continuously produced. It is necessary to 
be registered on the webpage http://bioinfo.vanderbilt.edu/webgestalt/ and it is 
recommended not to rely on the program for permanent data storage.  
 G-Profiler (http://biit.cs.ut.ee/gprofiler/) is another high throughput genetic 
profiling program. It is provided by the University of Tartu in Estonia and uses 
a number of analysis systems (g:GOst, g:Cocoa, g:Convert, g:Sorter, g:Orth) 
that can be chosen separately on the webpage depending on the type of 
grouping between genes that is desired (e.g. expression similarity, orthology 
search, etc.). 
 Gene Ontology Enrichment Analysis Software Toolkit (GOEAST) 
(http://omicslab.genetics.ac.cn/GOEAST) also belongs to a web based 
analysis toolkit that integrates input data, especially from microarray 
hybridization experiments, to visualize it comprehensively.  WEBGESTALT, G-
Profiler, and GOEAST all use information from the Kyoto Encyclopedia of 
Genes and Genomes (KEGG).  
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Real time RT-qPCR  
 
Purified total RNA was reverse transcribed (TaqMan® Reverse Transcription Kit, 
Applied Biosystems) in the presence of 2.5 μM random hexamere primers. Reverse 
transcription was performed using the Robocycler 40 (Stratagene) with the following 
parameters: 10 min at 25°C, 60 min at 42°C, 5min at 95°C, and kept at 4°C until 
further use. Following cDNA synthesis, real time RT-qPCR was performed in 96-well 
plates (Applied Biosystems, USA). 0.75 μl (~18 ng) of cDNA was combined with 
either 0.75 μl of Taq Man® Gene Expression Assay buffer containing a mix of pre-
designed primers and corresponding probes (www.appliedbiosystems.com), or 
designed primers (5 μM) and probes (1 μM) (Supplementary Table S1). Designed 
probes (obtained from Microsynth, Balgach, Switzerland) were labeled with the 
reporter dye FAM at the 5‟ end whereas the quencher dye, TAMRA, was attached at 
the 3‟ end. Expression Assays™ (Applied Biosystems, USA) contained just the 
reporter dye FAM, no quencher. Ribosomal 18 S RNA (18 S rRNA), used as a 
“Housekeeping” gene, had VIC as a reporter and TAMRA as a quencher. To the 
primer and probe mixture, Taq Man® Universal PCR master mix (Applied Biosystems, 
USA) was added to give a final volume of 15 μl. The 96-well plate was put into a 
centrifuge (Eppendorf centrifuge 5804) to spin down all contents. Finally, RT-qPCR 
was performed using the 7500 Fast Real Time PCR System (Applied Biosystems, 
USA). Standard thermal cycles (up to 40) were set as follows: 2 min at 50°C, 10 min 
at 95°C, 40 cycles of 15 s at 95°C and 1 min at 60°C. Data were analyzed using the 
7500 Fast Real-Time PCR System Sequence Detection Software v1.4 (Applied 
Biosystems, USA). Automatic threshold and baseline were calculated by the 
program. Each sample was run in triplicates, except for the negative control, and the 
mean Ct value used for evaluation. Abundance of a gene was calculated in relation 
to “housekeeping” genes (β-actin or 18 S rRNA). These values were determined by 
assuming an efficiency value of 2, which presents the fold-increase in input mRNA 
required to decrease the cycle number by 1. The relative expression ratios were then 
calculated as R = 2(Ct(control)-Ct(experiment)). 
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Isolation of nephron segments for RNA extraction 
 
Mice were anesthetized as described above. Perfusion was performed through the 
left ventricle with a solution containing 3 ml of Ham‟s F-12 medium (GIBCO BRL), 10 
mM (HEPES)-NaOH (pH 7.4), and 1 mg/ml of collagenase type I (Sigma, USA). 
Kidneys were removed and placed in RNAlater® (Ambion). 20 proximal tubules and 
20 thick ascending limbs were isolated from the cortex region and placed in 
Eppendorf tubes containing 50 µl RLT buffer™ (Qiagen, Germany) supplemented with 
1% β-mercaptoethanol (Sigma, USA). After vortexing for 30 s, tubes were either 
shock frozen in liquid nitrogen and stored at -80°C, or directly processed for RNA 
isolation according to the protocol of the manufacturer using the RNeasy® Micro kit 
(Qiagen, Germany, Cat. No. 74004).  
 
 
In-situ hybridization of SLC16A14/MCT14 
 
Mice were anesthetized as described above. After removing capsules, kidneys were 
placed in small baskets made of nylon mesh. All pre- and post-hybridization 
procedures, including paraffin embedding, were carried out using a BioLane HTI in-
situ hybridization machine (Holle & Hütter AG, Tübingen, Germany). The baskets 
containing the kidneys were placed in ice cold phosphate-buffered saline (PBS). A 
fixative solution of 4% paraformaldehyde (PFA) (Aldrich, USA) was prepared in PBS 
and then used for kidney incubation at 4°C for at least 3 days. Afterwards, kidneys 
were cut into thin longitudinal and transversal sections and placed in 50% ethanol 
(diluted in H2O) for 2 h, followed by 60% ethanol for 2 h. Further dehydration steps 
before paraffin embedding were as follows: 2 h in 70% ethanol, 2 h in 80% ethanol, 2 
h in 90% ethanol, twice for 1 h in 96% ethanol, twice for 1 h in anhydrous (≥ 99.5%) 
ethanol (Sigma, USA), twice for 1 h in xylol, and 3 times paraffin embedding for 1 h. 
Next, kidneys were cut into 5 µm thin slices using a microtome (Leica RM2235) and 
placed onto poly-lysine coated glass slides (O. Kindler GmbH & Co., Freiburg, 
Germany). Copeland jars were used for incubating slides with a volume of 200 ml for 
42 Materials and Methods 
 
Effects of changes in dietary phosphate on renal gene expression  
 
several steps. First, slides were immersed twice for 10 min in xylol followed by one 
wash in xylol/ethanol (1:1) for 2 min, followed by incubation in anhydrous ethanol 
(twice for 10 min each). Several ethanol solutions (diluted in PBS) with decreasing 
concentration were then applied for 1 min each: 96%, 90%, 70%, and finally 50%. 
Rehydration was completed by immersing the slides twice in PBS for 5 min. 
Proteinase K (Gibco, Roche Cat. No. 15401011) digestion was done at 37°C for 5 
min with a pre-warmed working solution of 10 mg/ml proteinase K in 0.1 M Tris-HCl 
(pH 8), 0.2% glycine in freshly prepared PBS solution. This reaction was stopped by 
two washes (5 min each) with PBS. Tissue was fixed for 20 min in 4% PFA / 0.2% 
glutaraldehyde (Sigma, USA) made in PBS. Again, slices were washed for 5 min with 
PBS. Slides were taken out of PBS and placed vertically over paper towels to remove 
excess solution. Tissue was encircled using the “ImmEdge” pen (Vector laboratories, 
USA, H-4000). This procedure was done quickly to avoid the slices from drying. 
Finally, they were placed back into Copeland jars with PBS for 5 min.  
The following hybridization buffer was prepared (for 50 ml solution): 25 ml formamide 
(50% final concentration), 12.5 ml 20xSSC (3 M NaCl, 0.3 M Na-citrate pH 7 in DEPC 
water and autoclaved), 3 ml blocking solution containing 500 mg blocking reagent 
(Roche, Switzerland, Cat. No. 11096176001), 500 µl of 0.5 M EDTA, 50 µl of Tween-
20 (Sigma-Aldrich, USA, P5927), 500 µl of 10% CHAPS (Sigma-Aldrich, USA, Cat. 
No. C3023-1G), 1 ml heparin solution (Sigma-Aldrich, USA, Cat. No. H3393-50KU), 
and 5 ml of 10 mg/ml yeast t-RNA (Invitrogen, USA, Cat. No. 15401011). 
The pre-hybridization buffer contained 95 µl of hybridization buffer and 5 µl of sterile 
dH2O while for the hybridization buffer, instead of dH2O, the DIG- labeled probe RNA 
at a concentration of 1 µg/ml was added. Before using the hybridization buffer with 
the labeled probe, it was pre-heated to 100°C for 5 min and then quenched on ice.  
Sense and anti-sense probes for SLC16A14/MCT14 were synthesized using Sp6 
and T7 RNA polymerases respectively. The myc tagged SLC16A14/MCT14 (see 
later section “creating a myc-SLC16A14/MCT14”) served as a template for RNA 
synthesis. The control probes (sense and anti-sense) for SLC5a2 and SLC12a1 were 
provided by the research group of Prof. Carsten A. Wagner of the institute of 
Physiology, University of Zürich. 2.5 µl of DIG-labeled nucleotide mix were added to 
2.5 µl of 10x buffer followed by 2.5 µl (Sp6 or T7) polymerase (Roche, Basel, 
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Switzerland). Finally, 1 µg of cDNA was dissolved in 25 µl of dH2O. Incubation was 
performed for 4 h at 37°C. Probes were kept on ice until hybridization, or snap frozen 
in liquid nitrogen followed by storage at -80°C. 
Slides were taken out of PBS and placed into rectangular boxes (Nunc™ boxes, 
Denmark) previously covered with paper towels soaked in 50% formamide / 2x SSC 
(approximately 50 ml per box). Pre-hybridization buffer (30-100 µl) was added to the 
kidney sections. Nunc™ boxes were closed and the slides were incubated at least 1 
h at 70°C. Pre-hybridization buffer was removed and replaced with hybridization 
buffer, containing sense or anti-sense probes. The incubation step was repeated 
using a large box covered with soaked solution where the smaller boxes were placed 
inside. The box was wrapped in aluminum foil to prevent excessive evaporation 
during overnight incubation at 70°C. 
Slides were rinsed with 2xSSC pH 7 and incubated twice for 20 min at 65°C in 50% 
formamide / 2xSSC pH 7 in Copeland jars. They were washed for 5 min in PBS- 
tween (3 times). Blocking buffer (B-Block) was prepared as follows: to 90 ml of PBS 
(at 95°C) 2 g of blocking reagent (Roche, Basel, Switzerland) were added. Solution 
was cooled and 100 µl of Tween-20 and 10 μl of goat serum (Vector laboratories, 
USA, S-1000) were added. B-Block was warmed to RT, pipetted on the slides (20 to 
30 µl) and incubated for 30 min at room temperature using the Nunc™ box. This was 
followed by incubation with anti-DIG alkaline phosphatase at a dilution of 1:5000 in B-
block (before use mixed for 30 min at RT). Incubation followed overnight at 4°C in a 
closed box containing water soaked paper towels. Next day, slides were washed 3 
times for 5 min in PBS-tween on the shaker. Slides were washed in NTN-tween 
solution (100 mM tris pH 9.5, 100 mM NaCl, 50 mM MgCl2, 0.05% Tween-20) for 5 
min. Slides were then incubated again at 4°C overnight with BMPurple AP substrate 
precipitation (Roche, Switzerland, Cat. No. 11442074001) in a box with water soaked 
paper towels and covered with aluminum foil to prevent light contamination. Next day, 
slides were washed in PBS and postfixed in 4% PFA (Sigma, USA) in Copeland jars 
for at least 1 hour. Finally they were washed for 5 min (two times) and mounted with 
cover slips (Menzel Gläser, Germany) using Mowiol® (Sigma, USA, Cat. No. 81381-
50G). Visualization and imaging was realized by light microscopy (Eclipse TE 300, 
Nikon Japan). 
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DNA related methods 
 
Myc-tagging SLC16A14/MCT14  
 
E. coli transformed with Mus musculus SLC16A14/MCT14 cDNA (inserted in pCMV-
Sport6) was purchased from imaGenes (Germany, Berlin). Bacteria were grown on 
agar plates containing 100 μg/ml of ampicillin. Overnight growth at 37°C resulted in 
colonies that were picked and grown overnight in liquid LB (Luria-Bertani) medium 
containing 100 μg/ml of ampicillin. A plasmid extraction kit (QIAprep® Spin Miniprep 
kit, Qiagen, Germany, Cat. No. 27106) was used to isolate plasmid DNA. 
SLC16A14/MCT14 was subcloned into a modified pSD-Easy vector (pSPOK-G 
obtained from S. Gisler). Besides containing a myc coding sequence (ATG-GAA-
CAA-AAA-CTC-ATC-TCA-GAA-GAG-GAT-CTG), pSPOK-G also contained a 
KOZAK consensus sequence and a poly-A tail sequence required for mRNA 
translation and stability. In order to insert the SLC16A14/MCT14 into the pSPOK-G 
vector, primers were ordered from Microsynth (CH-9436 Balgach) and SacI/XhoI 
restriction sites were created at the end terminals of SLC16A14/MCT14 gene upon 
PCR amplification (Figure 9 & 10). After SacI/XhoI digestion, SLC16A14/MCT14 was 
subcloned into pSPOK-G down-stream of the myc sequence (C-terminus). The 
chosen restriction sites had to fulfil various conditions: first, they were only allowed to 
exist once in the pSPOK-G vector for linearization containing the complementary 
ends of SacI (5‟ end) and the XhoI (3‟ end). Second, restriction sites for SacI and 
XhoI needed to be absent in the SLC16A14/MCT14 sequence except the added 
sequences for insertion to the pSPOK-G vector. Third, insertion of the SacI/XhoI 
digested SLC16A14/MCT14 gene needed to follow the myc tag sequence as close 
as possible without frame shifts. Fourth, the restriction site for linearization of 
pSPOK-G containing SLC16A14/MCT14 needed to be down-stream of the poly-A 
tail. For confirmation plasmids were sequenced at Microsynth® (CH-9436 Balgach) 
and additionally confirmed by enzymatic digestion.  
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 agactgggagccgagtgagatcttagcctctcgggctgcgtgcaaaaaccttagaaaatg 
 R  L  G  A  E  -  D  L  S  L  S  G  C  V  Q  K  P  -  K  M 
 tatacgagtcatgaagatatcgggtatgaccttgaagacgaccgaaaggctaagaataag 
 Y  T  S  H  E  D  I  G  Y  D  L  E  D  D  R  K  A  K  N  K 
 aagacgctgaagccccacccagatatcgatggcgggtgggcctggatgatggtcctctcg 
 K  T  L  K  P  H  P  D  I  D  G  G  W  A  W  M  M  V  L  S 
 tccttctttgttcacatcctcatcatgggctcacagatggccctaggagtcctcaacgtg 
 S  F  F  V  H  I  L  I  M  G  S  Q  M  A  L  G  V  L  N  V 
 gagtggcttgaagagtttcaccagagccgcggcctgaccgcctgggtcagctccctgagc 
 E  W  L  E  E  F  H  Q  S  R  G  L  T  A  W  V  S  S  L  S 
 atgggcatcaccttgatcgtgggacctttcatcggcttgttcattaacacctgcgggtgc 
 M  G  I  T  L  I  V  G  P  F  I  G  L  F  I  N  T  C  G  C 
 cgccagacagcaatcattggaggcctggtgaactccctcggctgggtgttgagcgcctat 
 R  Q  T  A  I  I  G  G  L  V  N  S  L  G  W  V  L  S  A  Y 
 gcagccaatgtgcagtctctctttattacctttggagtggcagcaggccttggcagtggg 
 A  A  N  V  Q  S  L  F  I  T  F  G  V  A  A  G  L  G  S  G 
 atggcttacctacctgcagtggtcatggtgggaaggtactttcagaagagacgagccctg 
 M  A  Y  L  P  A  V  V  M  V  G  R  Y  F  Q  K  R  R  A  L 
 gcccagggcctcagtaccacggggacaggatttgggacgttcctgatgaccgtgttgctg 
 A  Q  G  L  S  T  T  G  T  G  F  G  T  F  L  M  T  V  L  L 
 aaatacctgtgcgcagaatatggctggcggaatgctatgttcatccaaggtgctctgtcc 
 K  Y  L  C  A  E  Y  G  W  R  N  A  M  F  I  Q  G  A  L  S 
 ctgaacctgtgtgtctgtggggcgctcatgaggcccctctctcccgagaagttagaaaac 
 L  N  L  C  V  C  G  A  L  M  R  P  L  S  P  E  K  L  E  N 
 tgcccagaagcggaagagccgtgtgctctcccagcttactccactgaatctgttaagtct 
 C  P  E  A  E  E  P  C  A  L  P  A  Y  S  T  E  S  V  K  S 
 ggaggaccactgggcatggctgaagaacaggacagaaggcccgggaatgaggagatggtg 
 G  G  P  L  G  M  A  E  E  Q  D  R  R  P  G  N  E  E  M  V 
 tgtgaccttcaaacacaggagtgtcaaggtcaaacccatccgaggaagaatgtgtgtgcc 
 C  D  L  Q  T  Q  E  C  Q  G  Q  T  H  P  R  K  N  V  C  A 
 ttccgggttctgaagacagtgagccagctcactgtgcaagtccggaggggctttagggac 
 F  R  V  L  K  T  V  S  Q  L  T  V  Q  V  R  R  G  F  R  D 
 tggcactcaggctattttgggacggcttcactcttcaccaaccgcatgtttgtagccttt 
 W  H  S  G  Y  F  G  T  A  S  L  F  T  N  R  M  F  V  A  F 
 attttctgggctctgttcgcatacagcagctttgtcatccctttcatccacctgcccgaa 
 I  F  W  A  L  F  A  Y  S  S  F  V  I  P  F  I  H  L  P  E 
 atcgtcagtttgtataacttgtcagagcaaaatgacacattccctctgacctcgattata 
 I  V  S  L  Y  N  L  S  E  Q  N  D  T  F  P  L  T  S  I  I 
 gcaatacttcacatcttcgggaaggtgatcttgggggccgtggccgacctcccctgtatc 
 A  I  L  H  I  F  G  K  V  I  L  G  A  V  A  D  L  P  C  I 
 agcgtctggaatgtcttcctcatcgctaacttcaccctcgtcctcagcatcttccttctg 
 S  V  W  N  V  F  L  I  A  N  F  T  L  V  L  S  I  F  L  L 
 cctctgatgcacacctacgcgagtctggctgtcatttgtgccctaattgggttttctagc 
 P  L  M  H  T  Y  A  S  L  A  V  I  C  A  L  I  G  F  S  S 
 gggtatttctccctcatgcctgtggtgacagaggacctggttggcactgagcacttggcc 
 G  Y  F  S  L  M  P  V  V  T  E  D  L  V  G  T  E  H  L  A 
 aatgcctacggcatcatcatctgcgccaatggcatctcagccttactaggaccaccattc 
 N  A  Y  G  I  I  I  C  A  N  G  I  S  A  L  L  G  P  P  F 
 gcaggatggatctttgacatcacccaaaaatatgacttttccttttatatatgtggtttg 
 A  G  W  I  F  D  I  T  Q  K  Y  D  F  S  F  Y  I  C  G  L 
 ctttacatggtagggatactctttttgctcattcaaccgtgtattcagatgatagatcaa 
 L  Y  M  V  G  I  L  F  L  L  I  Q  P  C  I  Q  M  I  D  Q 
 tccagaaggaagtgcatagagggtgcacatgtttagtgtcctgtaacgtttcctgtgggt 
 S  R  R  K  C  I  E  G  A  H  V  -  C  P  V  T  F  P  V  G 
 
Figure 9. SLC16A14/MCT14 cDNA (without Myc sequence, see results for myc-SLC16A14/MCT14 construct) 
and protein sequence in red. Added restriction sites are marked in blue. Green represents the stop codon. Yellow 
marked letters are the first and the last amino acids respectively of the coding sequence. 
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Primers for PCR with annealing restriction sites for SacI and XhoI 
 
                                             SacI 
Forward Primer:  5‟ AAAAGAGCTCTATACGAGTCATGAAG 3‟ 
Length: 16b 
38% CG 
35,5°C = Tm 
                       XhoI    stop 
Reverse Primer: 5‟ AAAACTCGAGCTAAACATGTGCACC 3‟ 
Length: 15b 
47% CG 
39,7°C = Tm 
 
pSPOK-G (restriction sites for SacI and XhoI) 
5‟Myc...GAGCTCGCCCCCCTCGAG......3‟ 
3‟      ...CTCGAGCGGGGGGAGCTC......5‟ 
 
Figure 10: Primers designed for modification of the 3‟ and 5‟ ends of SLC16A14/MCT14 sequence. SacI and 
XhoI were chosen as restriction sites, since these sites were absent in the SLC16A14/MCT14 sequence and 
present only once in the pSPOK-G vector.  
 
 
Reverse transcription of myc-SLC16a14/MCT 
 
SLC16A14/MCT14 cDNA (2 μg) was linearized with PvuII at the 3‟ end down-stream 
the poly-A tail. The product was purified using the QIAquick gel extraction kit 
(Qiagen, Germany, Cat. No. 28704). cDNA was eluted in 25 µl of dH2O. cRNA was 
synthesized using the mMessage mMachine® kit (Ambion, USA). To 1 µg of purified 
template (12 µl), 3 µl of 10x buffer, 12 µl NTPs/Cap mixture and 2 µl of enzyme mix 
containing Sp6 RNA polymerase were added to a final volume of 30 µl. The mixture 
was incubated at 37°C for 5 h. RNA synthesis was then stopped on ice with 20 µl of 
RNAse free water and 40 µl lithium solution kept at -20°C for at least 1 h. Precipitated 
cRNA was recovered by centrifugation (13‟000 r.p.m. for 20min at 4°C) and the 
resulting pellet was washed with ice cold 70% ethanol. The tube was centrifuged for 
10 min (4°C), ethanol was removed as much as possible and traces of ethanol were 
left to evaporate for 1 h. Final cRNA was dissolved in 25 µl of RNAse free dH2O and 
its concentration determined. RNA was finally stored at -80°C until further use. 
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Xenopus laevis oocyte expression studies  
 
Frogs (Xenopus laevis) were anesthetized using tricaine mesylate (MS222) (Sigma, 
USA, Cat. No. A5040) and oocytes were collected by surgery. Ovaries were cut into 
small pieces, pulled apart with forceps and washed several times (in 50 ml Falcon 
tubes) in calcium free Barth‟s solution (Table 2) using a rotator (Model 151, Level 2, 
Bender + Hobein, Switzerland). After several washes, liquid was removed and 
collagenase containing solution [20 ml calcium free Barth‟s solution, 4 mg trypsin 
inhibitor (Sigma Aldrich, USA), 40 mg collagenase type 1A (Sigma, USA)] was added 
in a ratio 3:1 (15 ml of collagenase containing solution to approximately 5 ml of 
oocytes (measured in a Falcon tube)). Collagenase digestion was performed for 30-
35 minutes (at RT). Collagenase was removed by several washing steps with calcium 
free Barth‟s solution. Finally oocytes were washed twice with calcium containing 
Barth‟s solution and stored at 16°C. Final Barth‟s solution contained 5 mg doxycyclin 
(Fluka, USA, Cat. No. 44577) and 5 mg gentamicin (Fluka, USA, Cat. No. 48760) per 
liter. 
 
Table 2. Barth’s solution  
 Barth’s Solution 
NaCl 88 mM 
KCl 1 mM 
CaCl2 0.41 mM 
MgSO4 0.82 mM 
NaHCO3 2.5 mM 
Ca(NO3)2 2 mM 
HEPES 7.5 mM 
 
pH was adjusted to 7.5 with 1M TRIS  autoclaved  antibiotics added before use  stored at 4°C 
 
 
RNA was synthesized as described above and 25 ng in 50 nl were injected per 
oocyte using the Nanoject II (Drummond Scientific Company, USA). Ooocytes were 
incubated at 16°C for 3 days before uptake studies were conducted. Confirmation for 
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correct expression of the myc-Scl16a14 construct was realized by running a Western 
blot using oocyte homogenates (see oocyte homogenate preparation below). 
 
 
Uptake Studies 
 
Transport experiments with oocytes were performed either in the presence or the 
absence of Na+ - ions (Table 3). 
 
 
Table 3. Uptake solutions for transport experiments with Xenopus laevis 
 ND100                    ND0  
NaCl 100 mM Choline-Cl 100 mM 
KCl 2 mM KCl 2 mM 
CaCl2 1.8 mM CaCl2 1.8 mM 
MgCl2 1 mM MgCl2 1 mM 
 
pH was adjusted to the desired pH (see results) using 1 M HEPES and 1 M Tris base. 
 
 
Stock solutions of amino acids were prepared in uptake solutions or dH2O, 
depending on the concentration required and the solubility of each amino acid. 
Radioactively labeled amino acids were added in quantities depending on their 
specific radioactivity. Uptake buffers containing a single substrate were 
supplemented with 3H-labelled substrates (2 μCi/100 μl) or 14C–labelled substrates 
(0.4 µCi/100 µl).  
For each uptake, 10 oocytes (injected or non-injected) were used. Oocytes were 
added to a test tube and Barth‟s solution was removed carefully. 100 μl of uptake 
solution containing test substrate were added and incubation was performed at RT 
for 15 min. Uptake buffer was removed and oocytes were washed (3 to 4 times) with 
ice cold ND0 solution. Oocytes were transferred individually into single scintillation 
vials containing 200 μl of 4% SDS and put on a shaker for 30 min. Each vial was 
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filled with 3 ml scintillation liquid (Emulsifier-Safe™, Perkin Elmer, USA) and analyzed 
by liquid scintillation (Packard Tri-Carb 2900TR). 
 
 
Protein related methods 
 
Kidney homogenate and brush border membrane isolation  
 
Pieces of frozen kidneys were added to 800 μl of homogenization buffer (300 mM D-
mannitol, 5 mM EGTA, 12 mM Tris-base; adjusted with concentrated HCl to pH 7.1; 
buffer A). Protease inhibitor, Phenyl-methane-sulfonylfluoride (PMSF) (Sigma, USA), 
previously dissolved in isopropanol, was added to give a final concentration of 0.5 
mM. The amount of tissue (wet weight) did not exceed 10% of the total volume of the 
homogenization buffer. Homogenization was performed with a Polytron homogenizer 
(Model 2100, about 15‟000 r.p.m.) for 90 s on ice. The homogenate was shock frozen 
and stored at -80°C until further analysis.  
Proximal tubular brush border membranes (BBMV) were isolated as described [185]. 
To the homogenate of kidney tissue (see above), 1 ml of water and 1 M MgCl2 (to 
give a final 12 mM solution) were added. This mixture was kept on ice for 15 min 
followed by centrifugation (Sorvall® RC-5B) at 4‟500 r.p.m. (3‟000 gav) with a SS34 
rotor (Sorvall®) at 4°C. The formed supernatant was removed and centrifuged at 
16‟000 r.p.m. for 30 min at 4°C. The pellet was resuspended in 500 μl diluted (1:1) 
buffer A. Tubes were again centrifuged at 16‟000 r.p.m. for 30 min and the final pellet 
resuspended in a small amount of diluted (1:1) buffer A using a 25 G needle mounted 
on a 1 ml tuberculin syringe. Purified BBMV‟s were shock frozen and kept at -80°C 
until further use. 
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Oocyte homogenate  
 
Three oocytes were pooled in a 1.5 ml Eppendorf tube. Barth‟s solution was removed 
and 60 µl of homogenization buffer (20 mM Tris-HCl pH 7.6, 100 mM NaCl, 5 mM 
EDTA) were added. To prevent protein degradation, 1 µl of protease inhibitor cocktail 
(PIC) (Sigma, USA) was added to 5 ml of homogenization buffer. Oocytes were 
ruptured by pipetting (yellow tip) up and down until an even homogenate was formed. 
Following homogenization, Eppendorf tubes were vortexed for 20 s and placed on 
ice. Centrifugation was performed at 17‟000 r.p.m. (Sorvall® RP45-A rotor) for 3 min 
at 22°C and resulted in two separate layers and a pellet. Below the surface layer, 
cellular proteins can be collected with the homogenization buffer. In order to remove 
the homogenization buffer containing the proteins, a 200 µl pipette penetrated the 
surface and the solution below was extracted.  
 
 
Determination of protein concentration  
 
Protein concentrations were determined by the Bio-Rad Dc Protein Assay (BioRad, 
USA). Measurements were done in triplicates (in 96-well plates) and a standard 
curve was included using BSA (10 mg/ml stock solution). Homogenates and BBMV 
solutions were diluted 1:20 and 1:5 respectively and 5 μl were used for each 
determination. The reaction was performed according to the protocol of the 
manufacturer and after 15 min absorption was determined at 595 nm (Analyzer 
μQuant, Biotek®). 
 
 
Western blots  
 
Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).  
Minigels were prepared as described in Table 4.  
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Table 4. SDS-PAGE Protocol 
     
Gel %: 9% 10% 15%. stacker 
     
Water  3.21 ml 2.75 ml 0.50 ml 3.75 ml 
Tris/HCl, pH 8.8 (1.5 M) 2.50 ml 2.50 ml 2.50 ml -------- 
Acrylamide stock (22%) 4.10 ml 4.55 ml 6.80 ml 1.70 ml 
Tris/HCl,pH 6.8 (0.5 M) ---------- ---------- --------- 1.90 ml 
SDS 20% 0.05 ml 0.05 ml 0.05 ml 0.04 ml 
Am.-persulfate (10%) 0.10 ml 0.10 ml 0.10 ml 0.07 ml 
     
Before pouring gel add: 
TMED (Sigma)  
4 µl 4 µl 4 µl 5 µl 
 
Homogenate and BBM samples were thawed on ice prior to use. 6 mg of DL-
dithiotreitol (DTT) (Fluka, USA) were added to 100 μl concentrated 4x Laemmli buffer 
(4x LB; 8% SDS, 40% glycerol, 20% 2-mercaptoethanol, 0.008% bromophenol blue, 
0.25 M Tris-HCl with final pH 6.8, aliquoted and stored at -20°C). 50 μg homogenate 
or 15 μg BBM, were made up to a volume of 10 μl using dH2O. 4 μl of LB containing 
DTT were added, and samples boiled for 2 min at 95°C followed by quenching on 
ice. Electrophoresis was performed at 12-15 mAmp/gel in 25 mM Tris, 190 mM 
Glycine, and 0.1% of SDS .  
Separated proteins were transferred onto nitrocellulose membranes (Whatman® 
Schleicher & Schuell Protran BA 83 0,2 μm) in 25 mM Tris, 190 mM glycine and 20% 
methanol (100 V for 80 min). After transfer, nitrocellulose membranes were washed 
in TBS (150 mM NaCl, 25 mM Tris-HCl, pH 7.4) and incubated for 1 h in blocking 
buffer (TBS containing 5% of low fat milk powder (Coop-Switzerland) adjusted to pH 
7.4). Incubation with primary antibodies was performed in blocking buffer overnight at 
4°C (see supplementary table S2 listed at the end of “Materials and Methods”). On 
the next day, membranes were washed 3 times in TBS for 10 min each, followed by 
incubation in blocking buffer for 1 h. Secondary antibodies (coupled to horse radish 
peroxidase; GE Healthcare, UK) were added and incubation was continued for 
another 2 h. Blots were washed at least 3 times with TBS and incubated for 3 min in 
chemiluminescent substrate (SuperSignal®, West Pico, USA). Chemiluminescence 
was recorded with an image analyzer (LAS-4000, Fujifilm). 
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Immunohistochemistry 
 
Kidney tissue was fixed in situ with a fixative solution made from the the following 
stock solutions: 
 
- Fixative 1: 0.1 M cacodylate buffer: 10.71 g of sodium-cacodylate (Sigma, USA, 
Cat. No. CO250-250G) together with 17.12 g of sucrose were dissolved in 500 ml 
of dH2O and adjusted with HCl to a pH of 7.4. This solution was checked for an 
osmolarity of 300 mOsm.  
- Fixative 2: 0.1 M of phosphate buffer: (1) 0.2 M NaH2PO4 (Sigma, USA) (stored 
at 4°C). (2) 0.2 M Na2HPO4 (Sigma, USA) (stored at RT). (3) 0.1 M CaCl2 (Sigma, 
USA) (stored at 4°C). For use: 95 ml of (1) mixed with 405 ml of (2), 2.3 ml of (3), 
450 ml of dH2O, pH adjusted to 7.4, and final volume corrected to 1000 ml.  
- Caco-HAES or phosphate buffer-HAES: 0.33 g of MgCl26H2O together with 0.5 g 
picric acid were added to 200 ml 10% hydroxyethyl starch in isotonic NaCl 
(HAES) (Fresenius Kabi, Germany GmbH) and  300 ml of 0.1 M cacodylate 
buffer or 0.1 M phosphate buffer (see above) was added.   
- 33% PFA: 15 g of PFA (Aldrich, USA, Cat. No. 16005) were added to 45 ml H2O 
(pre-heated to 70°C). 10 N NaOH was added dropwise until the solution became 
clear.  
 
To obtain a working fixative solution, Caco-HAES buffer was mixed with 45 ml 33% 
PFA solution to a volume of 500 ml to obtain a 3% PFA fixative solution. The pH of 
the solution was adjusted to 7.4 (with HCl or NaOH) and filtered (Whatman®, 
Schleicher & Schuell, 0.2 μm). The final solution was used directly or stored at -20°C 
for up to one year. 
 
Perfusion of kidneys: 
 
In-situ perfusion of kidneys was performed via the left ventricle. Perfusion was started 
with 5 ml PBS followed by approximately 50 ml of final fixative solution. Kidneys were 
removed, cut in 2 pieces, and incubated for two hours in fixative solution followed by 
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washing steps (5 times) with PBS. Thin kidney slices were placed on cork pieces 
together with a small drop of Kryostat® (Medite, Nunningen, Switzerland) for tissue 
embedding. Tissue was snap frozen in liquid propane and stored at -80°C. 
A cryostat microtome (Leica CM1850) was used to cut kidney slices of 4-5 μm 
thickness that were fixed onto poly-lysine coated glass slides (O. Kindler GmbH & 
Co., Freiburg, Germany). Serial cuts were fixed and oriented on the same slide. 
Single tissue slices were encircled with the “ImmEdge” pen (Vector laboratories, 
USA, H-4000). Glass slides were placed in PBS and washed 3 times (10 min each). 
Finally, tissue slices were washed and incubated in PBS (at 4°C) overnight. Tissue 
sections were incubated (at RT) with blocking buffer (1% BSA and 0.02% Na+-azide 
in PBS) for 15 min in a humid chamber. Antibodies (see Supplementary table S2) 
were diluted in blocking buffer, and 50-100 μl were added to the slices followed by an 
incubation of 60 to 90 min. Slides were washed 3 times (10 min each) in PBS. The 
secondary antibody, donkey Alexa Fluor® 488 anti rabbit IgG (H+L) (2 mg/ml) 
(Molecular Tecnologies® Invitrogen, USA) was diluted in blocking buffer 1:1000 and 
applied to the slices for 60 min (humid chamber under dark conditions). Finally, slides 
were washed 3 times (10 min each) in PBS. Processed tissue slices were mounted in 
Glycero Gel mounting medium (DakoCytomation, Denmark) and left to dry for 30 min. 
Immunofluorescence was detected with a fluorescent microscope (Eclipse TE 300 
Nikon, Japan) and images were recorded with the NIS-Elements F3.0 software 
(Nikon, Japan). 
 
 
Urine and Blood Analysis 
 
Creatinine determination 
 
Urinary content of creatinine was determined according to the method of Jaffé [186-
187]. The following solutions were used: 
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- Reagent A: 4.4 g of NaOH dissolved in 400 ml dH2O. Then 9.5 g trisodium 
phosphate (Na3PO412H2O) and 9.5 g sodium tetraborate (Na2B4O710H2O) were 
added. After solutes where dissolved, pH was checked to be above 10 and if 
necessary adjusted with 10 M NaOH. Water was added to a volume of 500 ml 
and the solution was stored at 4°C (up to 3 months).  
- Reagent B: 5% sodium dodecyl sulfate (SDS) (Calbiochem® Merck, Darmstadt, 
Germany) in dH2O solution was prepared and kept at RT.  
- Reagent C: 7 g of moist picric acid was added to 500 ml of distilled water and 
mixed overnight at 37°C. The solution was filtered and stored light protected at 
room temperature. The reagent was stable for up to one year. 
- A creatinine (Sigma, USA) standard solution (1 mg/ml) was prepared in 0.1 M 
HCl.  
 
Sample solutions were prediluted 1:5 (10 μl urine + 40 μl dH2O) before 
measurements. The working reagent was made up with equal volumes of reagent A, 
B, and C. 10 μl of each sample or standard solution were added to a 96 well plate 
(Nunclon™ Surface, Denmark). 150 μl of working reagent was added, mixed and 
plates were incubated for 30 min at RT. Absorption was measured at 505 nm. 10 μl 
of 30% acetic acid were added and after 5 min at RT, absorbance at 505 nm was 
measured again. The second OD505 was subtracted from the first one and creatinine 
concentration was calculated.  
 
 
Phosphate determinations 
 
Pi concentrations in plasma and urine were determined according to Fiske and 
Subbarow [188]. The following solutions were used: 
 
- 20% trichloroacetic acid (TCA) 
- 1.25 g Ammonium molybdate in 100 ml of 2.5 N H2SO4 
- 1 g of Fiske & Subbarrow reducer (Sigma, USA, Cat. No. F5428-25G) per 6.3 ml 
of dH2O 
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- Phosphate standard solution was purchased from Randox® Laboratories (United 
Kingdom) 
 
Before measurements, urine samples from the HPD group animals were diluted 1:10. 
Serum Pi was determined without prior dilution of samples. Samples or standards (10 
μl) were mixed with 90 μl of 20% TCA and vortexed for 10 s. 900 μl of dH2O were 
added and tubes were vortexed again for 10 s. Samples were left on ice for 10 min 
followed by centrifugation for 20 min at 13‟000 r.p.m. at 4°C. 250μl of supernatants 
were added to a 96-well plate (Nunclon™ Surface, Denmark) and 50 μl of ammonium 
molybdate solution was added followed by the addition of 12.5 μl of Fiske & 
Subbarrow reducer solution. The plate was rotated gently and left at room 
temperature for 15-20 min. Absorption was determined at 620 nm. 
 
 
Ion chromatography and NH3/NH4
+ determination 
 
Urine samples of LPD and HPD mice were analyzed for K+, Na+, Mg2+, Ca2+, and Cl- 
using ion exchange chromatography (Metrohm ion chromatography, Herisau, 
Switzerland). Urinary content of ammonium was measured according to the protocol 
of Berthelot [189].  
 
Following reagents were prepared: 
 
- Phenol Reagent (Sigma, USA, Cat. No. 242322) (for 100 ml) containing 5 g 
together with 0.025 g of Sodium nitroprusside (Na2[Fe(CN)5NO]2H2O) (Sigma, 
USA, Cat. No. S0501) 
- Alkaline Reagent (for 100ml) containing 2.5 g NaOH and 2.82 ml Sodium 
hypochlorite (Sigma, USA, Cat. No. 425044) 
- Ammonium standard solution (50 mM of NH4
+) with 33 mg ammonium sulphate 
(Sigma, USA, Cat. No. A4418) made up to 100 ml.  
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Urine dilution was 1:10. A Standard curve was obtained using the ammonium stock 
solution. For control anaylsis, phenol reagent was used as a negative control (blank). 
To 20 μl of each urine sample, 1 ml of phenol reagent was added in an Eppendorf 
and vortexed briefly. 1 ml of alkaline reagent was added and vortexed again. Tubes 
were left incubated for 40 min at RT. 300 μl of each sample were added to a 96 well 
plate (Nunc™, Denmark) and analyzed at 623 nm.  
 
 
Statistics 
 
All experimental results (microarray analysis (see above), real time RT-qPCR, oocyte 
uptakes, quantification of immunoblots) are expressed as means ±SEM. The 2D 
graphical and statistical software GraphPad Prism® was used for data handling. Data 
evaluation analysis for statistical significance was done by unpaired student t-test. 
The levels of significance were defined as follows; highly significant (***p < 0.001), 
very significant (**p < 0.01), and significant (*p < 0.05).  
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Supplementary  
 
Supplementary table S1a. Designed primers and probes used for RT-qPCR 
 
Gene Acc. N. Primers Probe (reporter : FAM, quencher TAMRA) 
SLC38a3 NM_023805 F: 5'-CGAATCATGCCCACTGACAA-3' 5„-AGCCTGCAAGATCCACCCCTAAAATCCT -3' 
(SNAT3)  (1651-1670) (1673-1700) 
  R: 5'-AACCGCAGCGAAACAAAGG -3'  
  (1704-1722)  
PEPCK NM_028994 F: 5‟-GTGGGCGATGACATTGCC-3‟ 5‟-CCCAAGGCAACTTAAGGGCTATCAACCC-3‟ 
  (1062-1079) (1096-1123) 
  R: 5‟-ACTGAGGTGCCAGGAGCAAC-3‟  
  (1143-1162)  
SLC34a1 NM_011392 F: 5'-TGATCACCAGCATTGCCG-3' 5'-CCAGACACAACAGAGGCTTCCACTTCTATGTC-3' 
(NaPi-2a)  (907-924) (975-1006) 
  R: 5'-GTGTTTGCAAGGCTGCCG-3'  
  (1022-1039)  
SLC34a3 NM_080854 F: 5'-TAATCTTCGCAGTTCAGGTTGCT-3' 5'-CCACTTCTTCTTCAACCTGGCTGGCATACT-3' 
(NaPi-2c)  (1399-1421) (1427-1456) 
  R: 5'-CAGTGGAATTGGCAGTCTCAAG-3'  
  (1478-1499)  
β-actin NM_007393 F: 5'-GACAGGATGCAGAAGGAGATTACTG-3' 5'-AGGAGGAGCAATGATCTTGATCTTCATGG-3' 
  (1010-1034)  
  R: 5'-CCACCGATCCACACAGAGTACTT-3'  
  (1085-1107)  
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Supplementary Table S1b. Expression Assays® (AppliedBiosystems) for RT-qPCR 
 
Gene Acc. N. Assay ID 
SLC7a12 NM_080852 Mm00499866_m1 
SLC39a14 NM_001135151 Mm00522700_m1 
SLC16A14/MCT14  NM_027921 Mm01272722_m1 
Abcb1a NM_011076 Mm00440761_m1 
Glud1 NM_008133 Mm00492353_m1 
Acot1 NM_012006 Mm01622471_s1 
Acot11 NM_025590 Mm00452633_m1 
Cyp51 NM_020010 Mm00490968_m1 
Car4 NM_007607 Mm00483021_m1 
Cyp27B1 NM_010009 Mm01165921_g1 
18 S rRNA NM_022551 Hs99999901_s1 
Omd NM_012050 Mm00449589_m1 
FKBP51 NM_020009 Mm00444968_m1 
Gphn NM_172952 Mm00556895_m1 
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Supplementary Table S2.  Primary Antibodies used for Immunohistochemistry and Western Blots 
 
Antibody for: Type Raised against (peptide sequence) 
Dilution  
Source Reference 
Western 
Blot 
Immunohisto- 
chemistry 
       
ROMK  
(mouse, rat) 
Rabbit 
(polyclonal) 
Commercial (intracellular C-terminus)  1 : 200 Alomone Labs (Jerusalem, 
Israel), provided by Prof. Loffing 
(Institute of Anatomy, UZH) 
 
MCT14  
(mouse) 
Rabbit 
(polyclonal) 
NH2-
KSGGPLGMAEEQDRRPGNEEMVC
-COOH (affinity purified) 
1 : 4'000 1 : 200 Pineda Ab-Production (Berlin, 
Germany) 
 
NKCC2 
(mouse)  
Rabbit 
(polyclonal) 
NH2-
CEYYRNTGSVSGPKVNRPSLQE-
COOH  
 1 : 20'000 Provided by Prof. Loffing 
(Anatomical Institute, Universtiy 
of Zürich) 
[190] 
NaPi-2a  
(mouse)  
Rabbit 
(polyclonal) 
Synthetic 12-mer C-terminal and N-
terminal NaPi-2a peptides  
1 : 4'000 1 : 500 Physiological Institute, 
University of Zürich (Prof. 
Murer‟s Lab) 
[31, 46] 
NaPi-2c  
(mouse) 
Rabbit 
(polyclonal) 
NH2-CYENPQVIASQQL-COOH 
(affinity purified) 
1 : 1'000  Physiological Institute, 
University of Zürich 
[102] 
β-actin  
(mouse) 
Mouse 
(monoclonal) 
Commercial 1 : 30'000  Sigma, USA  
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Abbreviations 
 
LPD  Low phosphate diet 
HPD  High phosphate diet 
RT  Room temperature 
DEPC  Diethylpyrocarbonate 
RIN  RNA integration number 
FGCZ  Functional Genomics Center University Zürich 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
PBS  Phosphate buffered saline 
CHAPS 3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate 
EDTA  Ethylene diamine tetraacetic acid 
DIG  Digoxigenin 
PFA  Paraformaldehyde 
SDS  Sodium dodecyl sulphate 
EGTA  Ethylene glycol tetraacetic acid 
PMSF  Phenyl-methane-sulfonylfluoride 
BBMV  Brush border membrane vesicles 
PIC  Protease inhibitor cocktail 
BSA  Bovine serum albumin 
TCA  Trichloroacetic acid 
DTT  Dithiotreitol 
TBS  Tris buffered saline 
HAES  Hydroxyethyl starch 
SEM  Standard error of the mean 
RT-qPCR Real Time Quantitative PCR 
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RESULTS 
 
Microarray analysis after 5 days (“chronic”) of LPD and 
HPD administration 
 
In a first attempt to determine if altered intake of dietary Pi changes renal gene 
expression, mice were fed either a HPD or LPD for 5 days (“chronic” adaptation). 
Animals were sacrificed in the morning at 8 am of the 6th day, and kidneys and blood 
were harvested. The effect of different Pi-diets was controlled by a determination of 
plasma Pi-concentration and by analysis of the amount of the Na/Pi-cotransporter 
NaPi-2a. As illustrated in Figure 11 A, mice fed a LPD were hypophosphatemic 
whereas mice fed HPD were slightly hyperphosphatemic. Only traces of Pi were 
deteted in the urine of LPD mice while phosphaturia was observed in mice fed a HPD 
(data not shown). The pH values of the urine were determined as well, and a 
significant difference between both groups was assessed. There was a  clearly acidic 
urine in the HPD group when compared to the LPD group, which was rather 
scattered and partly basic (Figure 11 B). In agreement with published results [23, 47, 
119-120, 145-146], the amount of NaPi-2a protein was higher in kidneys of mice fed 
a LPD compared to mice fed a HPD (Figure 11 C).  
Total renal RNA was extracted and analyzed by RT-qPCR for contents of NaPi-2a 
and NaPi-2c mRNAs. As illustrated in Figure 12, no significant change for NaPi-2a 
mRNA, but a 2-fold difference in the NaPi-2c mRNA content was observed between 
the LPD groups; these data were in agreement with published data [49]. Of note, 
content of NaPi-2a mRNA was approximetely 100-fold higher than NaPi-2c mRNA 
reflecting the relative importance of the two Na/Pi-cotransporters in renal Pi handling 
[191].  
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Figure 11. “Chronic” adaptation (5 days) of mice to low (LPD) and high (HPD) Pi-diets. (A) Serum Pi 
concentration. (B) Comparison of urine pH between mice that received LPD and a HPD. (C) Western blot analysis 
for NaPi-2a in kidney homogenates. Immunoblot was stripped and reprobed with an antibody against β-actin for 
control of equal loading. Data with ± SEM; n = 6; *p < 0.05, ***p < 0.001. 
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Figure 12. RT-qPCR for Na/Pi-cotransporters after “chronic” (5 days) feeding of mice with LPD and HPD. (A) 
NaPi-2a mRNA shows no significant (ns) difference between LPD and HPD (B) NaPi-2c mRNA was significantly 
up-regulated by LPD compared to HPD. Data with ± SEM; n = 6; *p < 0.05. 
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Before total RNA samples were processed for microarray analysis, they were 
analyzed by electrophoresis for quality using the 2100 Bioanalyzer (Agilent 
technology, Waldbronn, Germany) (Figure 13). In all samples the ratio 260/280 nm 
was 2.15 to 2.25 and with a RIN of at least 9 (a RIN of 8 was required for microarray 
analysis). Best 4 total RNA samples of each group were processed and analyzed by 
hybridization onto GeneChip® Mouse Genome 430 2.0 arrays (Affymetrix).  
 
A                                                                         B                    
     
                  
 
Figure 13. Quality analysis of total kidney RNA. Samples 1-6 were from LPD animals and samples 7-12 were 
from mice that have been given a HPD. (A) Virtual gel of RNA samples integrated from the information obtained 
in (B) that shows the peaks of ribosomal 18 S and 28 S RNA. Quality is determined by the RIN (RNA integration 
number) which is obtained by integrating the area beneath the peaks obtained from the ribosomal RNAs.  
 
 
Of the 8 samples hybridized to the chip containing approximately 34‟000 protein 
coding genes with over 39‟000 transcripts, 12‟934 genes were detected representing 
38% of the total number that were present on the array. 3833 genes were detected to 
be changed significantly (p < 0.05) in response to LPD versus HPD feeding (see 
Supplementary table S3 on CD). Of those, 1892 were detected to be up-regulated 
(1259 genes with a fold change ≥ 1.5) and 1762 genes were down-regulated (631 
with a fold change ≤ 0.67). Only genes with a fold change of 50% and higher were 
considered for further analysis. Genes whose expression was affected mostly 
(microarray fold change (mFC) ≥ 50%, p < 0.01) by LPD vs. HPD diet are listed in 
Table 5 a & b. 
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Table 5a. Genes down-regulated after 5 days of LPD (p < 0.01) 
    
Gene Symbol Gene Name Fold Change GeneBank Acc. No.   
    
Ccl28   Chemokine (C-C motif) ligand 28 0.08 NM_020279 
Ces1 Carboxylesterase 1 0.12 NM_021456 
Odc1   Ornithine decarboxylase, structural 1 0.19 NM_002539 
SLC16A14/MCT14 Solute carrier family 16, member 14 0.21 NM_027921 
Frzb(SFRP3) Small frizzled related protein 3 0.40 NM_011356 
Trp53bp Transformation related protein 53 binding protein 2 0.42 NM_173378 
Lpl Lipoprotein lipase 0.42 NM_008509 
PEPCK Phosphoenolpyruvate carboxykinase 1, cytosolic 0.43 NM_011044 
SLC39A14 Solute carrier family 39, member 14 (zinc transporter) 0.48 NM_001135151 
CCKAR Cholecystokinin A receptor 0.50 NM_009827 
AACS Acetoacetyl-CoA synthetase 0.56 NM_030210 
 
Table 5b. Genes up-regulated after 5 days of LPD (p < 0.01) 
    
Gene Symbol Gene Name Fold Change GeneBank Acc. No.   
    
Cyp27B1 Cytochrome P450, family 27, subfamily b 10 NM_010009 
Abtb2 Ankyrin repeat and BTB(POZ) domain containing 2 7.7 NM_178890 
ABC1a     ATP binding cassette sufamily B (MDR/TAP) member 1A 4.3 NM_011076 
Olfm3 Olfactomedin 3 4.2 NM_153458 
Pik3ca Phosphatidylinositol 3-kinase, catalytic 4.2 NM_008839 
Acot3 Acyl-CoA thioesterase 3 3.7 NM_134246 
Acot1 Acyl-CoA thioesterase 1 3.5 NM_012006 
Lrat Lecithin-retinol acyltransferase 3.5 NM_023624 
SLC25A36 Solute carrier family 25, member 36 2.7 NM_138756 
Jub Ajuba 2.0 NM_010590 
 
List of selected genes that were down- and up-regulated after a LPD (vs. HPD). For each gene, the symbol, gene 
name, fold change, and GeneBank accession number is given. 
 
 
Some genes were selected and analyzed by RT-qPCR (Figure 14) chosen either 
randomly (e.g. Slc7A12, Supplementary table S3) or selectively (e.g. Cyp27B1, Table 
5b) to confirm changes observed on the GeneChip. Another solute carrier, SLC7A12, 
a cationic amino acid transporter, was shown by RT-qPCR to be up-regulated after a 
LPD, confirming microarray data (mFC = 3.5). The aromatic amino acid transporter 
SLC16A10/TAT1 (mFC = 3.6) was not significantly changed when tested using RT-
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qPCR. Amplification of gephyrin, a protein involved in sorting, did not agree with the 
data on the chip (mFC = 2). The zinc transporter SLC39A14/ZIP14 (mFC = 0.5) also 
showed lower expression in the LPD group when compared to the HPD group based 
on the data collected by RT-qPCR. The Abcb1a transporter was not significantly 
changed, even though a difference of mRNA content between both diet groups was 
detected on the chip (mFC = 1.8). Cyp27B1 (1α-hydroxylase), the enzyme 
responsible for the activation of Vitamin D, was strongly up-regulated as expected 
[176], in LPD when compared to HPD group (mFC = 10). This was also confirmed by 
RT-qPCR. SLC16A14/MCT14, a member of the monocarboxylate transporter family 
with unknown function (See below “Characterization of SLC16A14/MCT14”), was 
strongly down-regulated in the LPD group based on the chip data (mFC = 0.2). This 
was also supported by RT-qPCR experiments. Overall, for most genes tested, fold-
changes, as observed by microarray chip analysis, could be reproduced by RT-qPCR 
using total kidney RNA obtained from independent experiments (Figure 15). 
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Figure 14. RT-qPCR confirmation of gene transcripts from microarray data. Below the gene name, in paranthesis, 
the fold change (mFC) obtained from microarray data is presented. For confirmation, genes have either been  
randomly (A-F) chosen from the gene list obtained (See Supplementary table S3), or selectively based on known 
responsive actions to Pi, such as (H) 1α-hydroxylase, or for classification of a new dietary Pi responder, such as 
(I) SLC16A14/MCT14. Data with ± SEM. n = 6, ns: not significant **p ≤ 0.01,***p ≤ 0.001. 
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Figure 15. Linear regression after 5 days of LPD between fold changes (FC) of selected genes analyzed by RT- 
qPCR and micorarray analysis. n = 8, R
2
 = 0.803. 
 
 
Pathway Analysis 
 
Web based pathway analysis toolkits (e.g. WebGestalt, G-profiler) indicated that 
most of the genes affected by “chronic” (5 days) intake of a LPD were involved in 
oxidative phosphorylation and energy metabolism. Other pathways affected were 
lipid metabolism, skeletogenesis, adipogenesis, and Wnt signalling (see Discussion 
Table 10 a & b). Nine solute carrier transporters (SLC) responded to dietary Pi 
depletion (3 down- and 6 up-regulated, See Table 6). Of the monocarboxylate 
transporter family (SLC16), two members were found to be changed; the amino acid 
transporter Tat1 (SLC16A10) and the SLC16A14/MCT14, of unknown function, with a 
fold change of 2.6 and 0.2 respectively.  
As expected, Cyp27B1/1α-hydroxylase, was up-regulated (mFC = 10) in response to 
LPD (see also Discussion). In addition, phosphoenolpyruvate carboxykinase 
(PEPCK), a key enzyme in gluconeogenesis, was found to be regulated as well (mFC 
= 0.4). Interestingly, altered expression levels of PEPCK have also been observed in 
response to acid loading in mice [192]. Also, the small frizzled related protein SFRP3 
was down-regulated (mFC = 0.4) in LPD mice. SFRP3 has been demonstrated to 
regulate limb skeletogenesis, triggering hip osteoarthritis [193], cell growth, apoptosis 
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and differentiation of specific cell types [194]. It was previously shown that small 
frizzled related protein 4 (SFRP4) has phosphaturic effects by selectively inhibiting 
the Na/Pi-cotransport in the kidney [81] as well as acting as a soluble modulator in 
the Wnt signalling pathway [195]. Whether SFRP3 has a similar inhibiting or 
antagonizing effect on Na/Pi-cotransport as SFRP4 remains to be elucidated. 
Surprisingly, both factors, SFRP3 and SFRP4 have been shown to modulate cell 
apoptosis when acting through the Wnt signalling pathway [195].  
 
Table 6. Solute carriers affected by dietary Pi (p < 0.01) 
    
Gene Symbol Solute Carrier  Fold Change GeneBank Acc. No. 
    
SLC16A14/MCT14   Monocarboxylate transporter, unknown 0.2 NM_027921 
SLC39A14 Zinc transporter, widespread 0.5 NM_001135151 
SLC37A2 Glycerol 3-phosphate exchanger, widespread 0.6 NM_020258 
SLC43A2 Lat4, neutral amino (aa) acid transporter, kidney 1.5 NM_173388 
SLC6A8 Na
+
/Cl
-
/creatine cotransporter, ubiquitous 1.6 NM_133987 
SLC35E3 Nucleoside/sugar transporter family member, unknown 1.7 NM_029875 
SLC16A10 TAT1, Aromatic aa transporter, kidney (basolateral) 2.1 NM_028247 
SLC25A36 Mitochondrial carrier, unknown 2.7 NM_138756 
SLC7A12 Cationic aa transporter/glycoprotein family member, unknown 3.4 NM_080852 
 
 
In summary, the profile of renal gene expression after “chronic” (5 days) feeding with 
a LPD (versus HPD) showed that many genes involved in energy metabolism were 
affected (see discussion for details). This may be an obvious finding at first glance,, 
as intracellular Pi is directly involved in the generation of ATP. Therefore, 
disturbances of energy metabolism may affect in a more pleiotropic way various other 
cellular functions as manifested by the high number of genes, the expression of 
which was affected by “chronic” LPD. In order to find genes that are possibly more 
directly influenced by LPD, the period of intake of LPD was therefore shortened in a 
new experimental setup.  
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Investigating an early time point for responses to different 
Pi-diets  
 
Intake of different Pi-diets (under trained conditions) results, within a few hours, in an 
altered abundance of the Na/Pi-cotransporter NaPi-2a [152-154]. This effect, 
however, is not associated with altered expression of NaPi-2a mRNA. In order to 
establish a time point suitable to investigate early effects of altered Pi-diet on renal 
gene expression, mice were trained to eat for 5 days between 6 and 9 pm. On the 
day of experiment, mice were fed for 3 hours (h) (6 to 9 pm) with high (control) or low 
Pi-diets and kidneys and blood were harvested 4, 8 and 14 h after the onset (6 pm) 
of the different Pi-diets. As shown in Figure 16, hypophosphatemia was detected 
after 4 h and was not altered after 8 h. Interestingly, after 14 h of LPD, serum Pi was 
elevated again accounting for a significant increase from 8 to 14 h.  
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Figure 16. Serum Pi of mice given a LPD and a HPD over different time points. After 4 h, a significant decrease in 
serum Pi concentration of mice with LPD intake can be observed. This difference is further observed after 8 h 
which then increases in the LPD group significantly after 14 h. Data with ± SEM; n = 3-6; *p < 0.05, **p < 0.01, 
***p < 0.001. 
 
 
From kidneys harvested after the different time points, BBM were isolated and 
analyzed for abundance of the Na/Pi-cotransporter NaPi-2a by immunoblot. As 
illustrated in Figure 17, NaPi-2a abundance was increased after 4 and 8 h of LPD as 
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expected. Similar changes of NaPi-2a abundance were observed after 14 h (data not 
shown).  
 
 
 
Figure 17. Western Blot of NaPi-2a. Regulation of NaPi-2a abundance in the BBM of the proximal tubule after 4 h 
and 8 h of LPD in comparison to HPD. 
 
 
RT-qPCR for selected genes was performed on total renal RNA isolated after 4, 8 
and 14 h of feeding periods. These genes were found to be regulated during 
“chronic” adaptation to LPD (compared to HPD). For expression of selected genes, 
most significant differences between the two Pi-diets were observed after 14 h, 
whereas no significant changes were observed after 4 and 8 h (data not shown). As 
illustrated in Figure 18, expression of the SLC16A14/MCT14 gene was similarly 
affected  (0.2 fold) by LPD as observed after “chronic” (5 days) adaptation. Cyp27B1 
did not respond at any of the three periods, which agrees with data previously 
published [176]. After 14 h, altered expression of PEPCK and Acot1 were observed 
as well. Based on this data, a 14 h period (referred thereafter as “acute” adaptation) 
was selected for further investigations.  
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Figure 18. RT-qPCR of selected genes regulated 14 h after the onset of LPD and HPD. Genes were selected 
based on their regulation after 5 days of LPD and HPD administration. (A) SLC16A14/MCT14 changed 
significantly while (B) 1α-hydroxylase was not regulated after 14 h LPD. (C) PEPCK mRNA expression levels 
were very significantly decreased in the LPD group while (D) Acot1 mRNA was up-regulated in LPD animals. ns: 
not significant. Data with ±SEM, n = 6, *p < 0.05, **p < 0.01, ***p < 0.001. 
 
 
Urinary analysis after 14 hours (“acute”) LPD and HPD 
 
Mice (n = 12), after being training to eat between 6 and 9 pm, were exposed to HPD 
for a 3 h feeding period. Three days before sacrifice they were individually placed in 
metabolic cages with 3 h HPD administration in the evenings. On the last evening, 
the experimental group (n = 6) received a LPD for 3 h while the control group 
continued to eat the HPD. Overnight (14 h) urine was collected before blood and 
kidneys were harvested. Urine was analyzed for the content of several components. 
As shown in Table 7, no significant differences were observed for urinary excretion of 
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Cl-, SO4
2-, Na+, K+, Ca2+, and Mg2+. Excretion of Pi and NH3/NH4
+ was significantly 
decreased in LPD animals when compared to HPD animals. Similarly as observed 
after “chronic” (5 days) adaptation, urinary pH of the HPD mice was more acidic than 
the urine collected from LPD mice. All other parameters; food and water intake, body 
weight, and urine volume did not differ significantly between the two diet groups. 
Control of food intake was of particular importance, as mice could have eaten less of 
the low Pi-diet and therefore the energy balance could have been disturbed. 
 
 
Table 7. Summary of urine analysis 
   
 HPD (1.2%) LPD (0.01%) 
   
pH 5.79±0.070 6.16±0.100
* 
Creatinine (mg/dl) 29.50±7.530 35.50±10.800
ns 
Pi (mM)/crea (mg/dl) 6.47±0.940 0.79±0.240‡
 
Cl
-
 (mM)/crea (mg/dl) 3.64±0.720 3.75±0.800
ns 
SO4
2-
 (mM)/crea (mg/dl) 0.43±0.140 1.33±0.490
ns 
NH3/NH4
+
 (mM)/crea (mg/dl) 7.41±1.060 1.49±0.350‡ 
Na
+
 (mM)/crea (mg/dl) 3.26±0.760 2.37±0.440
ns 
K
+
 (mM)/crea (mg/dl) 6.89±1.080 4.36±1.020
ns 
Ca
2+
 (mM)/crea (mg/dl) 0.11±0.050 0.37±0.110
ns 
Mg
2+
 (mM)/crea (mg/dl) 0.44±0.060 0.61±0.170
ns 
Urine volume (ml) 1.30±0.200 1.10±0.200
ns 
Urine volume/BW 0.06±0.010 0.05±0.001
ns 
Body weight (g) 20.40±0.590 21.00±0.380
ns 
Water intake ml/ BW  0.20±0.020 0.18±0.010
ns 
Food intake g/ BW 0.08±0.001 0.09±0.001
ns 
 
Urine values summarized from mice receiving a low (0.1%) Pi and a high (1.2%) Pi-diet during a 3 h feeding 
period and sacrificed 14 h after receiving their diets. Urine was collected from the beginning of the feeding period 
(6 pm) and values normalized against creatinine (crea). n = 6 per group; BW, body weight; ns, not significant. *p < 
0.05, ‡p < 0.001. 
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Microarray analysis after 14 hours (“acute”) LPD and HPD 
administration 
 
RNA was extracted from kidneys and tested for quality. Samples had a 
260nm/280nm ratio of 2.2 and RIN between 8 and 9 (Figure 19). At the FGCZ, best 8 
samples (4 of each group) were processed for hybridization to GeneChip® Mouse 
Genome 430 2.0 arrays (Affymetrix). Approximately 40% (12‟893 protein coding 
genes) of total genes that were present on the array were detected. 210 transcripts 
were changed significantly (p < 0.05) after a 14 LPD vs. HPD. Of those, 156 were 
down-regulated (93 with a fold change < 0.67) and 54 up-regulated (50 with a fold 
change > 1.5). (see Supplementary table S4 on CD). Again, only genes with a 50%- 
fold change and more were considered.  
 
 A                                                       B 
  
Figure 19.  Summary of quality measurement of mouse kidney mRNA after 14 h LPD and HPD. (A) Virtual gel of 
RNA samples. Bands represent the 18 S and 28 S rRNA. This can also be demonstrated in graphic (B) where the 
integrated areas below the peaks represent the RNA integration number (RIN) by which RNA purity is 
determined.  
 
 
Analysis of “acute” GeneChip data 
 
Analysis of the microchip data revealed that numerous genes affected by 14 h of Pi 
depletion are involved in metabolic activities. However, pathway grouping was more 
difficult than with the data obtained after “chronic” Pi restriction. This was mainly due 
to fewer genes that could be grouped in single pathways (only 2-3 genes) and 
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therefore no direct conclusion was possible from these analyses. PEPCK is a main 
regulator of gluconeogenesis and was down-regulated after 14 h and 5 days of LPD. 
Down-regulation of PEPCK had been previously confirmed with RT-qPCR after 14 h 
of LPD (Figure 18 C). Also, after an “acute” Pi feeding period, ammoniagenesis was 
significantly changed as indicated by altered excretion of NH3/NH4
+ (see Table 7). 
Several genes previously found to be regulated in acidotic conditions [192] did also 
respond to dietary Pi changes (Table 8a). These are: the solute carrier SLC38a3 
(SNAT3), an basolateral Na+-coupled glutamine transporter; glutamate 
dehydrogenase 1 (Glud1), an enzyme responsible for releasing an NH4
+ ion from 
glutamate when converting to α-ketoglutarate; and PEPCK, responsible for 
converting oxaloacetate into phosphoenolpyruvate and carbon dioxide. 
SLC16A14/MCT14 is an orphan transporter belonging to the monocarboxylate 
transporter family, also shown to be changed during acidotic conditions [192]. It was 
also detected through gene chip analysis after 14 h of LPD as previously expected 
from RT-qPCR experiments. Of the genes that had been up-regulated, many are of 
unknown function or have not been throughly characterized. A number of selected 
genes are represented in Table 8. 
Selected genes obtained from micorarray analysis table (supplementary S4) were 
submitted to RT-qPCR to confirm altered expression levels (Figure 20). Fortunately, 
all of the genes selected were shown to agree with the approximate fold changes 
observed during microarray analysis as demonstrated by linear regression in Figure 
21.  
Many genes after 14 h of LPD were shown to be altered after “chronic” Pi deprivation, 
such as: PEPCK, Glud1, and SLC38a3/SNAT3 showed a strong regulation after 14 h 
of LPD. Osteomodulin and cholecystokinin A receptor (CCKAR) mRNA levels also 
showed significant difference. Osteomodulin (FC 3-fold), an extracellular matrix 
keratan sulphate proteoglycan, had been previously published to be involved in 
osteoclastic activity during bone resorption [196]. This may well be an indicator of an 
early Pi demineralising signal to the bone as short as 14 h after Pi deprivation. If 
osteomodulin directly acts on Na/Pi-cotransport is unknown (see discussion). 
CCKAR, a member of the G-protein coupled receptors (GPCR) that binds CCK, is a 
major physiological regulator of pancreatic secretion and smooth muscle contraction 
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of gall bladder and stomach [197]. The receptor regulates satiety in the central and 
peripheral nervous system [197]. How this factor interferes with Pi homeostasis or 
Na/Pi-cotransport mechanisms is not known. It is possible that by regulating the 
secretion of dopamine [198] this receptor may be indirectly involved (see Discussion). 
SLC16A14/MCT14 (MCT14) appeared to be a robust responder after 14 h and 5 
days of “chronic” dietary Pi changes. Based on gene clustering and homology 
analysis, this transporter belongs to the members of the monocarboxylic acid 
transporters (MCTs) [199]. Neither its function nor its renal localization has been 
determined to date. 
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Table 8a. Genes down-regulated after 14 hours of LPD (p < 0.01) 
    
Gene Symbol Gene Name Fold Change GeneBank Acc. No.   
    
PEPCK Phosphoenolpyruvate carboxykinase 1, cytosolic 0.16 NM_011044.2 
SLC16A14/MCT14   Solute carrier family 16, member 14 0.23 NM_027921 
SLC38A3   Solute carrier family 38, member 3 0.38 NM_0203805.2 
SLC13A2 Solute carrier family 13, member 2 0.40 NM_022411.3 
AACS Acetoacetyl-CoA synthetase 0.45 NM_030210.1 
CCKAR Cholecystokinin A receptor 0.45 NM_009827.2 
Glud1 Glutamate dehydrogenase 1 0.51 NM_008133.4 
PpaRα Peroxisome proliferator activated receptor alpha 0.58 NM_011144.6 
ENPP2 Ectonucleotide pyrophosphatase/phosphodiesterase 2 0.60 NM_015744.6 
Trp53bp Transformation related protein 53, binding protein 2 0.61 NM_173378.2 
Thyms Thymidylate synthase 0.63 NM_021288.3 
 
Table 8b. Genes up-regulated after 14 hours of LPD (p < 0.01) 
    
Gene Symbol Gene Name Fold Change GeneBank Acc. No.   
    
Omd Osteomodulin 3.2 NM_012050.2 
Acot11 Acyl-CoA thioesterase 11 2.1 NM_025590.4 
Tln2     Talin 2 1.9 NM_027458.1 
SLC25A36 Solute carrier family 25, member 36 1.9 NM_138756.4 
Jub Ajuba 1.8 NM_010590.4 
Acot1 Acyl-CoA thioesterase 1 1.8 NM_012006.2 
Olfm3 Olfactomedin 3 1.7 NM_153458.2 
Lrat Lecithin-retinol acyltransferase 1.6 NM_023624.4 
Itgb6 Integrin beta 6 1.6 NM_021359.3 
Spsb4 SplA/ryanodine receptor domain containing SOCS box  1.6 NM_145134.3 
 
Listed are number of selected genes that responded to ”acute” (14 h) LPD.  
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Figure 20. RT-qPCR of some selected transcripts (supplementary table S4) based on microarray analysis after 
14 h of LPD. (A) SLC16A14/MCT14 changed significantly in agreement with fold changes observed from 
microarray data. (B) Pepck, an enzyme involved in gluconeogenesis, was strongly down-regulated in the LPD 
group. (C) Na
+
- dependent glutamine transporter (SNAT3) was down-regulated in LPD as well as (D) 
cholecystokinin A receptor, (E) Glutamate dehydrogenase (Glud) and (F) Cyp51. (G) Acot1, (H) Osteomodulin, 
and (I) Carbonic anhydrase IV had an increased expression level in response to LPD. Data with ±SEM, n = 6, *p 
< 0.05 , **p < 0.01, ***p< 0.001. 
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Figure 21. Linear Regression after 14 h LPD between fold changes of selected genes analyzed by RT- qPCR 
and micorarray analysis. n = 9, R
2
 = 0.979. 
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Characterization of SLC16A14/MCT14 
 
Renal expression of SLC16A14/MCT14, a member of the monocarboxylate 
transporter family SLC16 [199], was affected by intake of a low Pi-diet after “chronic” 
(5 days) and “acute” (14 h) conditions. Therefore SLC16A14/MCT14 was regarded 
as a new gene whose expression is influenced by dietary Pi. Thus far, 
SLC16A14/MCT14 has not been localized in the kidney and its function has not been 
described. In the following experiments, the renal localization and a possible function 
of SLC16A14/MCT14 were investigated.  
 
 
Tissue distribution of SLC16A14/MCT14  
 
A variety of tissues from one wild type C57BL/6 mouse fed with standard chow was 
collected, total RNA extracted and analyzed by RT-qPCR. Among the tissues tested, 
the kidney showed the highest expression level of SLC16A14/MCT14 mRNA. Less 
pronounced expression was found in the pancreas and testis. Only very low 
expression was observed in the epididymis, salivary and vesicular glands. The 
stomach, intestine, colon, spleen and thyroid gland were also tested and did not 
present any detectable SLC16A14/MCT14 mRNA levels (Figure 22).  
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Figure 22. Tissue distribution of SLC16A14/MCT14 mRNA using RT-qPCR. Data normalized against β-actin. (n = 
1) 
 
 
Renal localization of SLC16A14/MCT14  
 
Expression of SLC16A14/MCT14 mRNA in kidney tissue was first assessed by in-situ 
hybridization (ISH) in wild type mice (C57BL/6) that were fed a standard diet. With the 
results obtained and presented in Figure 23, the localization of SLC16A14/MCT14 
mRNA could not be determined. No signal for SLC16A14/MCT14 could be detected 
(Figure 23 A & B). Anti-sense sequences for SLC12a5 and SLC5a2 were used as 
controls for the experimental procedure (Figure 23 C & D). 
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                   A                    B 
       
                   C           D 
                         
Figure 23. In-situ hybridization of SLC16A14/MCT14 in kidneys of wild type C57BL/6 mice fed with standard diet. 
(A) No visible signal after hybridization of the SLC16A14/MCT14 anti-sense sequence. (B) SLC16A14/MCT14 
sense sequence used for negative control. For the control of experimental procedure anti-sense sequences of (C) 
SLC12a5 and (D) SLC5a2 were used. 
 
 
Localization of SLC16A14/MCT14 by immunohistochemistry 
 
An antibody was raised against a synthetic peptide of SLC16A14/MCT14 
(Supplementary Table S2 at the end of Methods) and used to determine renal 
localization of SLC16A14/MCT14 by immunohistochemistry.  
From two immunized rabbits, sera were collected after 60, 90, and 105 days. Sera of 
both rabbits after 90 days of injection resulted in visible stainings when applied to 
sections prepared from kidneys (wild type mice fed with standard diet) fixed with 4% 
PFA. All following stainings were performed with serum from rabbit 1 (serum 1). First 
stainings indicated signals in the PTs and the outer medulla, most likely in the TAL 
(Figure 24). Based on these results, serum 1 from 105 days was used to affinity 
purify SLC16A14/MCT14 antibodies.  
After obtaining the purified antibody, new immunostainings were performed in 
kidneys from wild type mice that were fed standard diet. In order to determine the 
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exact localization of SLC16A14/MCT14, a number of serial cuts were performed on 
PFA fixed kidneys that were stained for SLC16A14/MCT14 as well as for NaPi-2a (as 
a marker for PT), NKCC2, and ROMK (as markers for the TAL). Comparison of the 
pattern of expression of SLC16A14/MCT14 (Figure 25 A) and NaPi-2a (Figure 25 B) 
indicates that both proteins are not expressed in the same tubular segments, ruling 
out the presence of SLC16A14/MCT14 in the PT. In contrast, SLC16A14/MCT14 
(Figure 25 C) was detected in tubular structures also stained with NKCC2 (Figure 25 
D) and ROMK (Figure 25 E). Together, these results indicate that SLC16A14/MCT14 
protein is expressed in the TAL, whereas no stainings in the PT were observed using 
the affinity purified antibody. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
83 RESULTS 
 
Effects of changes in dietary phosphate on renal gene expression  
 
             A                                    B                                    C 
         
             D                                    E                                    F 
         
             G                                    H                                    I 
         
Figure 24. Serum from rabbit 1 (not purified) after 105 days of SLC16A14/MCT14 peptide injection applied to 
kidney sections of C56BL/6 wild type mice fed standard chow. Stainings in the PT were detected as well as TAL 
like structures. (A) A glomerulus with its PT. (B) Convoluted tubular structures which present SLC16A14/MCT14 
in the PT of the cortex. (C) The urinary pole of a glomerulus shows staining in the PT. Also, the tubule attached to 
the glomerulus, which is the macula densa region of the TAL, is stained. (D) PT with its glomerulus. (E) Lower 
magnification of the cortex region revealing various PTs stained for SLC16A14/MCT14. (F) Detailed visualization 
of the BBM system of the PT in the cortex. (G & H)  Signal for SLC16A14/MCT14 in the TAL. (I) Outer medullary 
staining of SLC16A14/MCT14 reaching into the cortex. Magnification: A-D, F: x60 ; E, G-I: x20 
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   A                                                                  B 
      
   C                                           D                                          E 
           
 
Figure 25. Localization of SLC16A14/MCT14 in kidneys from standard diet fed wild type mice using affinity 
purified antibody. (A) Cross section of the whole mouse kidney reveals an outer medullary distribution of 
SLC16A14/MCT14 reaching into the cortex. (B) Staining in the cortex of the PT shows the distribution of NaPi-2a. 
Serial sections of mouse kidney show stainings for (C) SLC16A14/MCT14 that overlaps with the localization of 
(D) NKCC2 and the localization of (E) ROMK, which are all present in the TAL. Magnification: A & B: x4 ; C-E: 
x20.  
 
 
The cellular distribution of SLC16A14/MCT14 was confined to the apical side (Figure 
26 A). Moreover, when kidney sections were observed under higher magnification 
(x60), some SLC16A14/MCT14 signals of the CCD basolateral membrane most likely 
of principal cells were detected (Figure 26 B). In addition, affinity purified antibody 
specificity was confirmed by peptide blocking (Figure 26 C & D). 
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Figure 26. (A) SLC16A14/MCT14 staining in the apical membrane of a TAL and (B) the basolateral membrane of 
principal or intercalated cells in the CCD. (C) SLC16A14/MCT14 in the TAL without peptide block and (D) Pre-
incubation of anti-SLC16A14/MCT14 antibody with target directed peptide. Magnification: A & B: x60(oil) ; C & D: 
x20 & x80(oil) respectively. 
 
 
RT-qPCR analysis of SLC16A14/MCT14 in isolated nephron 
segments 
 
In order to confirm the observations made by immunofluorescence, it was necessary 
to determine SLC16A14/MCT14 mRNA in micro-dissected nephron segments. These 
segments (PT and TAL) were isolated from a freshly removed kidney of a wild type 
C57BL/6 mouse fed a standard diet and RT-qPCR was performed for 
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SLC16A14/MCT14. As shown in Figure 27, the expression level of 
SLC16A14/MCT14 mRNA abundance was very low in the TAL and even lower in the 
proximal straight tubule (PST). This low expression may explain the (almost) negative 
result obtained by in-situ hybridization. As controls, RT-qPCR for NaPi-2a (marker for 
PT) and NKCC2 (marker for TAL) were performed as well.  
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Figure 27. RT-qPCR performed for SLC16A14/MCT14 in the nephron segments of the PST and the TAL from 
one standard diet wild type mouse kidney. NaPi-2a served as a positive control in the PST and as a negative 
control in the TAL while NKCC2 served as a negative control in the PST and as a postivie in the TAL. mRNA was 
obtained from 20 tubuli of each segment. Data was normalized against 18 S rRNA. n = 1. 
 
 
Regulation of SLC16A14/MCT14 protein by dietary intake of Pi 
 
Kidney homogenates and BBMs were tested by Western blot analysis in order to 
determine whether the abundance of SLC16A14/MCT14 protein is regulated in 
response to dietary intake of Pi.  Animals were sacrificed after 3 h, 14 h, and 5 days 
of special diets. Western blots were performed either with homogenates or isolated 
BBMs. As seen in Figure 28 A & D, no difference of SLC16A14/MCT14 abundance 
was detected in kidney homogenates after 3 h of LPD ingestion (compared to HPD), 
even though abundance of NaPi-2a was already strongly upregulated in the LPD 
group after 3 h. After 14 h, a significant difference of SLC16A14/MCT14 abundance 
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was observed between LPD and HPD in kidney homogenates and BBM fractions 
(Figure 28 B & D). Again, NaPi-2a abundance was strongly up-regulated in BBM and 
homogenates after 14 h LPD. Similar as after 14 h, abundance of SLC16A14/MCT14 
was reduced by LPD intake after 5 days (Figure 28 C & D). As a control for the 
antibody that was raised against a specific synthetic peptide, an antibody-peptide 
block was performed using three different amount of homogenate loadings as seen in 
Figure 28 E.  
Taken together, Western blot analysis indicated that LPD decreased the abundance 
of SLC16A14/MCT14 after 14 hours and 5 days of Pi depletion. However, and in 
contrast to NaPi-2a, no change of SLC16A14/MCT14 abundance was observed after 
3 hours. This indicates that even though regulation of SLC16A14/MCT14 by dietary 
intake of Pi occurs already after 14 hours, the mechanism might differ from that 
involved in the rapid regulation of NaPi-2a protein.  
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Figure 28. Western blot anaylsis of SLC16A14/MCT14 in the kidney of wild type mice after different time periods 
upon LPD and HPD administration. (A) No change was observed after 3 h of LPD (B) Significant difference 
beween LPD and HPD after 14 h of food administration. The abundance of SLC16A14/MCT14 in BBM was also 
shown to be regulated after 14 h of LPD and HPD. (C) Homogenates of “chronic” (5 days) treated LPD and HPD 
animals show significant reduction of SLC16A14/MCT14 in the LPD groups. (D) Bar graphs summarize the data 
from immunoblots with homogenates for SLC16A14/MCT14. (E) Standard test for antibody specificity after affinity 
purification using three different homogenate concentrations (1: 70μg, 2: 50μg, 3: 30μg) from a standard fed wild 
type mouse while peptide concentration remained the same. Membranes were stripped and reprobed for β-actin. 
BBMV: Brush border membrane vesicles; αΜCT14: anti-SLC16A14/MCT14 antibody. All data were normalized 
against β-actin. Data with ±SEM, n = 6 per group, *p < 0.05 , **p < 0.01. 
 
 
Regulation of SLC16A14/MCT14 abundance was additionally investigated by 
immunofluorescence. Kidneys were fixed with PFA as described (see Methods). 
Expression of SLC16A14/MCT14 was first investigated under “acute” (14 h) dietary 
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conditions. When kidneys of “acute” HPD mice were stained for SLC16A14/MCT14, 
the transporter was localized in the BBM of PTs (Figure 29 A). However, 
immunostainings of kidneys from LPD fed animals did not show clear 
SLC16A14/MCT14 presence in the BBM (Figure 29 B). Instead, SLC16A14/MCT14 
appears in subapical compartments of the cell. This may suggest possible regulation 
of apical SLC16A14/MCT14 triggered by changes in dietary Pi. Interestingly, no 
significant presence of SLC16A14/MCT14 was detected in the TAL of these mice as 
previously shown in NPD mice.  
Additional experiments focused on renal SLC16A14/MCT14 distribution after 
“chronic” HPD and LPD adaptation. Mice treated for 5 days with HPD presented 
SLC16A14/MCT14 protein in PTs and randomly in the TALs (Figure 30 A). 
Nevertheless, after 5 days of LPD feeding, SLC16A14/MCT14 was detected apically 
in the TAL cells and in the cytosol of some PT and TAL cells. (Figure 30 B). Overall, it 
cannot be outruled that the distribution of SLC16A14/MCT14 in the nephron is 
regulated by other mechanisms different to the response caused by dietary Pi.  
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         A 
   
         B 
   
Figure 29. Expression of SLC16A14/MCT14 in the wild type mouse kidney cortex 14 h after the administration of 
LPD and HPD. (A) Mice after a HPD administration expressed SLC16A14/MCT14 in the renal cortex. Seen in 
more detail under higher magnification (right) (B) When given a LPD, the expression of SLC16A14/MCT14 in the 
cortex is reduced. Under higher magnification (right), the tubules reveal a subapical staining for 
SLC16A14/MCT14, suggesting a possible internalization of SLC16A14/MCT14 14 hours upon LPD ingestion. 
Under higher magnification (white box) SLC16A14/MCT14 signal is determined in the BBM of the PTs. 
Magnification: left: x20 ; right: x60 (oil). 
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Figure 30. SLC16A14/MCT14 localization in wild type mouse kidney after 5 days “chronic” HPD and LPD. (A) 
Kidneys of HPD mice show SLC16A14/MCT14 localization in BBM of PTs (B) while LPD kidneys show the apical 
distribution of SLC16A14/MCT14 in the TALs and in the cytosol of some PT and TAL cells. 
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Heterologous expression of SLC16A14/MCT14 in oocytes of 
Xenopus laevis and investigations of its transport properties 
 
Subcloning SLC16A14/MCT14 from pCMV-Sport6 to pSPOK-G  
 
In order to study the function of SLC16A14/MCT14, Xenopus laevis oocytes were 
injected with SLC16A14/MCT14 cRNA with the purpose to express the transporter at 
the plasma membrane. SLC16A14/MCT14 was tagged with a myc sequence at the 
N-terminal end of the transporter. After obtaining SLC16A14/MCT14 in the non-
expression vector pCMV-Sport6, it was consequently subcloned into pSPOK-G, a 
modified pSD-Easy vector containing a myc tag (see Methods). Using primers with 
modified ends for SacI and XhoI, a PCR was performed using as template the 
SLC16A14/MCT14 in pCMV-Sport6. A terminaly modified SLC16A14/MCT14 
sequence was obtained that allowed insertion into the SacI and XhoI sites of pSPOK-
G. Finally, colonies were selected that harvested the SLC16A14/MCT14 in the new 
vector. DNA was purified and sent for sequencing. Partial myc-tagged 
SLC16A14/MCT14 sequence from colony 1 is shown in Figure 31 A indicating that 
subloning of the transporter downstream of the myc tag was successful. This was 
further confirmed by restriction digestion using XhoI and SacI (Figure 31 B).  
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GNGCTACACNNTTAGGCTTGTACATATTGTCGTTAGAACGCGGCTACAATTAATACATAACCTTATGTATCATAC
ACATACGATTTAGGTGACACTATAGAATACACGTAGGCCACCATGGAACAAAAACTCATCTCAGAAGAGGATCTG
GAATTCGAGCTCTATACGAGTCATGAAGATATCGGGTATGACCTTGAAGACGACCGAAAGGCTAAGAATAAGAAG
ACGCTGAAGCCCCACCCAGATATCGATGGCGGGTGGGCCTGGATGATGGTCCTCTCGTCCTTCTTTGTTCACATC
CTCATCATGGGCTCACAGATGGCCCTAGGAGTCCTCAACGTGGAGTGGCTTGAAGAGTTTCACCAGAGCCGCGGC
CTGACCGCCTGGGTCAGCTCCCTGAGCATGGGCATCACCTTGATCGTGGGACCTTTCATCGGCTTGTTCATTAAC
ACCTGCGGGTGCCGCCAGACAGCAATCATTGGAGGCCTGGTGAACTCCCTCGGCTGGGTGTTGAGCGCCTATGCA
GCCAATGTGCAGTCTCTCTTTATTACCTTTGGAGTGGCAGCAGGCCTTGGCAGTGGGATGGCTTACCTACCTGCA
GTGGTCATGGTGGGAAGGTACTTTCAGAAGAGACGAGCCCTGGCCCAGGGCCTCAGTACCACGGGGACAGGATTT
GGGACGTTCCTGATGACCGTGTTGCTGAAATACCTGTGCGCAGAATATGGCTGGCGGAATGCTATGTTCATCCAA
GGTGCTCTGTCCCTGAACCTGTGTGTCTGTGGGGCGCTCATGAGGCCCCTCTCTCCCGAGAAGTTAGAAAACTGC
CCAGAAGCGGAAGAGCCGTGTGCTCTCCCAGCTTACTCCACTGAATCTGTTAAGTCTGGAGGACCACTGGGCATG
GCTGAAGAACAGGACAGA 
 
 
B                                                         
 
 
Figure 31. (A) pSPOK-G myc tagged SLC16A14/MCT14 sequenced with Sp6. Red: myc tag. Yellow: 
SLC16A14/MCT14 (not completely shown). Box: modified sequence with restriction site. (B) Agarose gel after 
restriction enzyme digestion with SacI and XhoI. L: ladder, Col: Colony, Con: Control (circular plasmid without 
restriction cut). 
 
 
Expression of the mouse SLC16A14/MCT14 gene in Xenopus laevis oocytes 
 
The pSPOK-G vector containing myc-SLC16A14/MCT14 was used to 
2synthesize cRNA. After injecting 25 ng (in 50 nl) of cRNA per oocytes, they 
were incubated for 3 days and expression was analyzed by Western blot and 
immunofluorescence (Figure 32).. Western blots were performed using 
homogenates of injected and non-injected oocytes. Using anti-myc and anti-
SLC16A14/MCT14 antibodies, a 57 kDa band corresponding to 
SLC16A14/MCT14 was detected in the injected oocytes  
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Furthermore, immunofluorescence indicated that SLC16A14/MCT14 was 
incorporated into the plasma membrane of the oocytes. These results further 
confirmed the specificity of the affinity purified anti-SLC16A14/MCT14 antibody used 
for Western blots and immunofluorescence as described before.  
 
 A           B 
                              
 
C 
 
Figure 32. (A) Staining of SLC16A14/MCT14 protein in the plasma membrane of Xenopus laevis oocyte after 
third day of SLC16A14/MCT14 cRNA injection. (B) Control using non-injected oocytes. (C) Western blot analysis 
of injected and non injected oocytes with anti-myc and affinity purified anti-SLC16A14/MCT14 antibody. Inj.: 
Injected oocytes, NI: Non-Injected oocytes, αΜyc: anti-myc antibody, αΜCT14: anti-SLC16A14/MCT14 antibody. 
 
 
Transport studies with Xenopus laevis oocytes expressing 
SLC16A14/MCT14 
 
Based on transport data obtained from other SLC16 family members [199], it was 
likely that SLC16A14/MCT14 would carry monocarboxylates (i.e. lactate and 
pyruvate) and/or amino acids. These substrates were therefore investigated first. 
Initial experiments showed no differences for lactate transport between injected and 
non-injected oocytes (Figure 33). Some MCT members (MCT1 and MCT4) require 
the ancillary protein CD147 [199] for correct function and expression of their 
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transporter (see also discussion). An experiment was conducted to determine 
whether transport function could be affected by co-expressing SLC16A14/MCT14 
together with CD147. However, co-injection of CD147 did not result in transport of 
lactate. Similarly, no evidence was obtained for pyruvate as being a substrate for 
SLC16A14/MCT14 (data not shown). 
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Figure 33. Transport study using radioactive labeled 10 mM lactate solution. Xenopus laevis eggs that have been 
co-injected with ancillary protein CD147 and SLC16A14/MCT14 showed no significant difference in transport rate 
compared to the non-injected (NI) oocytes. When injected with CD147 or SLC16A14/MCT14 alone, no difference 
in transport rate was observed either. No significant difference was observed in lactate uptake when injected with 
two different cRNA concentrations. 
 
 
Further studies were conducted, in absence of CD147, by using amino acids as 
substrates. However, even though CD147 did not enhance transport function of 
lactate (Figure 33), it cannot be discarded that it may affect amino acid transport. 
Nevertheless, the following studies were conducted in the absence of CD147. Of 
interest, after 3 days of expression and in the presence of 100 mM sodium (ND100 
solution) uptake of L-alanine was observed, but no uptake was observed for L-
isoleucine or L-valine (Figure 34). The same observation was made when transport 
studies were performed in the absence of sodium (ND0 solution) (data not shown), 
indicating that SLC16A14/MCT14 transports L-alanine in a sodium-independent 
manner.  
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Figure 34. Uptake experiments with amino acids in Xenopus laevis oocytes expressing SLC16A14/MCT14 
protein. (A) A significant transport of alanine had been determined. Transport was neither observed for (B) 
isoleucine nor for (C) valine. Data with ±SEM, n = 8-10, ***p < 0.001. 
 
 
To test whether other amino acids may represent possible substrates for 
SLC16A14/MCT14, different amino acid cocktails were prepared for competition 
transport assays. All cocktails prepared included 6mM of each amino acid. The 
cocktails also contained L-alanine as non radioactive (6 mM) and radioactively (3H) 
labeled. The uptake of L-alanine in each cocktail was measured relative to the uptake 
of L-alanine alone. The data presented in Figure 35 indicate, that at least one of the 
components in cocktail C2 (L-methionine, L-tryptophane or L-phenylalanine) is 
competing with L-alanine transport by SLC16A14/MCT14. This competition is also 
shown for L-glutamate in cocktail C6b. In other words, at least two more amino acids, 
which are structurally very different from each other and from L-alanine may be 
transported by SLC16A14/MCT14 based on these transport assays.  
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Figure 35. Different amino acids tested for transport by SLC16A14/MCT14. Each amino acid is present at 6 mM 
concentration in a cocktail. The goal was to determine amino acid uptake through inhibitory competition. A 
number of amino acid cocktails were prepared and then tested in-vitro for competition; (+) is the positive control 
using Xenopus oocytes injected with 25 ng cRNA of SLC16A14/MCT14 in presence of alanine whereas (–) 
presents the negative control, non injected oocytes, in the presence of alanine. Cocktails C2 and C6b both show 
an inhibition when compared to the positive control indicating a competition between alanine and another amino 
acids present in the cocktail. n = 6-10, *p < 0.05, **p < 0.01. 
 
 
Based on competition assays shown in Figure 35, new experiments were carried out 
to test single amino acids (specifically amino acids contained in C2 and C6b) that 
reduced L-alanine uptake. These experiments indicate that L-methionine and L-
glutamate indeed could be transported by SLC16A14/MCT14. Transport of L-
tryptophane as well as L-phenylalanine was however not observed (Figure 36).  
In summary, first results obtained characterizing transport function of 
SLC16A14/MCT14 transport function, indicated that it is likely that SLC16A14/MCT14 
represents an amino acid transporter. However, some carboxylates (e.g. lactate, 
pyruvate) need to be further investigated, even though preliminary experiments 
suggested that SLC16A14/MCT14 does not transport them. Also, more information 
needs to be gathered regarding the kinetics for L-alanine, L-glutamate, and L-
methionine transport.  
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Figure 36. Experimental uptake of various amino acids. (A) Methionine is significantly transported in 
SLC16A14/MCT14 injected oocytes when compared to non-injected oocytes. (B) Tryptophane was not carried by 
SLC16A14/MCT14 and neither was (C) phenylalanine. (D) Glutamate was carried by SLC16A14/MCT14. Data 
collected in the absence of sodium. Data with ±SEM, n = 8-10,  **p < 0.01, ***p < 0.001. 
 
 
 
 
 
 
 
 
 
 
\ 
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DISCUSSION 
 
Inorganic phosphate (Pi) is essential for a variety of systemic and molecular functions 
in the organism. Extracellular concentration of Pi is balanced mainly by the rate of 
renal reabsorption in the proximal tubules, and to a lesser extent by the rate of 
intestinal absorption of ingested Pi. Control of renal reabsorption of Pi is achieved by 
regulation of the abundances of Na/Pi-cotransporters that are localized at the apical 
membrane of proximal tubular cells. Different regulatory networks, such as an 
intestine-kidney axis or a bone-kidney axis are involved in the adjustment of intestinal 
and renal Pi-handling (see Introduction).  
Deviations of extracellular concentration of Pi in either direction have severe 
consequences for the organism. Deficiency of Pi has been related to muscle 
weakness, rhabdomyolysis, impaired leukocyte function, and abnormal bone 
mineralization causing rickets and osteomalacia [13-15]. On the other hand, recent 
data has revealed that high dietary intake of Pi might promote tumor formation, as 
has been observed in animal models with skin cancer [200]. Another study has 
shown that high intake of Pi perturbs the growth of the brain in young mice [201]. 
Also, high Pi diets have been related to premature aging and cardiovascular 
diseases [202].  
This study describes the effect of altered intake of dietary Pi on renal gene 
expression. To this end, mice were fed two different Pi-diets (LPD and HPD) for two 
different durations. On the one hand, mice were fed continuously with the diets for 5 
days (“chronic” adaptation; “chronic” hypophosphatemic conditions) and on the other 
hand, mice were fed during three hours and analysis was performed 14 h after the 
onset of food intake (“acute” hypophosphatemic conditions). This later time point was 
chosen, because initial experiments demonstrated that gene expression of selected 
genes was not altered by LPD (compared to HPD) at earlier time points (4 and 8 h). 
Obtained microarray results will be discussed first in the context of the “chronic” (5 
days) dietary Pi changes. Then, the 14 h dietary Pi gene expression study will be 
separately analyzed and discussed. In addition, a comparison between the “acute” 
and “chronic” data set will be assessed. For all situations, special emphasis is given 
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on genes (gene products) that potentially could be involved in the control of renal 
handling of Pi (transporters, gene products potentially involved in trafficking, 
regulation). 
 
 
“Chronic” (5 days) effect of LPD on renal gene expression  
 
Dietary Pi-depletion for 5 days resulted in altered expression of genes that encode a 
variety of enzymes and transporters. Analysis of the microarray data set revealed, 
that close to one third of the genes present in the genome had been detected as 
transcripts in the kidney. This is in agreement with studies published on genes 
regulated by metabolic acidosis [192]. Expression of approximately 10% of the genes 
detected on the array was significantly changed (p < 0.05) by LPD and 80% of those 
were changed considerably (mFC > 50%). A number of genes were validated by RT-
qPCR to confirm the data obtained from the microarray gene list, and the correlation 
between RT-qPCR and microarray experimental results was examined by linear 
regression (R2 =0.803). 
As will be discussed in more detail below, the major effect of LPD given “chronically” 
(5 days) was a decrease of expression of genes involved in energy metabolism. This 
effect was not surprising considering the role of Pi in glycolysis and oxidative 
phosphorylation. Therefore, expression of many genes (including transporters), may 
not be changed due to a Pi imbalance but rather may be changed as a result of an 
alteration in energy status. 
The following paragraphs discuss the most relevant changes of gene expression 
induced by LPD given chronically. Statistics were performed on fold changes higher 
than 50% at a significant level of p < 0.01. 
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i) SLC Transporters  
 
A total number of 12 transporters were found to be regulated after 5 days 
of “chronic” changes in dietary Pi: 3 ABC transporters and 9 SLC 
transporters. Interestingly, in this study, none of Na/Pi-cotransporters were 
detected on the microarray data set (neither at the level p < 0.01 nor at 
level p< 0.05). This result was not in agreement with the data obtained by 
RT-qPCR which demonstrated a significant increase of NaPi-2c mRNA 
after “chronic” low Pi-dietary conditions [1]. 
All ABC transporters detected were up-regulated: ABCb4 (mFC = 1.7), 
ABCa13 (mFC = 1.9) and ABCb1a (mFC = 4.3). These three ABC 
transporters have not been characterized thoroughly and therefore their 
implication in Pi homeostasis is not known. 
Three SLC transporters were down-regulated; the monocarboxylate 
transporter family member SLC16A14/MCT14 (mFC = 0.2), the zinc 
transporter SLC39A14 (mFC = 0.5), and the glycerol/phosphate 
exchanger SLC37A2 (mFC = 0.6). Six other SLC members were up-
regulated; L-type amino acid transporter SLC43A2 (mFC = 1.5), creatine 
transporter SLC6A8 (mFC = 1.6), nucleoside-sugar transporter family 
SLC35E3 (mFC = 1.7), aromatic amino acid transporter SLC16A10 (mFC 
= 2.1), mitochondrial family carrier SLC25A36 (mFC = 2.7) and cationic 
amino acid transporter/glycoprotein-associated family member SLC7A12 
(mFC = 3.4).  
 
 
ii) Electron transport chain and oxidative phosphorylation 
 
Most of the genes affected by “chronic” low Pi belong to the electron 
transport chain and the mechanism of oxidative phosphorylation. 21 genes 
of the electron transport chain were found to be down-regulated as a 
consequence of LPD compared to HPD (Table 10a). As seen in Figure 37, 
most of the genes are grouped in Complex I (Ndufa3, Ndufa5, Ndufa7, 
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Ndufb7, Ndufs7, Ndufb4, Ndufb2, and Ndufc1). All of them are down-
regulated between 1.5-2 fold. All other members of the electron transport 
chain regulated by Pi are grouped in Complex III, IV, and V. These genes 
are: Uqcrq, Uqcr, Cox5b, Cox7a2, Cox7c, Cox8a, Atp5e, Atp5g1, Atp5k, 
Atp5j2, and Atp5l. No changes of genes functioning in complex II were 
detected. 
 
Table 10a. Main processes with the highest number of down-regulated genes           
(p < 0.05)* 
    
Process Total in Pathway Down-regulated p Value 
    
Electron transport chain  131 21 <0.001 
Oxidative phosphorylation  73 13 <0.001 
Adipogenesis 139 8 <0.001 
Ossification 69 7 <0.001 
Complement and coagulation cascades 66 5 <0.01 
Complement activation, classical pathway 20 4 <0.001 
Folic Acid Network 25 3 0.01 
Prostaglandin Synthesis and Regulation 33 3 0.02 
 
Table 10b. Main processes with the highest number of up-regulated genes               
(p < 0.05)* 
    
Process Total in Pathway Up-regulated P Value 
    
TNF-α NF-κΒ Signaling pathway 203 16 <0.001 
Regulation of Actin Cytoskeleton  160 15 <0.001 
EGFR1 Signaling pathway 188 13 <0.001 
Androgen receptor signaling pathway 150 12 <0.001 
Focal adhesion 199 12 0.001 
Wnt signaling 135 11 <0.001 
Amino acid metabolism 102 10 <0.001 
G-protein signaling  111 9 <0.001 
Keap1-Nrf2 14 4 <0.001 
*p value refers to the student‟s t-test applied to all genes with a fold change higher than 50% 
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Figure 37. Electron transport chain of the mitochondria appears to be strongly targeted by dietary Pi. A low Pi diet after 5 days shuts down many genes responsible for ATP 
generation. Complex I contains most of the genes that are down-regulated. 
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iii) Glucose metabolism 
 
Two genes have been detected that determine rate limiting steps in 
gluconeogenesis and glycolysis, respectively. Phosphoenolpyruvate 
carboxykinase, PEPCK, which is responsible for the production of 
oxalacetate from phosphoenolpyruvate and carbon dioxide was strongly 
down-regulated (mFC = 0.42). The other gene, also down-regulated (mFC 
= 0.64), is pyruvate kinase, Pk-1, which controls the metabolic breakdown 
of glucose, in particular responsible for catalyzing the transphosphorylation 
of phosphoenolpyruvate into pyruvate and ATP. These two genes are 
responsible for maintaining a balanced energy supply to all cells. In the 
kidney, the proximal tubular cells would be most affected since the need 
for oxygen and therefore glucose is very high. The strong inhibition of Pk-1 
can cause a drastic decrease in ATP production and thus may affect many 
other processes that are dependent on this, causing a chain reaction of 
processes that are secondarily affected.  
PEPCK is known to be crucial for gluconeogenesis in the organism and 
studies have shown the involvement of PEPCK in the kidney proximal 
tubular glucose metabolism [203]. Liver and kidney are two organs known 
to be involved in gluconeogenesis and glycolysis. Under certain conditions 
their activity can be measured in the blood plasma [203]. Early studies with 
hepatectomized and nephrectomized rats clearly demonstrated that the 
kidney is a source of plasma glucose [204-206]. Thus, the kidney is a 
consumer and a generator of glucose. The medulla predominates mostly 
in the consumption of glucose whereas the cortex (proximal tubules) 
functions in the reabsorption, release, and production of glucose. Since 
the kidney is both, a consumer and a producer of glucose, it is difficult to 
monitor the involvement of the kidney in glucose handling during different 
metabolic or pathological states. Glucose turnover is 
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defined by the enzyme distribution along the nephron [207-209]. First 
studies involving glucose metabolism on isolated proximal tubuli from Pi 
depleted animals reported that basal gluconeogenesis was diminished 
[210]. 
Recently, a known stress responder, p53, had been determined in relation 
to transitory glucose or ATP depletion [211-212]. In these occasions, p53 
pathway induces antioxidant defences. On the other hand, severe 
oxidative stress leads to p53 dependent cell death and apoptosis. 
However, function of p53 is very versatile and can affect a number of 
different pathways. The microarray data collected after 5 days of dietary Pi 
(also 14 h, see comparison below) reveals that transformation related 
protein 53 binding protein 2 (Trp53bp2) was strongly affected by dietary Pi 
(FC=0.42). Trp53bp related mechanisms will be discussed further below in 
relation to genes that were regulated by “acute” dietary Pi changes.  
 
 
iv) Lipid metabolism 
 
After 5 days of Pi-depletion, several genes involved in lipid metabolism 
were affected. These are: Acot12 (mFC = 0.6), Acot11 (mFC = 1.9), Acot2 
(mFC = 2.6), Acot1 (mFC = 3.4), Acot 3 (mFC = 3.7). These genes encode 
thioesterases, a type of hydrolases responsible for catalysis (hydrolysis) of 
Acyl-CoA to free fatty acids and coenzyme A (CoASH). They contribute to 
the regulation of intracellular availability of Acyl-CoA, CoASH, and free fatty 
acids (see Acyl-CoA thioesterases below). The individual function of each 
thioesterase has not been determined in context of Pi homeostasis. Many 
of these thioesterases have not been characterized and therefore their role 
in lipid metabolism is not well understood. 
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v) Receptor mediated endocytosis and early endosomal trafficking 
 
At the apical site of the proximal tubular cell, two routes for endocytosis 
have been described; receptor mediated- and fluid-phase endocytosis 
[213-214]. It was shown by colocalization of NaPi-2a and megalin, that 
upon PTH stimulation, NaPi-2a is likely to be internalized via receptor 
mediated endocytosis [215]. Shortly after PTH treatment (5 - 15 min), 
colocalization of NaPi-2a with clathrin has been demonstrated, and after 15 
- 30 min this overlap became weaker [215]. The role of megalin, a receptor 
for endocytosis in the proximal tubule for multiple ligands [213-214, 216-
217], seems to be essential at early stages of NaPi-2a endocytosis, since 
loss or reduction of megalin expression affected NaPi-2a internalization 
[216-217]. Further processing of NaPi-2a after endocytosis resulted in the 
colocalization of NaPi-2a with early endosomal antigen 1 (EEA1). 
Interestingly, microarray analysis data revealed an up-regulation of EEA1 
(mFC = 1.6) after 5 days of low Pi-diet. EEA1 binds to phosphatidylinositol-
3 phosphate (PtdIns(3)-P) and colocalizes together with Rab5 on 
endosomes [218-220]. Phosphatidylinositol-3 kinase (PI-(3)K) as well as 
Rab 5 were also up-regulated on the gene list with a 4- and 2-fold increase 
respectively. How these genes are involved in NaPi-2a regulation during 
internalization is unknown.  
Other membrane proteins that have been detected on the list and that may 
be involved in membrane trafficking of NaPi-2a are Syntaxin 6 (mFC = 
1.7), cortactin binding protein 2 (ORF4) (mFC = 5), melanoregulin (Mreg) 
(mFC = 5), Ankyrin repeat and BTB domain protein Abtb2 (mFC = 8), 
Synaptogyrin Syngr2 (mFC = 2) as well as some genes with products 
involved in microtubular association (e.g. microtubule-actin cross-linking 
factor 1 Macf1 (mFC = 1.5) and microtubule associated protein 1, Mapre1 
(mFC = 1.9)).  
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vi) Activation Vitamin D 1α-hydroxylase (Cyp27B1) 
 
The active form of Vitamin D (1α,25-(OH)2 Vitamin D3), is primarily formed 
in the kidney by 1α-hydroxylase (Cyp27B1) that is localized at the inner 
mitochondrial membrane. Among other factors, extracellular concentration 
of Pi is a well established regulator of Cyp27B1. Up-regulation by a LPD of 
Cyp27B1 mRNA levels and enzyme activity has been demonstrated [167, 
171, 176]. Regulation of Cyp27B1 by Pi is independent of PTH and 
requires somatomedins as hypophysectomy blocks stimulation of Cyp27B1 
by LPD [167, 171, 221]. Of interest, although hypophysectomy blocks 
stimulation of Cyp27B1, up-regulation of proximal tubular Na/Pi-cotransport 
by LPD was not affected [167, 171]. These results are also in agreement 
with studies performed with Cyp27B1 knock out mice, which demonstrated 
intact adaptation of Na/Pi-cotransport to LPD [222]. Thus, adaptation of 
renal Na/Pi-cotransport to LPD is independent of increases of active 
Vitamin D3. In agreement with published data [176], gene expression data 
showed a 10-fold increase of Cyp27B1 mRNA after “chronic” intake of a 
LPD. This value was validated in a separate experiment by RT-qPCR. On 
the other hand, despite severe hypophosphatemia, no increase of 
Cyp27B1 mRNA content was detected after 14 h of LPD (see analysis of 
“acute” adaptation). Also this finding was validated by separate 
experiments. Taken together, results obtained with respect to regulation of 
Cyp27B1 were in agreement with published data [176] and suggest that 
the Vitamin D metabolism is not affected acutely by hypophosphatemic 
conditions. Active Vitamin D3, with a half life of 4-6 hours [223], has been 
described as an important stimulator of the secretion of the phosphatonin 
FGF-23 [224]. Thus, a change in the level of FGF-23 by “acute” decreases 
of the extracellular concentration of Pi appears unlikely. On the other hand, 
FGF-23 reduces renal expression of 1α-hydroxylase and increases 
expression of catabolic enzyme 24-hydroxylase resulting in decreased 
circulating active Vitamin D3 and thus phosphaturia [87]. 
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“Acute” (14 hours) effect of LPD on renal gene expression  
 
The data collected during “chronic” (5 days) Pi deprivation indicated a strong impact 
on energy metabolism that indirectly could have affected expression of other genes. 
In order to understand early adaptive mechanisms due to Pi deprivation, a shorter 
period, after administration of a LPD, was investigated. Based on RT-qPCR data 
obtained with selected genes that were regulated under “chronic” Pi depletion 
condition, a minimal time of 14 h after the onset of LPD has been chosen.  
As shown in supplementary table S4, altered expression of 609 genes was detected 
with a statistical significance of p < 0.05. Of these, only those with a fold change 
higher than 50% were used for pathway analysis. These included 228 genes that 
were regulated (130 down- and 98 up-regulated genes). Pathway analysis grouping 
was not as efficient as with the data obtained after 5 days LPD and HPD. However, 
the pathways which mostly seemed to be affected after 14 hours of LPD vs. HPD 
were pointing to ammoniagenesis (and gluconeogenesis), cholesterol biosynthesis 
and lipid metabolism, apoptosis and the senescence pathway. Strikingly, after 14 h of 
LPD, no alteration of expression of genes involved in oxidative phosphorylation was 
detected.  
 
 
i) Ammoniagenesis/Gluconeogenesis 
 
In the PT, gluconeogenesis is closely linked to ammoniagenesis due to 
transformation of glutamine into glutamate and α-ketoglutarate (Figure 38). 
The conversion from glutamine to α-ketoglutarate releases two ammonium 
molecules. Animals that received a LPD, showed reduced expression of the 
Na+-dependent glutamine transporter SLC38A3/SNAT3 (mFC = 0.38). This 
may be connected with the observation that in LPD mice ammonium excretion 
is reduced. In addition to reduced PEPCK (mFC = 0.16) expression, glutamate 
dehydrogenase Glud1 (mFC = 0.5) was also down-regulated after an “acute” 
LPD. Once α-ketoglutarate is converted into malate inside the mitochondria, 
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malate is antiported for citrate via the mitochondrial dicarboxylate transporter 
SLC25A10 [225-226]. SLC25A10 was also shown on the microarray list to be 
down-regulated (mFC = 0.58). 
Down-regulation of this cascade of reactions, leading to the inhibition of 
gluconeogenesis, has been well known to occur during metabolic acidosis 
[192]. However, in association with renal Pi handling, these genes have not 
been put in context until now. It could be that Pi deficiency impairs malate 
export out of the mitochondria therefore causing a negative feedback loop on 
Glud and SNAT3.  
A number of substrates for renal gluconeogenesis have been identified. 
Glycerol for example, has been shown to be unaffected in isolated proximal 
tubules depleted of glucose or Pi [227-228]. The microarray data obtained 
supports this idea during short- and long term Pi deprivation. However, after 5 
days of Pi depletion, a strong down-regulation (mFC”chronic” = 0.5) of SLC37A2 
transporter was detected. SLC37A2 belongs to a sugar-phosphate/ phosphate 
exchanger family [229], which may indicate that this transporter may be 
involved during phosphate depletion. In addition, in “acute” Pi depletion 
glycogen synthase was found to be up-regulated (mFC”acute” = 1.7). Why this 
occurs during Pi depletion, while gluconeogenesis is impaired, is currently 
unknown.   
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Figure 38: Down-regulation of various genes involved in gluconeogenesis and ammoniagenesis due to “acute” Pi 
deficiency. The strong down-regulation of the glutamine transporter SNAT3 (mFC = 0.38) may indicate less 
glutamine uptake into the PT cell. This leads to less substrate availability for the glutamine dehydrogenase (Glud) 
which is down-regulated as well.  
 
 
ii) Cholesterol metabolism 
 
After giving a LPD for 14 h, several genes involved in cholesterol 
metabolism were down-regulated. Previous experiments on NaPi-2a 
showed an inverse correlation of cotransport function with the content of 
cholesterol in the BBM [230-231]. In addition, modification of cholesterol 
content in isolated BBM in-vitro, selectively changed Na/Pi-cotransport 
activity. These studies indicated that cholesterol may have a direct effect 
on Na/Pi-cotransporter activity via alteration of membrane fluidity [232]. 
The microarray data agrees with these observations, as a series of 
enzymes involved in cholesterol metabolism were down-regulated after 
“acute” LPD ingestion (Figure 39). Reduction of 3-hydroxy-3-methyl-
glutaryl-CoA synthetase (HMGCS, mFC = 0.5) and HMGC reductase 
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(HMGCR, mFC = 0.5) prevent the formation of mevalonate. And, the 
conversion of mevalonate into cholesterol is further impaired by a reduction 
of Cyp51 (mFC = 0.5). This suggests that the down-regulation of these 
genes may have a strong impact on cholesterol biosynthesis.  
Earlier data obtained using dexamethasone showed inhibition of NaPi-2a 
cotransporter in the BBM associated with increased amount of 
glucosylceramide [233]. The study shows that renal BBM of rats treated 
with dexamethasone have a 2.5-fold decrease in NaPi-2a expression 
compared to control rats. This transport inhibition appeared to be selective 
since no transport changes of Na-dependent glucose and proline was 
detected after dexamethasone administration [233]. Dexamethasone did 
not significantly change the abundance of cholesterol in the BBM. In 
contrast, glucosylceramide concentration increased significantly in rats 
treated with dexamethasone. Interestingly, the enzyme sphingosine-1 
phosphate phosphatase 1 (SPP1), which is involved in the pathway of 
ceramide synthesis and the production of glucosylceramide, is strongly 
down-regulated (mFC = 0.5) after 14 h of LPD. Taken together, it seems 
likely that Na/Pi-cotransport activity is not solely affected by membrane 
fluidity. Even though changes in membrane composition such as 
cholesterol and glucosylceramide may affect the NaPi-2a cotransporter 
through changes in membrane behaviour, the activity of glucosylceramide 
was also shown to specifically affect the Vmax of the NaPi-2a cotransporter 
[233]. To which extent lipids play a role for NaPi-2a activity in the BBM 
during Pi deficiency, needs more investigation. Based on the microarray 
data collected, the question is raised, whether during a 14 h period of LPD 
an alternative mechanism is activated, since Vitamin D does not respond 
after this short period. By changing membrane lipid composition using 
cholesterol and ceramide derivatives, it seems likely that this response 
may act as a potential physicochemical modulator of NaPi-2a activity by 
affecting membrane fluidity. Eventually, it might be a combination of 
biochemical and physico-chemical properties that change NaPi-2a 
behavior at the BBM.  
113 DISCUSSION 
 
Effects of changes in dietary phosphate on renal gene expression  
 
 
 
Figure 39: Impaired cholesterol synthesis causes disturbances in the membrane fluidity state of the cell. This in 
turn affects NaPi-2 function. In addition to that, cholesterol has been shown to directly affect NaPi-2 function.  
 
 
iii) Apoptosis stimulating factor (ASPP2) and p21 
 
Heat shock proteins (HSPs) can be activated in response to stress 
conditions, such as heat, alcohol, oxidative stress, heavy metals, fever, 
inflammation and inhibitors of energy metabolism. By increasing 
expression, HSPs act to promote cell survival by protecting other less 
stable proteins from proteolysis or disaggregation [234-236]. When HSPs 
are not stimulated by stress, they have other multiple “housekeeping” 
functions, such as assisting translocation of newly synthesized proteins 
into the nucleus, activating regulatory proteins (e.g. transcription factors), 
control protein degradation, signalling, and antigen presentation [237-238]. 
The overall function for HSPs was summarized as a “molecular 
chaperone”, a protein assisting other proteins in their process of folding or 
cellular maturation. As mentioned before, HSPs can modulate transcription 
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factors, such as p53 which is a transcriptional activator involved in tumour 
suppression, known to bind specifically to double stranded DNA. Hsp40 
has been studied lately with immunoprecipitation methods and was found 
to be a key factor in recruiting other chaperones (Hsp70 and Hsp90) to p53 
(Figure 40). Moreover, Hsp40 contains a J domain, responsible for 
regulating the ATPase activity of Hsp70 when binding to p53 [239]. While 
Hsp40 is able to bind p53 in absence of Hsp70 or ATP, Hsp70 is unable to 
form a complex with p53 in absence of Hsp40, unless a glutaraldehyde 
cross-linker is used [240]. This indicates that the interaction of p53 with 
Hsp70 is weak and its complex formation is driven by interaction with 
Hsp40. In this study, Hsp40 was found to be down-regulated in LPD kidney 
(mFC”acute” = 0.7, mFC”chronic” = 0.6). Under normal conditions, p53 has a low 
expression level but when stress signals are present (e.g. radiation, heat, 
hypoxia, inhibition of RNA synthesis through metabolites, heat shock, low 
extracellular pH, DNA damage), p53 is activated and induces cell cycle 
arrest. Many studies have demonstrated loss of p53 function in tumour 
cells due to mutations, where cells were growing indefinitely [241-243]. In 
35-40% of all cancers, p53 is mutated. p53 can act either to promote cell 
cycle arrest or apoptosis. Which of the two pathways is finally chosen is not 
known. However, there are certain co-transcriptional factors that guide p53 
to choose either one or the other [244-245]. p53 activity was shown to be 
regulated by post-translational modifications and also through post-
transcriptional regulation, explaining the absence of mRNA changes [246-
247] (as observed in some cases for NaPi-2a). Therefore, protein 
associations with p53 can modulate its activity. One of the binding proteins 
is the apoptosis stimulating p53 protein (ASPP2/TB53bp2), which was 
found on the microarray list to be down-regulated in LPD kidney (mFC”acute” 
= 0.6, mFC”chronic” = 0.4). Upon UV irradiation of MCF-7 cells, p53 
association with ASPP2 was observed to increase 3.4-fold [248]. 
Interestingly, ASPP2 did not bind to mutated p53 and therefore apoptosis 
was not observed in these cells. This may explain the aggressiveness of 
cancers associated with p53 mutations, where ASPP2 is unable to 
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stimulate cell apoptosis [248]. When Saos-2 cells were transfected with 
p53, 17% of the cell population died through apoptosis. In contrast, when 
these cells were cotransfected with p53 and ASPP2 together, apoptosis 
was observed in 50% of the cell population [248]. Therefore, it seems that 
ASPP2 specifically enhances the apoptotic function of p53. The exact 
molecular mechanism how p53 and ASPP2 interact to stimulate apoptosis 
is not well established at the moment.  p53 mediates transient or 
irreversible cell cycle arrest in the transitional phase G1 to S of cell 
replication, it then transcriptionally activates factors, such as the cyclin 
dependent kinases p16 and p21 [249]. p21/WAF1, known as the cyclin-
dependent kinase inhibitor 1 or CDK-interacting protein 1, was originally 
found to bind and inhibit the activity of cyclin-CDK2 and –CDK4 complexes, 
therefore functioning as a regulator in the cell cycle progression at G1 
[250]. This regulation is tightly controlled by p53 activity [250]. In this study, 
p21 was up-regulated after 14 hours of LPD (mFC”acute” = 1.5) which may 
indicate that cell cycle arrest is inhibited by reduced amount of ASPP2 
allowing p21 transcription by p53. Interestingly, a study involving dietary Pi 
demonstrated how p21 mRNA expression level increased (2-3 fold) in rat 
parathyroid glands 2 days after receiving a LPD (compared to HPD rats) 
[251]. Increased expression levels of p21 may therefore be an indicator of 
hypophosphatemia. Since the kidney and the parathyroid cells both 
increase expression of p21 after a LPD, Pi homeostasis could be linked to 
the regulation of p21.  
In summary, Pi deficiency in mice observed in this study causes ASPP2 
down-regulation, which further prevents association with p53 to cause 
apoptosis. Also, Hsp40 is down-regulated, not able to form a complex with 
p53. p53 may then bind to the p21 promoter to initiate transcription. An 
increased binding (2.2-fold) of p53 to p21 promoter was also observed in 
studies where cells where irradiated with UV light [248]. 
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Figure 40. An overview of HSPs that participate in trafficking from and to the nucleus with p53 activity involved in 
p21 transcription. Image taken from [252]. 
 
 
iv) NaPi-2a mRNA interaction with p21 and Cyclin D1 
 
Up-regulation of NaPi-2a cotransporter in the BBM as soon as two hours 
after LPD administration has suggested the existence of pre-formed NaPi-
2a localized in endosomes and targeted to the apical membrane by a 
microtubular transport mechanism [253-254]. Even though NaPi-2a 
cotransporter presence is increased at the BBM [106], changes in mRNA 
levels have been controversial. Thus, while some observations confirm 
increases in mRNA levels during “chronic” hypophosphatemia [255],  
others, including this study, have not. The adaptive response to 
extracellular Pi deprivation in OK cells has shown no changes in mRNA 
abundance for the first two hours. This suggests a post-translational 
regulation of NaPi-2a that may be responsible for the presence at the BBM, 
independently of mRNA synthesis or regulation. However, following this 
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early adaptive response, a delayed effect on NaPi-2a expression was 
associated with an increase of mRNA abundance in these cells [256-257]. 
The data collected with RT-qPCR in this study shows a significant increase 
in NaPi-2c mRNA after “chronic” LPD and no significant change of NaPi-2a 
mRNA. However, in this study, no changes were observed for either NaPi-
2a or NaPi-2c on the microarray list, neither after 5 days nor after 14 hours 
of LPD.  
For correct regulation of NaPi-2a at the apical membrane of the proximal 
tubule, it is necessary to control the recruitment and the breakdown of the 
transporter in response to Pi [106, 145]. In-vivo studies in rats have shown 
post-transcriptional regulation of NaPi-2a [257-258]. NaPi-2a mRNA 
contains a cis-acting element at the junction of the coding, and the 3„-
untranslated region (UTR), that interacts with trans-acting proteins (e.g. 
p21, cyclin D). These proteins may be involved in the regulation and 
translation of NaPi-2a mRNA in response to dietary Pi [259]. On the other 
hand, a number of binding proteins have been identified that may 
contribute to either the apical distribution of NaPi-2a protein or its sub 
apical/lysosomal traffick. These are PDZ proteins such as NHERF, as well 
as AKAP and PEX19, the latter a protein that may be actively involved in 
controlling the internalization of NaPi-2a from the BBM [128, 130, 260]. 
Recent studies have also revealed calcineurin Aβ to be involved in renal Pi 
homeostasis [261]. Calcineurin inhibitor cyclosporin A (CsA) decreased 
NaPi-2a mRNA levels in in-vivo kidneys from animals fed LPD and in in-
vitro cells that were grown in low-Pi medium. Also, calcineurin gene 
deletion caused decrease in NaPi-2a expression and further LPD 
administration did not result in increased expression of NaPi-2a [261]. This 
response was specific for NaPi-2a, because Vitamin D 1α- hydroxylase 
increased upon LPD administration [261].  
It is likely that post-transcriptional regulation is mediated by proteins that 
can interact with target mRNA sequences. Binding of regulatory proteins to 
the 5‟-UTR region of the mRNA is often associated with a translational role. 
To see whether binding proteins exist for NaPi-2a, a radioactively labelled 
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assay riboprobe study was conducted from rats treated with LPD and HPD 
[258]. Isolated 3‟ and 5‟ UTR ends were tested for binding sites of proteins. 
Proteins isolated from rat kidney cortex (e.g. PTH, p21, and cyclin D1) 
were shown to compete for 5‟ UTR binding region of NaPi-2a mRNA 
suggesting possible regulation. These proteins demonstrated an increased 
affinity for the 5‟-UTR of NaPi-2a during hypophosphatemia. As mentioned 
earlier, p21 (mFC”acute” = 1.5) had been detected in relation with p53. 
Interestingly, cyclin D1 was also up-regulated at a later stage (mFC”chronic” = 
1.8) suggesting a regulatory role for the translation of NaPi-2a mRNA.  
A new role of p21 and cyclin D to control translation of NaPi-2a mRNA may 
explain the insignificant differences observed in NaPi-2a mRNA levels after 
administration of LPD and HPD. When p53 is assembled as a tetramer 
inside the nucleus, it promotes the transcription of p21 (mFC”acute” = 1.5). 
Down-regulation of Hsp40, as observed in this study (mFC”acute” = 0.7, 
mFC”chronic” = 0.6), could indicate that Hsp40 cannot act with its ATPase 
activity on Hsc70 to disassemble the p53 tetramer and therefore prevents 
its export from the nucleus. This would be consistent with the up-regulation 
of p21 after a LPD. Down-regulation of ASPP2 (mFC”acute” = 0.6, mFC”chronic” 
= 0.4) would prevent the cell from apoptosis.  
There is evidence that aging is affected during Pi deprivation. Aging is a 
fundamental process in all organisms ranging from yeast to mammals. 
Klotho was discovered nearly 15 years ago as a novel gene which has 
been associated with Pi, calcium and Vitamin D metabolism [262].  
Mutations of klotho, resulting in loss of function, were associated with 
hyperphosphatemia, hypervitaminosis D and accelerated senescence 
[262]. In contrast, over-expression of klotho extended life span of mice and 
reduced damage done by oxidative stress [263-264]. The human klotho 
gene encodes a type 1 membrane protein with a putative signal sequence 
at its N-terminal, anchored at its C-terminal to the membrane [265]. Klotho 
has been localized to the renal distal convoluted tubule, the choroid plexus 
of brain epithelia, and the parathyroid gland [266]. A soluble form of klotho 
has been described [266]. Whether this soluble fraction is of the same 
119 DISCUSSION 
 
Effects of changes in dietary phosphate on renal gene expression  
 
functional importance as its membrane bound form or not, is unknown to 
date. FGF-23 ablated mice are phenotypically very similar to the klotho-/- 
mice. This raises the question whether both share the same molecular 
pathways. Knock-down (RNAi) of klotho in human cells has shown an 
increase in p21. These cells were analyzed for their different cell cycle 
phases and determined that the klotho RNAi cells are arrested at G1/S 
boundary of their cell cycle. Further, early senescence has been shown to 
be dependent on p53 activity which results in the up-regulation of the p21 
regulatory factor [267]. Klotho may have the ability to control senescence 
and apoptosis by regulating p53 action by mechanisms yet to be identified.  
Taken together, elevated p21 may directly modulate translation of NaPi-2a 
mRNA and act to promote senescence via the klotho and p53 pathway 
during hyphosphatemia. Which of the two pathways is a consequence of Pi 
deprivation is currently unknown. Since both, NaPi-2a and klotho have 
been described in context of Pi homeostasis, it is reasonable to think that 
p21 has been activated to promote both NaPi-2a mRNA binding and p53-
dependent senescence.  
 
 
Comparison between 5 days and 14 hours Pi deprivation 
 
Comparison of gene expression after a low Pi-diet of 5 days to gene expression after 
14 h revealed a number of common genes shared during dietary Pi deprivation. In 
this study, gene lists were compared on the significance level of p < 0.01. Most of 
these genes could not be identified after chronic low Pi-diet, suggesting a transient 
effect that is caused after an “acute” low Pi-diet period. In Table 11, genes that were 
affected by low Pi-diet, both after 14 h and 5 days, are listed. Two genes encode 
SLC transporters. These are, the unknown transporter SLC16A14/MCT14 (mFC”acute” 
= 0.23 and mFC”chronic” = 0.21) which belongs to the monocarboxylate transporter 
family (see below characterization of SLC16A14/MCT14), and SLC25a36 (mFC”acute” 
= 1.9 and mFC”chronic” = 2.6) also of unknown function.  
120 DISCUSSION 
 
Effects of changes in dietary phosphate on renal gene expression  
 
Table 11. Genes regulated by dietary Pi after 14 hours and 5 days (p < 0.01) 
    
Gene Description FC “acute” FC “chronic” 
    
Pepck Phosphoenolpyruvate carboxykinase 1, cytosolic 
 
0.16 0.43 
Fkbp51 FK506 binding protein 5 0.19 0.50 
SLC16A14/MCT14 Family member of the monocarboxylate transporters (see below) 0.23 0.21 
Aacs Acetoacetyl-CoA synthetase 0.45 0.56 
Cckar Cholecystokinin A receptor 0.45 0.51 
Syngr2 Synaptogyrin 2 0.53 0.51 
AI314027 Expressed sequence AI314027 0.56 0.53 
Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 0.60 0.69 
Trp53bp2 Transformation related protein 53 binding protein 2 
 
0.61 0.42 
Tyms Thymidylate synthase 0.63 0.64 
Spsb4 SplA/ryanodine receptor domain and SOCS box containing 4 1.6 2.5 
Itgb6 Integrin beta 6 1.6 2.7 
Lrat Lecithin-retinol acyltransferase 1.6 3.4 
Olfm3 Olfactomedin 3 1.7 4.2 
Acot1 Acyl-CoA thioesterase 1 1.8 3.4 
Jub Ajuba 1.7 1.9 
SLC25A36 Solute carrier family 25, member 36 (mitochondrial pyruvate carrier) 1.9 2.6 
Tln2 Talin 2 1.9 2.1 
Acot11 Acyl-CoA thioesterase 11 2.1 1.8 
Gimap8 GTPase, IMAP family member 8 1.5 2.2 
Omd Osteomodulin 3.2 1.6 
 
Some of the selected genes listed in Table 11 will be discussed in more detail below: 
 
 
 
 
 
 
 
 
 
 
 
 
121 DISCUSSION 
 
Effects of changes in dietary phosphate on renal gene expression  
 
FK506 binding protein 51 (FKBP51) 
 
FKBP51, has been shown to inhibit calcineurin in previous studies using in-vitro 
experiments [268]. FKBP51 was first discovered and identified in context with the 
progesterone receptor (PR) and shows a 60% sequence identity with FKBP52 [269-
270]. In contrast to FKBP52, FKBP51 can bind to calcineurin independently from 
Ca2+ and FK506. Also, FKBP51 has the ability to be induced by heat in contrast to 
FKBP52 [268]. Both, FKBP51 and FKBP52, bind with their TPR domain to Hsp90 
(see above Apoptosis and senescence), whereas the C-terminal end of FKBP51 
enhances binding affinity to Hsp90 while the same C-terminal end of FKBP52 
decreases binding affinity to Hsp90 [271-272].  
Members of the FKBP family are intracellular enzymes that catalyze isomerizations of 
the peptidyl-proline bonds from cis to trans conformations in peptides and proteins. 
They have been shown to bind immunosuppressive drugs rapamycin (RAP) and 
FK506 [273-275]. First studies in immunology revealed, that the complex of FKBP 
and FK506 can bind and exhibit inhibition of calcineurin [276]. The participation of 
FKBP51 in phosphate homeostasis and the importance in regulation of calcineurin 
and NaPi-2a needs to be investigated further. 
 
 
Cholecystokinin type A receptor (CCKAR) 
 
The CCK receptors belong to the large family of GPCRs which are widely distributed 
in the organism [277]. The receptors for cholecystokinin (CCK) and other CCK-like 
peptides were first classified in acinar cells of the pancreas and named CCK type A 
receptors (CCKAR) [277]. Shortly thereafter, another receptor was identified in the 
brain with a different pharmacology, the CCK type B receptor. These two were mainly 
distinguished by their affinity for the agonist CCK and gastrin which share the same 
COOH-terminal but differ in sulphation of some amino acids in their peptide 
sequence. CCKAR is highly selective (500-1000 fold) for sulfated CCK analogs 
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whereas CCKBR has similar high affinity for sulfated and non-sulfated agonist 
peptides [277]. 
CCK release in the small intestine causes satiating effects in many species, also in 
humans. Even though cholecystokinin has been mostly related to pancreatic activity 
and intestinal bile secretion, other functions related to the kidney had been 
documented as well [278]. Nearly 25 years ago, a study with rabbits that were 
injected with CCK-8 in the renal artery presented a log-dose dependent increase in 
fractional sodium excretion and a log-dose dependent decrease in the fractional 
excretion of calcium and magnesium [278]. More detailed study of calcium 
distribution in the rabbit tissues showed a clear accumulation of calcium in the kidney 
and skeletal muscle upon CCK-8 infusion [278]. Moreover, CCK has been shown to 
activate calcineurin signaling, both in-vitro and in-vivo [279].   
Microarray data obtained after both, “chronic” and “acute” Pi deprivation indicated a 
stable down-regulation of CCKAR (mFC”acute” = 0.45, mFC”chronic” = 0.51). It may be 
that the down-regulation of this G protein coupled receptor inhibits a pathway 
involved in Pi regulation. Whether there is a direct interaction of this receptor with 
dietary Pi or other factors involved in Pi homeostasis remains to be elucidated. More 
studies are required to see whether CCK or CCK like peptides can bind to CCKAR in 
the kidney and may be involved in renal regulation of Pi transport. 
 
 
Acyl-CoA thioesterases (Acot1 and Acot11) 
 
Acyl-CoA thioesterases (Acots) hydrolyze activated long- or short-chain fatty acids, 
saturated or poly-unsaturated, into non-esterified fatty acids and Coenzyme A 
(CoASH) [280]. In higher organisms, they are confined to the mitochondria, 
endoplasmic reticulum, peroxisomes and the cytosol. A wide range of tissues have 
been shown to contain these hydrolases, such as the brain, liver, heart, lung, kidney, 
steroidogenic and brown adipose tissue (BAT) [281]. The Acots have been grouped 
into two classes (type I and type II) which are determined by their molecular weight 
as well as by their different sequence similarity. “Acute” and “chronic” dietary Pi 
changes both increased gene expression of Acot1 and Acot11 (see Table 11).  
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Acot 1: 
 
This thioesterase belongs to the group I and is mainly expressed in the 
cytosol. It has been most extensively studied in the rat liver [282-285], but its 
presence has also been documented in other tissues, such as the heart, 
kidney, brain, and testis [285-286]. Acot1 is responsible for catalyzing long-
chain saturated fatty acyl-CoA esters. Usually, this enzyme is weakly 
expressed, but exogenous administration of peroxisome proliferating agents 
caused higher expression [282, 284-285]. Moreover, fasting and diabetes 
have both been shown to increase gene expression of Acot1 [282]. Detailed 
localization studies using Western blotting of Acot1 in the kidney revealed that 
its presence was mainly confined to the peroxisomal proximal tubular sites 
and other intrarenal sites involved in β-oxidation. In-situ hybridization 
suggested colocalization of Acot1 with Acot2 [286].  
 
Acot11: 
 
Acot11, a group II thioesterase, has been shown to be induced in brown 
adipose tissue of mice upon exposure to low temperatures. High 
temperatures however, have been associated with repression of Acot11 gene 
expression [287]. Thermogenesis involves the up-regulation of UCP1, also 
called thermogenin, which is involved in uncoupling oxidative phosphorylation 
from the proton motive force. This results in heat generation when energy is 
released from the oxidation of NADH instead of participating as part of the 
electron flow and generation of ATP. Therefore, up-regulation of Acot11 can 
serve various purposes; it can cause and increase in non-esterified fatty acids 
available to avoid UCP1 inhibition, it may serve to lower levels of esterified 
fatty acids therefore slowing β-oxidation and ATP generation, and it could 
modulate mitochondrial availability of CoASH [287]. Acot11 has been linked to 
obesity, where obesity-resistant mice have a two-fold increase of Acot11 
mRNA as compared to mice that are susceptible to become obese. Nothing is 
known about the localization of Acot11. However, Acot11 is likely to be 
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present in the kidney since the microarray data collected in this study indicate 
an altered expression pattern after a LPD for both time periods (14 hours and 
5 days). 
 
β-oxidation is a process essential for cellular activity. Fatty acids are degraded within 
the mitochondria and peroxisomes to provide the energy required for cellular 
processes. When pristanoyl-CoA is oxidized to propionyl-CoA it can be further 
oxidized to succinyl-CoA in the mitochondria. Since propionyl-CoA is only slowly 
metabolized to succinyl-CoA, any disturbance in this reaction may result in metabolite 
accumulation within the cells and thereby impair metabolism [288-289] (Figure 41). 
An autosomal recessive metabolic disorder has been described involving the 
methylmalonyl-CoA mutase [290-292]. Mutation of this enzyme, responsible for 
succinyl-CoA synthesis, can lead to methylmalonic-aciduria [293]. This disorder is 
frequently diagnosed in early neonatal period, and symptoms observed are 
progressive encephalopathy, secondary hyperammonemia, and eventually death if 
left untreated [290].  
Acots are involved in a variety of biological processes. Apart from β-oxidation, they 
have also been documented to regulate lipid biosynthesis (using an allosteric 
negative feedback of acetyl-CoA carboxylase [294] and fatty acid synthase), ion 
channel activity, signal transduction, fusion and budding of intracellular membranes, 
and gene transcription activity via nuclear receptors [289]. The energy status of the 
cell may be the key factor regulating the activity of Acots. Substrate inhibition had 
been documented for Acot1 where 5-10 μM of long chain CoA substrates in mice 
impaired its activity.  
The increased activity of Acot1 and Acot11 after dietary Pi restrictions, as soon as 14 
h and prolonging over 5 days, may be an alternative pathway to supply ATP since 
other ATP supplying pathways (e.g. gluconeogenesis, glycolysis) are inhibited. 
Whether Acots are directly influenced by Pi homeostasis or are involved in the 
regulation of Na/Pi-cotransport cannot be determined for now.  
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Figure 41. An alternative pathway for gluconeogenesis through β-oxidation of propionyl-CoA. Methylmalonyl-
CoA, formed as an intermediate during the oxidation, can also be produced during catabolism of branched 
chained amino acids. Deficiencies in Vitamin B12 or mutations in methylmalonyl-CoA mutase cause 
methylmalonic-aciduria.  
 
 
Osteomodulin/Osteoadherin (Omd) 
 
Osteomodulin, a member of the small leucine-rich repeat (SLRP) family, has been 
recently described as a proteoglycan present in mineralized tissue, such as bone and 
teeth [295-299]. Over the past decade, new SLRP family members were found and 
momentarily are composed of 17 genes [300-303]. Not all of them are true 
proteoglycans, some of them have a glycosaminoglycan side chain and are therefore 
functionally related. Currently they have been further grouped into five different 
classes depending on their chromosome location, the presence of N-terminal Cys-
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rich domains with defined spacing, and their conservation and homology at the 
protein and genomic levels.  
Omd belongs to the class II of SLRPs and has been mostly related to mature 
osteoblasts where its secretion into the bone matrix is involved in mineralization [295, 
297, 304-306]. Most of core protein of Omd comprises the leucine-rich repeat (LRR) 
sequence, while the acidic C-terminus most likely allows binding to hydroxyapatite 
mineral in the bone matrix [299]. Therefore, it is suggested that Omd functions partly 
as a bridging protein where cells bind to their extracellular matrix (ECM) of bone. 
Another member of the SLRP class II is decorin, which has been shown to signal via 
the LRR motif. This may imply that LRR motif containing proteins, such as 
osteomodulin, are part of signalling cascades [297]. 
The microarray data obtained after 14 h and 5 days low vs. high Pi diet clearly show 
an up-regulation of osteomodulin (mFC”acute” = 3.2,  mFC”chronic” = 1.6), which was 
independently supported by RT-qPCR (see Results). This data may feed the idea 
that osteomodulin may not just be restricted to mineralized tissue after all.  However, 
it is not possible to determine to which extent osteomodulin plays a role in 
maintaining Pi homeostasis. Preliminary data obtained by Western blot analysis 
using kidney homogenate incubated with anti-osteomodulin antibody presented a 
difference in protein abundance between low and high Pi-diet animals (data not 
shown), nevertheless this experiment was not re-validated and therefore needs to be 
repeated.  
 
 
Integrin beta 6 and Talin  
 
The cell maintains its shape with the help of various cytoskeletal proteins that are 
present at the cell membrane and in the cytosol. Moreover, a physical and dynamic 
connection between the cytosol and the membrane is constitutively present and 
regulates cell migration and adhesion besides structural properties [307]. Talin, a 
cytoskeletal associated protein, is composed of a globular N-terminal domain with 
~200 residues that are similar to the membrane N-terminal binding domain of the 
ERM (ezrin-radixin-moesin) family of proteins. Unlike the ERM family members that 
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attach to cytoplasmic tails of membrane proteins through their N-terminal site, talin 
binds to integrins with its C-terminal rod-shaped-like structure, while its N-terminal 
site attaches to actin filaments [307]. Direct interactions between the cytoplasmic tail 
of β-integrin and talin have been experimentally confirmed with site directed 
mutations of their binding motifs [307].  
Talin and β-integrin 6 were both regulated after a 14 h and 5 days of low vs. high Pi-
diet. The microarray lists show a clear up-regulation of both, Integrin beta 6 
(mFC”acute” = 1.6,  mFC”chronic” = 2.7) and talin (mFC”acute” = 1.9,  mFC”chronic” = 2.1).  
 
 
SLC16A14/MCT14  
 
The monocarboxylate transporter family SLC16A14/MCT14 is composed of 14 
isoformes [199]. Initially, it was thought that lactate and pyruvate were carried by non-
ionic diffusion through the plasma membrane, but when applying α-cyano-4-
hydroxycinnamate (CHC) and organomercurials, the translocation in erythrocytes 
was inhibited [308-309]. After extensive characterization of the MCTs in erythrocytes, 
hepatocytes, and cardiac myocytes, it was proposed that a new family of MCTs could 
exist [309]. MCT1 was first characterized by specific labelling studies in rat and rabbit 
erythrocytes, and was therefore purified and sequenced. Further on, it was shown 
that the wild-type protein, catalyzed proton dependent pyruvate and lactate transport 
activity [310]. Garcia proceeded to clone the human MCT1 transporter [311] and after 
screening a rat liver cDNA library, a related protein, MCT2 was found to be highly 
expressed in the liver [312]. X-chromosome inactivation studies had revealed another 
MCT transporter, MCT8 which was originally called XPCT for X-linked, proline, 
glutamic acid, serine, threonine (PEST)-containing transporter [313]. MCT3 was 
detected in retinal pigmental epithelium of chicken and others (MCT4-7) were 
identified as well in the same laboratory [314-316]. Another isoform of the MCT family 
was very recently identified as a sodium- and proton-independent amino acid 
transporter called TAT1 [317]. MCT9 as well as MCT11-14 have all been identified on 
genetic sequence level through human genomic expressed sequence tag (EST) 
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database [199], but they have not been characterized in terms of their transport 
function. 
In this study, SLC16A14/MCT14 was identified as a protein regulated by dietary Pi 
after 14 h and 5 days. Its distribution in the mouse was determined by screening 
different tissues using RT-qPCR. Results obtained, indicate the highest presence of 
gene expression in the kidney, 10 to 12 fold higher than in the pancreas and the 
testis. Expression of SLC16A14/MCT14 in the epididymis, the vesicular and the 
salivary glands was 40- to 50-fold less compared to the expression levels in the 
kidney.  
Regulation of SLC16A14/MCT14 mRNA after 14 h of LPD may suggest modulation 
of the transporter by dietary Pi. Unfortunately, in-situ hybridization experiments did 
not reveal the presence of SLC16A14/MCT14 mRNA. In addition, mRNA 
quantification of selected nephron segments indicated a low mRNA presence in the 
TAL, whereas no mRNA was detected in the PT. In addition to RT-qPCR, Western 
blot anaylsis and immunohistochemical studies indicated a regulation of 
SLC16A14/MCT14 protein by changes in dietary Pi after both periods. Immunoblots 
revealed no change in regulation after 3 h of LPD. However, after 14 h, and 
prolonged over 5 days of LPD, a significant difference was observed. When 
SLC16A14/MCT14 protein was studied by immunohistochemical studies in NPD 
mice, it was shown to be evenly distributed along the TAL and the regions of the 
macula densa. However, after the administration of Pi diets, SLC16A14/MCT14 was 
shown to be regulated in the proximal tubule. Moreover after 14 h of LPD decreased 
abundance was detected in the PT when compared to the high expression of the 
transporter in the PT of HPD mice. Interestingly, the TAL was not targeted by 
changes in dietary Pi as much as the PT. Furthermore, the cellular distribution of 
SLC16A14/MCT14 changed in HPD mice upon receiving a LPD for 14 h or 5 days. 
Those mice that received a HPD presented strong expression of SLC16A14/MCT14 
in the BBM of the proximal tubules. However, after a 14 h LPD period the transporter 
was detected no longer at the BBM, but rather in the sub apical regions of the 
membrane. This difference was also observed after “chronic” administration but not 
as pronounced as after the “acute” treatment.  
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Taken together, although transcriptional regulation exists for SLC16A14/MCT14, as 
detected by RT-qPCR and microarray analysis, immunofluorescence data for 
SLC16A14/MCT14 indicates that the transporter may also be regulated on protein 
level (post-translational). Overall, mRNA levels for SLC16A14/MCT14 measured 
were low, and translocation of the transporter protein away from renal BBMs as early 
as 14 h after LPD was visually assessed by immunofluorescence.  
SLC16A14/MCT14 was shown in this study to respond to dietary Pi as early as 14 h 
after a LPD administration. The mechanism of action is independent of the Vitamin D 
metabolism, since the 1α-hydroxylase was not regulated after 14 hours of LPD. 
Whether the mechanism of response of SLC16A14/MCT14 after 14 hours is the 
same as after 5 days, or another mechanism is involved (e.g Vitamin D) cannot be 
determined for now.  
Transport studies obtained with oocytes expressing SLC16A14/MCT14 indicate that 
this carrier may be involved in renal amino acid handling. However, a link between 
dietary Pi changes and amino acid transport changes has not been established to 
date. Apparently the function for SLC16A14/MCT14 is very specific to the kidney, as 
its expression is rather restricted to this organ. This may be important to understand 
the renal adaptation of SLC16A14/MCT14 to dietary Pi changes for two reasons: first, 
the SLC16A14/MCT14 abundance (mRNA and protein) is regulated as early as 14 h 
after LPD administration, indicating that its involvement in renal Pi handling is likely. 
Second; the effect of LPD on the kidney, causes a sudden (14 h after LPD) decrease 
in SLC16A14/MCT14 abundance in the PT shown by transporter internalization. On 
the other hand, HPD animals present SLC16A14/MCT14 highly abundant in the BBM 
of the PT, suggesting that SLC16A14/MCT14 is not only regulated on the level of the 
kidney, but also on the level of the nephron.  
Other MCT members have been previously described to interact with the chaperone 
CD147 in order to enhance their stability [199]. However, CD147 did not enhance 
lactate transport in SLC16A14/MCT14 expressing oocytes. A number of amino acids 
had been transported by SLC16A14/MCT14. L-Alanine, L-Methionine, and L-
Glutamate all were transported by SLC16A14/MCT14. It cannot be excluded that 
other substrates, such as mono- di- or tricarboxylates are substrates for 
SLC16A14/MCT14. Also, no difference in L-Alanine uptake was observed in 
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SLC16A14/MCT14 expressing oocytes when compared to oocytes that co-expressed 
the transporter with CD147 (data not shown). More experiments are required to 
characterize SLC16A14/MCT14 fully and therefore understand its role in the kidney 
as well as its role in Pi homeostasis.  
 
 
Outlook 
 
The results obtained by microarray analysis reveal new insights related to renal gene 
expression during dietary Pi deprivation. However, many of these genes have not 
been previously associated with Pi, neither have they been identified in the kidney. 
Osteomodulin, as its name indicates, could eventually link dietary Pi, skeletogenesis 
and renal adaptation to low Pi-diet intake. Also, CCKAR had not been previously 
detected in the kidney, but it may play a currently unknown regulatory role in Pi 
reabsorption. Others, like cholesterol or calcineurin, have already been associated 
with changes in dietary Pi.  In addition, the role of p53, p21 and klotho is not clear 
and could help understand senescence related to changes in dietary Pi. Future 
studies will shed light on this factors and their possible role in Pi homeostasis. 
Interestingly, different mechanisms of adaptation after 14 h and 5 days of Pi 
deficiency appear to exist. It would be interesting to understand the mechanisms of 
adaptation during dietary Pi deficiency in context of “chronic” and “acute” LPD. Also, 
further investigation would be necessary to identify the role of SLC16A14/MCT14 
during dietary Pi changes leading to the regulation (on mRNA and protein level) of 
this transporter. SLC16A14/MCT14 was localized partly in the basolateral membrane 
of the cortical collecting ducts. This and other experimental findings need to be 
repeated in independent studies to characterize the transporter fully. Previous 
microarray experiments using isolated proximal tubular total RNA [192] shows the 
regulation of SLC16A14/MCT14 by metabolic acidosis. Therefore different metabolic 
states (i.e. metabolic acidosis and low Pi-diet) seem to affect expression level of 
SLC16A14/MCT14 in the proximal tubule and the TAL. 
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